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Supporting information sharing in families at-risk of bowel cancer 
through a secure website 
Selina Goodman 
Background: Bowel cancer is a significant health threat as it is the third most 
commonly diagnosed cancer worldwide. Screening can detect tumours early, thus 
allowing treatment to reduce morbidity and mortality. However, many relatives who 
share a high lifetime risk of bowel cancer remain unaware of their familial diagnosis 
and so are unable to access genetic testing or screening. Providing family letters and 
verbal recommendations to patients diagnosed with a vulnerability to bowel cancer 
has not been sufficient to support effective communication in these families. Little is 
known about how electronic methods of communication could be used to facilitate 
communication in families affected by a genetic vulnerability to cancer.  
Aim: To investigate whether a secure website could support families with an 
increased risk of bowel cancer to share information with their relatives.  
Methods: A pragmatic mixed methods approach with four phases was used. 
First, patients at high risk of bowel cancer who had been advised to have regular 
colonoscopy were invited to participate in an anonymous cross-sectional survey 
administered online and through NHS clinical services (n=286). Second, more in depth 
qualitative data were elicited through telephone interviews with a purposive sample 
of volunteers (n=14). Third, a secure website was designed to help relatives share 
sensitive documents online, with content informed by the experiences and views of 
survey and interview participants. Fourth, reactions to the website from 12 volunteers 
were elicited through three phases of video recorded Think-Aloud interviews, which 
guided further refinement of the website.  
 Findings: The survey showed that: 43% of those at risk were first informed of 
the familial diagnosis by their relatives. The majority of participants needed much 
more practical information after learning they had an increased risk of cancer. Key 
issues were: a healthy lifestyle, genetic testing, bowel surveillance and talking to 
children. These topics were endorsed in the interviews, which also identified four main 
themes: impact of the genetic diagnosis; the need for practical information; the 
importance of adaptation to sharing information; and appropriate communication in 
contacts with relatives. Reactions to the website were positive; access to tailored 
information, plus the opportunity to store and share personal information were all 
welcomed.  
 Conclusion: A personalised web-based information resource and document 
sharing facility like www.familyweb.org/ could improve health communication within 
families. It requires further research to confirm that it is effective in practice. Such 
innovations could help improve early detection and treatment though increased 
awareness of familial cancer risk. Patients need more support from health 
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Chapter One  
Genetic predisposition to cancer 
 
1.1 Introduction 
Cancer is a significant health problem, with an estimated 14.1 million new cases 
worldwide in 2012 alone (Torre et al., 2016). While cancer can affect anyone, it is now 
well recognised that a subset of cancers arise due to inherited genetic vulnerability 
(Vogelstein & Kinzler, 2004). Those individuals who have inherited a susceptibility to 
cancer may benefit by receiving surveillance or prophylactic surgery to reduce their 
likelihood of developing a malignancy or to detect the cancer early and thereby lessen 
morbidity and mortality of, for example, thyroid cancer, breast cancer or colon cancer 
(Domchek et al., 2010; Guillem et al., 2006; Jarvinen et al., 2000). People with such an 
increased risk, if not already affected by cancer, would usually learn of their risk 
through their family (Gilbar et al., 2016; Stol et al., 2010).  However, evidence suggests 
that a substantial proportion of those ‘at risk’ relatives remain unaware of their 
potential genetic susceptibility (Hodgson et al., 2014; Sharaf et al., 2013) and are 
therefore unable to access screening or take steps to reduce their likelihood of cancer.  
Attention therefore needs to be given to identifying how more people with such a 
predisposition can be forewarned of their risk and given the opportunity to seek 
advice and have appropriate cancer surveillance.  In this chapter, I will present 
evidence to demonstrate how significant this problem is, how people at risk are 
currently identified and why further research is needed in this area. In addition, I will 




In the following chapter I will look in more detail at issues of communication in 
families affected with a genetic condition, what motivates patients to share 
information with their relatives and how new technology could help in the process of 
disclosure. In the subsequent chapter I will describe the systematic review I carried out 
to find out if there was any evidence around the use of email or websites to share 
confidential health information securely within families. Then I explain the research 
methods I used to find out about patients’ experiences of sharing information within 
their families in Chapter Five. I set out the results of each phase of this research 
(Chapters Six, Seven and Eight) and how it culminated in the creation of a website 
designed to help families at risk of bowel cancer share information about their familial 
diagnosis. Finally, the results will be discussed in Chapter Nine and the implications of 
those results presented in Chapter Ten.  
1.2 Biological mechanisms of cancer 
Increased understanding of the biological mechanisms that lead to cancer may help 
reduce the incidence of certain cancers (Vogelstein & Kinzler, 2004). Research has 
shown that exposure to extrinsic factors, such as teratogens in our environment or 
lifestyle choices , such as smoking or alcohol consumption, can significantly increase 
the risk of certain cancers (Torre et al., 2016). The fundamental mechanisms that 
underpin this process arise from the accumulation of damage to the functional 
instructions within each cell that are contained in long strands of deoxyribonucleic 
acid (DNA); where ‘somatic’ DNA damage in cells builds up during an individual’s  
lifetime (Krogan et al., 2015); the accumulated changes in DNA can eventually result in 
cells behaving or functioning differently (Vogelstein & Kinzler, 2004). The alteration 
may not be evident or result in any significant change in health, however in some 
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situations it does. Most cells within the body have two copies of DNA strand, 
providing two versions of the biological instructions contained within the DNA 
(Turnpenny & Ellard, 2016). Studies of the epidemiology of cancers have revealed that 
certain cancers have huge accumulations of very many alterations or mutations within 
the different clones of cells that constitute the tumour and are therefore termed 
‘hypermutated’ (Roberts & Gordenin, 2014). What initiates or drives the process of 
carcinogenesis is not yet fully understood but it is being unravelled through the 
application of new genomic technologies such as next generation sequencing, which 
has revealed the highly varied genetic constitution of many tumours (Helleday, Eshtad 
& Nik-Zainal, 2014).  
The hypothesis that, in relation to cancer, cells need to accumulate at least two 
mutations which result in a fundamental change in the action of certain genes was 
proposed in a seminal paper by Alfred Knudson in 1971 and since referred to as 
‘Knudson’s Two Hit Hypothesis’ (Knudson, 1971). Knudson described this mechanism 
based on his work on retinoblastoma, a rare tumour of the eye but it has since been 
shown to apply to many different cancers (Dyer, 2016). What this indicates is that 
people who are born with, or inherit, a constitutional variant in certain genes can have 
an increased risk of particular cancers (Turnpenny & Ellard, 2016). This is because all 
their cells already have a variation in the DNA which makes them less fit to function, in 
effect the first ‘hit’ described by Knudson. This then means that the likelihood that the 
DNA in any one cell will be affected by a second ‘hit’ or mutation in the course of that 
person’s life is greater than for someone with two functioning copies of the same gene 
(Dyer, 2016). More recent work has indicated that certain cell types have a propensity 
to accumulate variations in the DNA due to rates of mutagenesis that are influenced 
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by intrinsic factors and are usually tissue specific (Wu et al., 2016). Conversely, 
extrinsic or external factors are thought to make the most major contribution to 
mutagenesis and cancer development (Wu et al., 2016). Without going into further 
detail to describe the complex and varied hypotheses of malignancy, the principle 
remains that a proportion of people who get cancer have an underlying genetic 
predisposition to certain cancers (Vogelstein & Kinzler, 2004) which greatly increases 
the risk of them developing cancer.  
1.3 Bowel cancer as a focus 
Although a large proportion of bowel cancers could be prevented (CRUK, 2017) it 
remains one of the most common cancers in the United Kingdom (UK) and across 
other developed countries, with 34,729 new cases in England in 2015 (ONS, 2017) and 
an estimated 1.4 million new cases of bowel cancer diagnosed worldwide in 2012 
(IARC, 2012). Although bowel cancer mortality rates have decreased, there has been 
an increase in the number of younger people diagnosed with bowel cancer, prompting 
a campaign by Bowel Cancer UK to improve awareness, particularly amongst GPs, 
entitled ‘Never Too Young’ (BowelCancerUK, 2017). The likely cause of an increased 
incidence of bowel cancer in younger people has been suggested as being connected 
with increased rates of obesity and alcohol consumption in the young (Siegel, Jemal & 
Ward, 2009). Clearly more research is needed to investigate the complex interactions 
between genetic predisposition, environmental factors and epigenetic changes to 
understand this phenomenon. However, we are already aware that individuals with an 
inherited vulnerability to bowel cancer tend to be affected by cancer at younger ages 




I have worked in clinical genetics services since 2000 and during my work I have 
repeatedly been told of younger relatives being falsely reassured by their doctors that 
they were not at an increased risk of bowel cancer, when in fact their family history 
indicated they were. Although my experience is only anecdotal evidence, this 
situation was tragically illustrated by the death of Stephen Sutton. He was a young 
man who died from bowel cancer at the age of 19 in May 2014 but campaigned and 
raised over £5.5 million for the Teenage Cancer Trust (Harley, 2016). Although 
Stephen was exceptionally young to develop symptoms at 16, his father had already 
been diagnosed with a genetic vulnerability to bowel cancer called Lynch syndrome 
(LS). Consequently the family were well aware of the potentially high risk of cancer in 
those with the gene variant. Andy Sutton, Stephen’s father, reported appealing 
unsuccessfully to get investigations for his son when Stephen was losing weight and 
suffering from persistent constipation (Weathers, 2014). However, despite the media 
interest in Stephen’s tragic story, the support group Lynch syndrome UK describe a 
frustrating lack of awareness amongst clinicians and the general public, as reported by 
their members via their closed Facebook page. Since then, Bowel Cancer UK, as part 
of their ‘Never Too Young’ campaign, have promoted a new risk assessment tool 
developed for primary care (Stapley et al., 2017) stating that with more than 2,300 
people diagnosed under the age of 50 with bowel cancer in the UK in 2014 (CRUK, 
2017) these issues need to be urgently addressed.  
By contrast, public awareness of the familial nature of breast cancer increased 
dramatically following the publication of an article by the actress Angelina Jolie in the 
New York Times in May 2013 (Jolie, 2013), explaining how she had learnt that she had 
a BRCA1 gene variant giving her a high lifetime risk of breast and ovarian cancer. This 
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led to significant increases in the number of women seeking genetic testing for BRCA1 
or BRCA2 gene variants (Evans et al., 2014). No equivalent high profile 
announcements have been made about familial bowel cancer yet. However data from 
Holland (van Lier et al., 2012) now suggests that there are likely to be many more 
people affected by Lynch syndrome (LS) than previous believed. These authors have 
reassessed estimates of population incidence based on the results of applying 
immunohistochemical tests (IHC) of mismatch repair (MMR) deficiency to every case 
of bowel cancer diagnosed under the age of 70 years. This method of ‘reflex’ or 
universal screening of incident cancers was applied prospectively to 1117 consecutive 
cases of colorectal cancer between 2007 and 2009 from 11 hospitals and has indicated 
that a high lifetime risk of cancer due to LS is something that is likely to affect many 
more people than previously believed (van Lier et al., 2012). Current estimates 
extrapolated from these data now suggest that the prevalence of LS alone is around 1 
in 350 (Staffa et al., 2015), making it a much more common condition than previously 
thought. These data also indicate that probably only 5% of individuals with this 
condition are currently aware of their risk. Of course, some caution needs to be 
applied to the evidence from the Netherlands as it may be population specific. To 
counter that concern, there does not appear to be a high frequency of founder 
mutations in any of the mismatch repair genes in the Netherlands (van Lier et al., 
2012). However the authors do note that they have detected a higher frequency of 
germline mutations in MSH6 and PMS2 than previously suspected (van Lier et al., 
2012). The authors conclude that this result may reflect the fact that variants in MSH6 
and PMS2 are of lower penetrance (Baglietto et al., 2010; Caron, 2015; Senter et al., 
2008) so giving rise to fewer cancers, than the other mismatch repair genes MLH1 and 
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MSH2 (Dowty et al., 2013). Therefore families with MSH6 and PMS2 pathogenic 
variants are less likely to present with a family history of cancer indicative of LS 
(Møller et al., 2017). 
In addition to LS, there are other rarer but well recognised genetic conditions where 
individuals with high penetrance pathogenic gene variants are at a significantly 
increased lifetime risk of bowel cancer, such as familial adenomatous polyposis (FAP), 
MYH associated polyposis (MAP), Peutz Jeghers syndrome (PJS) and juvenile 
polyposis (JPS) (de la Chapelle, 2004; Gross & Brand, 2015).   The proportion of 
individuals affected by these in relation to all those diagnosed with colorectal cancer is 
illustrated in Figure 1.1 (taken from Burt 2000 and reproduced online (PDQ® Cancer 
Genetics Editorial Board, 2018)).  
 
Figure 1.1 Proportion of colorectal cancers due to different family risk settings taken from 
Gastroenterology, Burt (Burt, 2000) 
Altogether, evidence of heritability from twin and kindred studies indicates that 
around a third of all bowel cancers occur because of an inherited vulnerability 
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(Jasperson et al., 2010; Lynch & Shaw, 2013; Papaemmanuil et al., 2008). 
Management for these different conditions varies based on their natural history, and it 
is not appropriate to detail them here, but a principle factor that can lead to some 
symptoms of disease being overlooked is the unusually young ages at which 
pathology can develop in genetic predispositions to cancer (Giardiello et al., 2014). For 
example, in FAP hundreds of colonic adenomas start to form from the mid-teens 
onwards. This then necessitates regular bowel screening by colonoscopy from age ten 
or eleven years and usually leads to colectomy in the early twenties (Vasen et al., 
2008) with the average age of diagnosis with cancer (if treatment is not received) of 
around 39 years (Jasperson et al., 2010).  Recently published prospectively collected 
cumulative cancer incidence data for 1,942 people with Lynch syndrome and proven 
pathogenic mutations calculated a 15% risk of any cancer by age 40 for women and 
14% for men, rising to 75% by age 70 in women and 58% by age 70 for men (Møller et 
al., 2017). The authors reporting these new data avoided the ascertainment bias that 
has previously affected estimates of cancer risk, by excluding index cases and starting 
when patients had their first colonoscopy.  However, the data only reflected the 
experience of those patients receiving regular colonoscopy at those centres 
participating in their study. Therefore, it is logical to assume that if pre-cancerous 
polyps are being detected and removed at colonoscopy in their research participants, 
then the incidence of cancer is likely to be even higher in an unscreened group.  
Screening recommendations for high risk groups start at the ages appropriate to that 
condition, for example, colonoscopy is recommended from 25 years in LS (Cairns et 
al., 2010) . However, such recommendations may be unfamiliar to professionals 
outside clinical genetic services. Indeed, research into the rising incidence of bowel 
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cancer diagnosed under the age of 50 years have shown that younger people with 
symptoms are more likely to have to visit their General Practitioner (GP) several times 
before they are referred for investigation (Stapley et al., 2017). Similar data from an 
online survey concur with these findings but it is possible that the survey data could 
contain bias as the online survey might have attracted more responses from those 
patients who received delayed care (BowelCancerUK, 2016b).  The evidence from the 
study by Stapley and colleagues (Stapley et al., 2017) is likely to be more robust as 
their data came from a large case control study comparing the primary care records of 
1661 cases of colorectal cancer diagnosed under 50 years with 3979 age matched 
controls.  
In my experience, problems with diagnosis may be partly attributable to the fact that 
the high risk of cancer and the potentially young age at which individuals can be 
affected is not widely appreciated outside of the clinical specialties such as 
gastroenterology, genetics and colorectal surgery. Thus symptoms may not be 
recognised as significant, which in turn can lead to delays in diagnosis (Barrow et al., 
2015). Consequently, charitable groups representing patients are now campaigning 
for greater awareness, both in the public and amongst health professionals, in the 
hope that this will improve symptom awareness and reduce times from presentation 
to treatment (BowelCancerUK, 2016b; Monahan et al., 2017). 
1.4 Clinical responsibility to support information sharing  
Patients diagnosed with an inherited vulnerability to cancer are encouraged to share 
information about their diagnosis with their relatives (Adelson et al., 2013; Mendes et 
al., 2016; Peterson et al., 2003); however, there is evidence that many relatives remain 
unaware of it (Hodgson et al., 2014; Landsbergen et al., 2005). Clinical guidelines 
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published in the Netherlands in 2013 (Menko et al., 2013) and the UK (Lucassen & Hall, 
2012) have both emphasised the responsibility of clinicians to promote and support 
communication in families with LS, due to the potential benefits to other family 
members once a diagnosis had been made. This perspective is not new (Forrest et al., 
2007; Godard et al., 2006) but the 2013 Dutch guidelines were preceded in the 
Netherlands by a qualitative interview-based study of the attitudes of clinical 
geneticists to this issue. The authors found that all nine of the geneticists interviewed 
thought it was important to inform family members of their risk but they held with the 
accepted practice of leaving this process up to the index patient. This was a small 
sample so may not be generalizable; it is interesting to note that these geneticists 
were aware that a significant proportion of relatives probably remained ignorant of 
the familial diagnosis. However, they continued to practice according to their clinical 
‘mores’, citing the relatives right not to know and their uncertainty of their legal 
position in this respect, plus a lack of resources to support them contacting the wider 
family (Stol et al., 2010).  
The study by Stol et al (2010) provides an insight into the perspectives of a small group 
of experienced geneticists and may not be representative. However, it could reflect a 
degree of inertia towards changing clinical practice, despite evidence to suggest that 
this current approach is not effective and many relatives remain at risk and unaware 
(Hodgson et al., 2014; Pujol et al., 2013; Sharaf et al., 2013).  In fact, the authors argue 
that there is a moral duty to inform relatives; which they say is shared between the 
doctor and the patient. They cite Beauchamp and Childress (Beauchamp & Childress, 
2001) and claim that the duty to warn described by the interviewed doctors does fulfil 
ethical criteria described by Beauchamp and Childress of beneficence and justice, 
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describing a moral imperative that: “1) the person to be helped is at significant risk of 
harm; (2) assistance is needed to prevent that risk from materialising; (3) there is a high 
probability that assistance will prevent the harm (4) assistance would not pose 
significant risks, costs or burdens to the person asked to help (5) the benefit for the 
person to be helped outweighs the costs or burdens to the person asked to help”. (Stol et 
al., 2010)(p.393). Therefore there appears to be an inconsistency in current clinical 
practice, where clinicians acknowledge that there is a duty to warn relatives, but they 
do not accept that this responsibility should rest with them, even though they also 
recognise that the index patient is not always able or willing to discharge this duty.  
In France the law has recently changed regarding this issue. The problem of non-
disclosure to relatives was considered so significant that there have been changes to 
the law so that  patients are now legally required to inform their relatives of the 
familial diagnosis (Van Haecke & de Montgolfier, 2015). However this law does allow 
index patients to delegate their responsibility in this respect to a health professional 
(Derbez et al., 2017).   This change in legislation appears to have already resulted in a 
shift in practice in France. In an ethnographic survey carried out over eight months in 
2014, a sociolologist observed altered clinical practice in a cancer genetics department 
in Paris following the new legislation (Derbez et al., 2017).  The authors of that paper 
saw that clinicians in the department were now introducing the topic of passing on 
information to relatives at their first appointment, using a different consent form 
(which acknowledged the responsibility to disclose information) and the discussions 
were being documented more routinely in patient notes (Derbez et al., 2017). 
Clearly patient confidentiality is very important and a fundamental aspect of patient 
trust and professional responsibility. Previously it has been suggested that a genetic 
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diagnosis could be a ‘familial diagnosis’ rather than an individual one (Lucassen & 
Parker, 2010) and this concept should extend to the process of taking consent at the 
time of any genetic testing. The evidence from France does appear to endorse the 
option of including a clause in the patient consent process, which draws attention to 
the familial nature of a genetic diagnosis (Derbez et al., 2017). This would then help 
draw attention to the shared responsibility to inform others who might be at risk in 
the event of a genetic diagnosis being made (Dheensa et al., 2017). Patients’ 
perspectives on this issue have been gauged through a qualitative study (Dheensa, 
Fenwick & Lucassen, 2016) where patients affected by a genetic condition were 
interviewed regarding their views about confidentiality, consent and information 
sharing. Using scenarios about non-disclosure to initiate discussion on these topics, 
the researcher interviewed 33 patients who had been seen in clinical genetics services 
within the last two years regarding risk of cardiac conditions or hereditary cancers 
(Dheensa, Fenwick & Lucassen, 2016). Their analysis revealed two major themes, 
firstly genetic information is familial and therefore should be disclosed; and secondly 
that patients prefer to maintain some degree of control over the flow of genetic 
information. Although their participants broadly supported the stance of a ‘relational 
joint account’ model for genetic information (where no one family member should 
have control over the familial diagnosis) the participants were still mindful of the 
sensitive nature of some personal information. These findings provide a different 
perspective to the study by Stol and colleagues (Stol et al., 2010), who elicited the 
views of clinical geneticists, although Dheensa et al note that the researcher may have 
subtly influenced the interviews through the selection of questions posed in them (a 
factor in many qualitative studies).  The patients who were interviewed appeared 
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pragmatic and accepting that a familial diagnosis should be available to all family 
members. The authors acknowledged that each families’ circumstances were unique 
and would influence that actual process of information sharing and that their findings 
were based on reactions to hypothetical situations (Dheensa, Fenwick & Lucassen, 
2016). This research further strengthens the argument that knowledge of a familial 
diagnosis should not be constrained by the views of particular individuals and genetics 
health professionals could be more proactive in the process of disseminating 
information. Ideally genetics health professionals could provide opportunities for 
follow-up in order to identify potential barriers to information flow. 
One barrier to dissemination of information frequently cited by clinicians is the 
situation where their patient is reluctant to inform their relatives of their risk. This 
then presents the clinician with a conflict between their role in facilitating information 
sharing and the need to avoid breaching confidentiality. Fortunately, the authors of a 
study of genetic professionals’ experience found it was rare that patients refused to 
inform their relatives (Clarke et al., 2005). When the situation did arise, then some 
clinicians decided to inform at risk relatives directly in order to avoid harm and alert 
other family members to the opportunities to have genetic testing or surveillance for 
early signs of disease. Acting against the wishes of an individual patient to share 
information with relatives directly is likely to be considered only in exceptional 
circumstances in the UK but informing relatives directly after a genetic diagnosis is an 
alternative strategy (Aktan-Collan et al., 2007; Suthers et al., 2006). Direct contact 
with at risk relatives to inform them of the familial diagnosis is not usual practice in 
families with an increased risk of cancer. However direct contact by clinicians has been 
investigated in Finland (Aktan-Collan et al., 2007) and Australia (Suthers et al., 2006) 
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with families at increased risk of cancer and this strategy was found to be acceptable 
to most families contacted in this manner. However, while cascade testing for 
pathogenic variants in families at risk of cardiac disease (e.g. hypertrophic 
cardiomyopathy, Long QT syndrome or familial hypercholesterolaemia) is sometimes 
facilitated through direct contact, this is usually with the knowledge of the proband 
(Newson & Humphries, 2005; Ormondroyd et al., 2014; Sturm, 2016).  This is regarded 
as a legitimate method of contact by specialist clinicians treating these conditions and 
by those relatives who received notification. 
1.5 Lack of awareness amongst relatives under the current system 
The correct identification and treatment for people with LS has now been recognised 
to be an important public health issue (Giardiello et al., 2014), gaining prominence and 
endorsed in the recent guidelines by the National Institute of Clinical Excellence(NICE) 
(Gulland, 2017; NICE, 2017). These guidelines draw attention to the increased risk of a 
range of cancers including: stomach, endometrial, ovarian, small intestine, skin, 
urinary tract, and brain cancer. The guidance (DG27) also explains that “expanding 
testing to all people with colorectal cancer may increase the detection of Lynch 
syndrome and, because Lynch syndrome is an inherited condition, identify families who 
could benefit from cascade genetic testing to determine if other family members have 
Lynch syndrome. This could lead to increased surveillance and consequently improved 
patient outcomes through earlier diagnosis and treatment, if cancer is present.” (NICE, 
2017)(p.6) 
While attention has recently been focussed on LS, it remains equally pressing that 
people suffering with other inherited cancer syndromes receive appropriate specialist 
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clinical management (de Vos tot Nederveen Cappel et al., 2013; Jong et al., 2006; 
Vasen et al., 2008). 
The health economic argument for pathological testing of incidental bowel cancers 
described by Snowsill and colleagues (Snowsill et al., 2014) has added weight to the 
recommendations published in 2014 by the Royal College of Pathologists (RCPath) 
(Loughrey, Quirke & Shepherd, 2015).  The Royal College of Pathologists in the UK 
had updated their dataset for colorectal cancer histopathology reports, advocating 
universal screening or ‘reflex testing’ of tumour specimens. The organisation also 
recommended testing tumour specimens from anyone diagnosed with bowel cancer 
under the age of 50, regardless of family history, either by microsatellite instability 
(MSI) or through immunohistochemistry (IHC) tests to distinguish patients who might 
have Lynch syndrome (Loughrey, Quirke & Shepherd, 2015). Subsequently, NICE 
published their recommendations in 2017, as referred to earlier(NICE, 2017), indicating 
that all newly diagnosed colorectal tumours should be tested for MSI or IHC, 
regardless of the patient’s age (Gulland, 2017). It is interesting to note that the health 
economic calculations were predicated on the potential to diagnose unaffected at risk 
relatives following the diagnosis of bowel cancer in an index case through cascade 
testing (Hampel, 2016; Snowsill et al., 2014). Snowsill et al (Snowsill et al., 2015) 
calculated that the cost of universal tumour screening would still be cost effective 
even if no unaffected relatives chose to be tested. However, the cost benefit to the 
NHS was estimated to be substantially improved if healthy relatives were 
subsequently tested and received screening appropriate to their risk. 
Current evidence collected via a systematic review and meta-analysis of uptake of 
genetic testing has indicated that less than half of at risk first degree relatives were 
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found to access testing (Sharaf et al., 2013). In fact the actual proportion of relatives 
who choose to have pre-symptomatic testing is likely to be even lower, as the data 
reviewed and analysed by Sharaf and colleagues (Sharaf et al., 2013) were derived 
from studies undertaken either at leading cancer centres or disease registries, where 
you might expect optimal information and support for newly diagnosed families 
(Barrow et al., 2013). Whether or not relatives choose to have genetic testing is a 
matter of knowledge and personal choice and that is not the key issue in this study; 
what remains a concern is whether relatives are aware of their risk and can exercise 
that choice. 
1.6 Increasing numbers of people diagnosed with a familial risk of bowel cancer 
With the changes to colorectal tumour screening reported in Section 1.5, it is 
anticipated that there will be a substantial increase in the number of families 
diagnosed with a susceptibility to bowel cancer (Monahan et al., 2017).  The drivers for 
this change come from two areas; firstly, there are new approaches to oncological 
treatment (Kawakami, Zaanan & Sinicrope, 2015) and secondly, there are changes in 
guidance (NICE, 2017) regarding disease prevention. Both aspects will potentially 
result in a rise in the number of patients newly diagnosed with LS, which I will 
elaborate below. 
Treatment for advanced stage colorectal cancer has been dominated for many years 
by the chemotherapy agent 5-fluorouracil (5FU).  However it has now been recognised 
that this treatment is less effective in tumours that are mismatch repair (MMR) 
deficient (Ryan et al., 2017a; Sargent et al., 2008) and 5FU may in fact cause harm in 
these patients as MMR deficient cells are resistant to 5FU (He et al., 2016; Jover et al., 
2006). Conversely, MMR deficiency has also been found to be a positive prognostic 
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indicator in studies involving age and stage matched controls (Coppedè et al., 2014; 
Hewish et al., 2010; Popat, Hubner & Houlston, 2005). In addition, new evidence 
suggests that MMR deficient colorectal tumours are potentially a good target for 
treatments that use immunotherapies instead of traditional cytotoxic therapy and 
have less morbidity associated with them (Cohen et al., 2017). Therefore, for all these 
reasons, oncologists are now more likely to be interested in the mismatch repair 
status of their patient’s tumours in order to optimise treatment modalities 
(Kawakami, Zaanan & Sinicrope, 2015; Ryan et al., 2017a), thus adding weight to the 
argument for improving methods to diagnose LS in patients with cancer.  
Taking a different perspective, authors of the economic evaluation referred to earlier 
(Snowsill et al., 2014) examined different strategies to diagnose LS in patients with 
colorectal cancer. They demonstrated both patient and cost benefits when routine 
molecular testing of tumour samples was performed in any patient diagnosed before 
70 years of age(Snowsill et al., 2017). These authors found multiple benefits for this 
approach including: decreased cost of overall care, increased rates of identification of 
LS (de la Chapelle, 2004; Lynch & Lynch, 1979), better management for patients 
known to be at risk of several malignancies, reduced mortality in these patients and 
their relatives and reduced morbidity for those at lower risk (by releasing their 
relatives from surveillance colonoscopy)(Snowsill et al., 2017). The economic 
argument has therefore again endorsed the need to improve existing methods used to 
identify families at high genetic risk of this cancer, where traditional approaches using 
family history and clinical presentation have been ineffective (Adelson et al., 2013; 
Barrow et al., 2015).  
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The proposal for universal testing of incident colorectal tumours recommended by 
NICE has been welcomed by geneticists, surgeons, pathologists and physicians caring 
for this group of patients.  However, in a letter recently published in the British 
Medical Journal, Monahan and colleagues (Monahan et al., 2017) called for a more 
comprehensive approach to the diagnosis and management of individuals with LS. 
They noted that this policy change should result in the prevention of several hundred 
new cancers each year (Monahan et al., 2017).  
However, in order to deliver such a policy there is a pressing need for improved 
education across clinical specialties and probably a shift in funding. This is because the 
2014 Royal College of Pathologists guidelines are not yet being fully implemented, 
even for tumours in people under 50, according to the results of a freedom of 
information request carried out by Bowel Cancer UK (BowelCancerUK, 2016a).  
Although I might suggest that the slow implementation could be due to lack of 
knowledge about LS amongst clinicians, it is also conceivable that there is a reticence 
to test tumours when the patient pathway is not necessarily fully understood and 
there are cost implications to carrying out these additional tests on tumour 
specimens. In addition, a plausible perceived barrier to screening incident tumours is 
the timing and opportunity to consent patients to the testing. Concern about whether 
patients have been counselled adequately could inhibit pathologists from initiating 
testing (personal communication with a pathologist). This is because this type of 
testing of tumour specimens could have implications for family members, so it is 
important to counsel patients appropriately before doing the immunohistochemistry 
or alert them to the likelihood of further tests being indicated.  
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Another limitation to the efficiency of tumour screening as a route to diagnosis is the 
proportion of people who decide to have diagnostic genetic testing following an 
abnormal tumour screen. In order to inform this issue, different pathways to universal 
tumour testing were analysed in the United States of America (USA) (Cragun et al., 
2014). This study took place across 15 different institutions with ‘patient follow-
through’ (when patients had germline testing following abnormal tumour screening 
results) as one of their primary outcome measures. The researchers used surveys and 
interviews with genetic counsellors (GCs) to elicit what factors might influence higher 
levels of patient follow-through (PF) (Cragun et al., 2014). Institutions were 
categorised into high, medium or low-PF, with frequency of PF as above 40%, 
between 11% - 40% or below 10% respectively. Qualitative comparative analysis 
(QCA) was used to identify variables associated with high or low PF. All high PF 
institutions shared some common conditions for implementation, namely: reflex 
testing for BRAF and MLH1 promoter methylation happened if tumour tests indicated 
MMR deficiency, that screen positive patients did not need to be referred to clinical 
genetics for counselling as genetic counsellors were automatically informed of tumour 
screening results, or alternatively the GCs helped facilitate clinician referrals, 
abnormal screening results were always given by a genetic nurse or counsellor and 
difficulty contacting patients was not given as a barrier to implementation. The 
adaptations that the high PF institutions made to help overcome barriers to universal 
testing of tumour specimens were first, the GCs reminding referring clinicians and 
helping facilitate referral of relevant patients for counselling, and second, the GCs 
being able to meet patients at follow-up appointments to initiate contact. In 
summary, the authors of this research report that a key element to increasing PF was 
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a high degree of involvement by GCs in the process of consent and disclosure of 
results to patients (Cragun et al., 2014). As might be anticipated in the USA, cost or 
lack of insurance cover was seen as a barrier to testing in some areas, but patient 
disinterest or failure to appreciate the importance of the test were also reported.  
Although some of the findings described above (Cragun et al., 2014) may not be 
applicable to the UK, the importance of having GCs, or other appropriately qualified 
clinicians, available to meet and counsel patients following abnormal tumour 
screening results is a factor that is likely to apply in the UK too. A weakness of this 
study was that it only sought the opinion of 21 ‘informants’ from 15 institutions and 
did not necessarily gather a broader view from multiple stakeholders. The barriers 
were those that were perceived by the GCs and may not have truly reflected all the 
factors that influenced test uptake by patients or why clinicians from other disciplines 
found it hard to implement universal tumour testing. 
Fortunately, two recent studies by Hunter and colleagues (Hunter et al., 2017; Hunter 
et al., 2015) in the USA have investigated the perspective of patients with newly 
diagnosed colorectal cancer about testing tumour samples for signs of LS (Hunter et 
al., 2017; Hunter et al., 2015). Initially they surveyed the views of 145 patients whose 
tumours were being tested for signs of LS using microsatellite instability (MSI) testing. 
Distress was measured using the Impact of Event Scale-Revised (IES-R) and attitudes 
to different statements were assessed using Likert-type scales. Family history and 
personal information was captured and both multivariate and multinomial logistic 
regression calculations were used to analyse predictors of response. Over 90% of 
respondents indicated that they thought they would cope with the MSI result, they 
understood the reason for such testing, they wanted information that could benefit 
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their family and they thought the test should be widely available; all of these findings 
demonstrated the acceptability of the testing. Distress associated with the testing 
was reported as minimal and was not linked to patient age or stage of cancer 
(although the numbers in the stage of cancer subgroups were too small to have 
sufficient statistical power). Overall the study authors concluded that patients 
recently diagnosed with bowel cancer had a ‘positive attitude’ towards screening for 
LS. However they did recommend that both patients and health care providers would 
benefit from education to understand more about Lynch syndrome and the fact that a 
lack of family history of colorectal cancer did not rule out LS (Hunter et al., 2015).  
Following on from the study to assess acceptability of tumour testing in patients with 
newly diagnosed colorectal cancer (Hunter et al., 2015), the same research group 
looked at the feasibility of screening by gathering data on patient perspectives on 
both screening and sharing the test results with their relatives (Hunter et al., 2017). 
The authors recruited 189 patients recently diagnosed with bowel cancer and 
administered a survey to assess their attitudes to a range of questions regarding 
genetic screening. Of the 38 participants who received a high MSI result from the 
tumour tests, 35 completed a second survey. The results from the first survey broadly 
endorse the acceptability of tumour screening, with 175  patients (92.6%) who wanted 
to know if they were at risk of hereditary cancer, learn their genetic risks (85.6%) or 
understand why they had developed cancer (93%). Patients were also asked to report 
the likelihood that they would share screening results with their relatives. The 
majority of patients with at least one close living relative indicated their intention to 
share test results, with over 95% saying that they would share a result with their 
sibling or child. Of those who received a high risk result, again the majority felt it was 
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important to share results with their relatives so that relatives could seek to reduce 
their risk of cancer (78%) and stating that they had a responsibility to inform their 
relatives of their risk (89%) (Hunter et al., 2017).  
Both the studies discussed above (Hunter et al., 2017; Hunter et al., 2015) indicate that 
screening patients newly diagnosed with colorectal cancer for LS without other 
selection criteria is acceptable to the majority of patients. They also provide 
encouraging evidence that patients are likely to pass on information about test results 
to their relatives. Clearly intention and action may differ and there may be bias in 
these findings because participants interested in the issue and more likely to discuss it 
openly could be more inclined to take part in such a survey. The authors speculate that 
the provision of educational material at the time of consent could be a key element of 
uptake. They provided such material to potential research participants but note that 
authors of another study found that patients did not understand the clinical utility of 
the screening test (Tomiak et al., 2014). These studies were done in the USA and 
through a health care provider (Kaiser Permanente Northwest) where the participants 
were all insured and most were well educated, so while informative they may not be 
generalizable. In the UK, where care is free at the point of delivery in the NHS 
(Goddard & Smith, 2001) the financial barriers to implementation are more likely to be 
institutional rather than personal. Consequently, despite the apparent delay in the 
implementation of screening for LS in all bowel cancers, it is highly plausible that over 
time increasing numbers of patients will be diagnosed with an inherited vulnerability 
to their cancer. Therefore I would advocate again that it is important to inform and 
support these individuals so they are able to adjust to the diagnosis themselves and 
disclose relevant information to relatives for whom there are health implications.  
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1.7 The benefits of knowing about familial risk of bowel cancer 
I will now change my focus from those patients already diagnosed with a cancer to 
their relatives who have not yet had cancer. I would suggest that in the context of an 
inherited risk of bowel cancer there are clear advantages to knowing about the 
familial risk because such knowledge can enable relatives to receive regular bowel 
screening by colonoscopy (Lowery et al., 2011). Alternatively, those relatives who are 
tested and found not to have inherited the familial variant can be reassured that their 
cancer risk is not increased and they do not need to have regular colonoscopy (Cairns 
et al., 2010; Menko et al., 2013). I will now elaborate further on the potential benefits 
of such knowledge. 
Investigations such as colonoscopy are done on the premise that cancer is likely to be 
detected early or even prevented through the removal of precancerous polyps or 
adenomas (de Vos tot Nederveen Cappel et al., 2013; Jarvinen et al., 2009). This form 
of surveillance has therefore been recommended for individuals at increased risk 
(Cairns et al., 2010; Vasen et al., 2013) i.e. with a recognised genetic condition in their 
family or where their family history of cancer has indicated that an increased risk of 
bowel cancer is likely.  
In addition to targeted cancer surveillance, such individuals could take action to 
influence their personal risk of cancer by following advice regarding aspects of diet 
and lifestyle that can change the likelihood of developing cancer (van Duijnhoven et 
al., 2013). This is something that may not be appreciated by people who have a strong 
family history of cancer and, in my experience, some consider that developing cancer 
is inevitable.  Cancer arises through somatic changes to DNA (Krogan et al., 2015) this 
means that lifestyle factors (such as smoking, alcohol or high consumption of red or 
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processed meat) that lead to DNA damage are potentially going to result in a higher 
incidence of cancer (Anand et al., 2008).  These theories have been demonstrated 
through observational longitudinal studies (Song, Garrett & Chan, 2015). Conversely, 
having a lifestyle that is ‘healthy’, avoiding or reducing such factors will have particular 
benefit for people with an inherited predisposition to bowel cancer (van Duijnhoven et 
al., 2013). In addition, there is now strong evidence that regular use of non-steroidal 
anti-inflammatory drugs (NSAIDs) can reduce cancer incidence (Ait Ouakrim et al., 
2015).  This has been most clearly demonstrated in the case of aspirin, with evidence 
from a randomised controlled trial indicated there was up to a 50% reduction in bowel 
cancer incidence in people with LS taking daily aspirin (Burn et al., 2011). It is similarly 
encouraging that taking regular supplements of calcium and multivitamins have also 
been shown to significantly reduce the risk of cancer in people with LS (Chau et al., 
2016). These findings are exciting and add weight to the perspective that there is a 
positive benefit from people knowing their risk status. Therefore, there is now an 
increasing body of evidence that indicates that there are actions individuals can take 
to reduce their risk of bowel cancer, and these factors apply to people with an 
inherited vulnerability to this cancer, as well as those in the general population. 
1.8 Opportunities to improve health  
It would be logical to assume that if a person knew that they could influence their risk 
of cancer by adopting a healthier diet or lifestyle they would do so, but this is not 
always the case (Burton et al., 2010; Quillin, 2016; Visser et al., 2017). I would suggest 
that the process of acceptance and adjustment to living at risk is a complex one 
(Kenen, Ardern-Jones & Eeles, 2003) but this could be aided by providing counselling 
and support to those individuals who are experiencing particular difficulties. Burton 
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and colleagues, in their review of evidence relating to health behaviours in patients 
and families with hereditary bowel cancer (Burton, Hovick & Peterson, 2012), 
concluded that people who had been affected by cancer demonstrated more healthy 
behaviours than people who had not had cancer. They also found that being less than 
50 years of age, being male and being less well educated were all associated with 
more ‘risk behaviours’. In addition, individuals who perceived themselves to be at high 
risk of cancer were likely to anticipate the result of testing and adopt a healthier 
lifestyle than those who anticipated having a low risk result (Brodersen et al., 2004), so 
perception of risk does influence behaviour but cannot fully predict it. 
How personal risk is understood and acted on is a complex issue. I will touch on this 
issue to show that it is possible to promote knowledge, but that behaviour that 
promotes health does not necessarily follow.  Using the Health Belief Model (HBM) 
(Rosenstock, Strecher & Becker, 1988) as a theoretical framework, Visser and 
colleagues (Visser et al., 2017) conducted a series of focus groups with a total of 29 
people with pathogenic variants in LS genes and therefore at increased risk of cancer. 
They were investigating determinants of, or barriers to, adherence to health and 
lifestyle recommendations (Visser et al., 2017). Key barriers to adherence to a healthy 
lifestyle were found to be the desire to continue to ‘enjoy life’: participants also 
adopted an attitude where the diagnosis of LS was not allowed to dominate. Those 
who had had colorectal surgery reported finding it hard to maintain a healthy diet 
when they craved sugar or salt and had difficulty finding alternatives to processed 
meat in their diets. Some participants lacked self-efficacy regarding their compliance 
with health recommendations and several cited a habit of unhealthy eating as being a 
barrier to adherence. Interestingly, you might assume that the diagnosis of LS could 
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be considered a ‘cue to action’ as described in the HBM, and for some people it was.  
However most said that they had not been given any advice about how their diet or 
lifestyle could alter their risk of cancer when they were given their diagnosis. Despite 
this lack of guidance, some actively sought out information about how they might 
improve their lifestyles, particularly after a personal diagnosis of cancer (Visser et al., 
2017).  
The evidence from the study by Visser et al (Visser et al., 2017) provides insight into 
some of the competing pressures and factors that can have an impact on people who 
learn they have a high risk of cancer. Although this group of patients reported not 
receiving much advice about their diet and lifestyle, this is less surprising when 
considering that they were diagnosed between 7 and 32 years ago. Severity of threat 
in terms of potential cancer diagnosis was not felt to be a motivator, which conflicts 
with the HBM. This may reflect the ‘perceived locus of control’ (Goldzweig et al., 2016; 
Rotter, 1966; Visser et al., 2017) over cancer risk which appeared to vary widely 
between participants; some felt they had no control over their risk of cancer whilst 
others felt they should do whatever they could to influence their likelihood of getting 
cancer. A limitation to this study is the older age of the participants (mean age 54 
years) and the length of time since their diagnosis.  It is possible that a younger group 
might have expressed different views and received more advice on this issue.  
However, the findings concur with those reported by Albada and colleagues (Albada 
et al., 2012) below.  
On the issue of whether lifestyle advice was given in genetic counselling I am 
interested in the evidence from a Dutch study (Albada et al., 2012). This showed that 
in their cohort of women seeking advice about their risk of breast cancer (between 
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February 2008 and April 2010) lifestyle factors were only discussed in 52 out of 192 
(27%) taped genetic counselling sessions. On those occasions when lifestyle factors 
were raised, the discussion was mostly initiated by the woman seeking advice (56%) 
rather than the counsellor. How lifestyle factors (such as smoking, diet, alcohol 
consumption, contraception, exercise and breast feeding) influence breast cancer risk 
was almost never discussed with women already affected by cancer. Despite this 
apparent lack of guidance, after counselling 29% of the affected women attributed 
lifestyle factors to causing cancer, compared with 19% prior to counselling, which was 
a significant difference (p=0.003). I would infer from this that those women felt the 
genetic contribution of their risk had been assessed and dismissed as the cause of 
their cancer, but this is only speculation. The strength of this study is the fact that the 
researchers analysed consecutive routine genetic counselling sessions regarding 
familial breast cancer and follow-up appointments. In addition, counsellees were 
asked to complete a questionnaire providing demographic details and giving 
responses about how they attributed the cause of their cancer, if they had received a 
cancer diagnosis. Since the genetic counsellors and their clients consented to take 
part in the research, and were being videotaped, this might have influenced their 
behaviour in some way but the study design comes as close as possible to capturing 
data on actual clinical practice. In conclusion, there are other factors that contribute to 
cancer risk, some with greater weight than genetic vulnerability (Wu et al., 2016). 
Therefore genetic counselling provides an opportunity to inform and advise patients 
in ways that can empower them to have greater control over their health. 
Given the opportunities for health behaviour change, it is relevant to consider the 
evidence from the Health Information National Trends (HINTS) survey of 2013. This 
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was a large population based survey in the USA, in which the authors analysed data 
from 3016 individuals, of which 135 (4%) had had genetic testing for either familial 
breast and ovarian cancer or LS (Quillin, 2016). These data were analysed to see if 
there was any difference in reported health behaviours between those who had 
received a genetic test and those from the general population. Across all the 
measured factors there was no significant difference between the two groups. In fact, 
Quillin draws attention to the fact that of the 135 people with genetic tests, 58% were 
overweight or obese (with a BMI greater than 25), 24% were current smokers, 18% 
indicated that they had no regular moderate intensity physical activity and between 
18% and 36% consumed less than the recommended daily amount of two and a half 
cups of fruit or vegetables. However, it was not possible to distinguish from the survey 
data if participants had received a high risk genetic test result or not and what, if any, 
genetic counselling they received at the time of their test. The author noted that 
these were all risk factors for anyone in the population and factors that were within 
the control of the individual to change. He speculated whether in the USA lifestyle 
factors are not given the same prominence in genetic counselling, where there is a 
greater readiness to discuss medical interventions to reduce risk such as screening for 
cancer through colonoscopy, mammogram or MRI and prophylactic surgery rather 
than lifestyle factors (Quillin, 2016). He suggested that this reticence amongst genetic 
counsellors may be influenced by the central tenant of a non-directive approach 
within counselling, but this assertion may be more valid in the USA and would require 
research to support it. It may be that discussion around oral contraceptive use is 
relatively common for women at increased risk of breast cancer, but risk reduction 
through changing lifestyle has not previously been supported by strong evidence to 
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demonstrate their relevance to people at high risk of bowel cancer. Fortunately that 
situation is changing with more robust evidence of the benefits of smoking cessation 
(Pande et al., 2010), healthy weight (Movahedi et al., 2015) and diet being accrued 
(Song, Garrett & Chan, 2015). 
 
1.9 Conclusions 
In this chapter I have focussed on the clinical aspects of familial predispositions to 
cancer, particularly bowel cancer. I have presented some of the mounting evidence 
that there are opportunities to reduce the risk of disease for those people living with 
an increased risk of bowel cancer. There are improvements in diagnosis which are 
resulting in increasing numbers of families becoming aware of their genetic 
vulnerability to bowel cancer. However, many individuals still remain unaware of their 
potential risk of this cancer and what action they could take to reduce their chances of  
being affected by it. In the following chapter I will consider how different factors can 
influence communication in families and how this might impact on how relatives 












2.1 Introduction  
In the first chapter I have explained how there are increasing numbers of people for 
whom knowledge of their familial diagnosis of a susceptibility to cancer provide an 
opportunity to access screening or improve their health.  In this chapter I will focus on 
issues beyond the specific relevance of genetic information to families with an 
increased risk of bowel cancer, as I think many of the same issues are applicable across 
a wide range of conditions. Therefore I will draw on evidence from a range of different 
genetic conditions to demonstrate the common factors that influence communication 
in families. I will present evidence that informs our understanding of the barriers to 
communication in families and suggest how using new technology may provide an 
innovative way to improve support to families affected by genetic disease. 
2.2 Implications of a familial diagnosis across different conditions 
We now recognise that while the familial nature of inherited disease is implicit, it can 
still create a burden of responsibility for newly diagnosed patients when they 
recognise that they need to alert their relatives to possible symptoms of disease (de 
Geus et al., 2014a; Ormondroyd et al., 2014). Alternatively, having a familial diagnosis 
can provide opportunities for at risk relatives to access screening for the early 
detection of disease and genetic counselling to understand and empower them, 
through this knowledge, to make the most appropriate decisions for themselves and 
their family (Skirton et al., 2013). Therefore, personal understanding of a familial 
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diagnosis, and the ability to share that knowledge with relatives for whom it also has 
implications, is an important issue for many people (Gaff et al., 2007). 
In order to prepare for a future where genomic information is increasingly 
incorporated into health care and needs to be understood and assimilated by patients, 
it is vital to optimise the way in which patients and their families are supported 
(Mendes et al., 2017). This may involve the wider dissemination of information and 
knowledge about genetics and heritability from an early age (Harding et al., 2017; 
Metcalfe et al., 2008; Santerre-Theil et al., 2016). It may also necessitate a greater 
profile of genetics in the media (Haga et al., 2013). I would also argue that access to 
genetic information warrants the development of sophisticated web-based 
information that is available in different formats to suit the needs of readers of all 
ages and backgrounds. 
Individually perceived as rare, in fact genetic diseases together impact the health of 
many people and are estimated to affect around 24 million people in Europe alone 
(EURORDIS, 2016). While inherited conditions may occur for the first time in a person, 
occurring ‘de novo’ due to a genetic change at conception, they are more commonly 
passed down through the family (Turnpenny & Ellard, 2016). Where a genetic 
condition is inherited from a parent, or both parents, there is the potential that it 
could affect several members of the same family. This means that when one member 
of the family is diagnosed, then that diagnosis probably has implications for some of 
their biological relatives as well.  
2.3 Personal understanding is necessary before information sharing is possible 
It is reasonable that someone diagnosed with a genetic condition is likely to take time 
to adjust to that diagnosis. They may be aware of the responsibility to inform their 
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relatives but fearful of the reaction they might receive. Therefore tension may exist 
between the needs of the individual and the needs of the family (Wiseman, Dancyger 
& Michie, 2010).Some individuals may lack confidence in what they understand about 
the condition and this, or actual lack of knowledge, can inhibit information sharing 
(Bartuma, Nilbert & Carlsson, 2012).  
In a longitudinal study, 80 people from 16 families affected by LS were interviewed to 
learn about their views around the duty to inform relatives and the role of health 
professionals supporting this communication (Pentz et al., 2005). Although those who 
agreed to participate may have had a more positive attitude to communication and 
genetic testing (i.e. individuals who didn’t participate may have been more likely to 
have declined genetic counselling and testing) the majority of participants endorsed 
the need to inform relatives about their risk. Family members were seen as the most 
appropriate informants, but the majority of participants also supported information 
coming from health professionals; who were regarded as being trustworthy and more 
reliable informants about complex genetic information (Pentz et al., 2005). These 
findings concur with those by Forrest and colleagues (Forrest et al., 2003) who 
conducted a qualitative interview based study and found that, particularly in families 
at risk of hereditary breast and ovarian cancer, patients needed health professionals 
to ‘legitimize’ information when they were seeking to inform their relatives about the 
condition (Forrest et al., 2003). It is therefore important that health professionals are 
available to families to support their sharing of information about the diagnosis and 
reduce the chance of incorrect information being circulated, as well as to help those 
who lack confidence or motivation in the process. 
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It has also been observed that misconceptions can occur about the way a condition is 
inherited in the family, leading to errors in who is thought to be at risk. For example, in 
some families with a dominantly inherited risk of breast cancer with a known BRCA 
gene pathogenic variant, brothers were not seen as at risk of inheriting the variant 
(Hallowell et al., 2005). Where uncertainty exists about who needs to know, what they 
need to know and when it is appropriate to inform them, these factors can all inhibit 
information sharing about the genetic diagnosis (Wiens et al., 2013). 
2.4 The importance of timing 
An intervention to facilitate communication is likely to be more successful if it comes 
at the right time for that individual; typically, information and supporting letters are 
provided to patients at the time or shortly after they are given their genetic testing 
result (Barrow et al., 2015). This may not be the best time for patients to consider who 
they should contact and how they will do so, as they themselves are going to need 
time to adjust to their diagnosis (Forrest et al., 2008). Interviews conducted with 
patients and their relatives affected by a range of genetic conditions indicated how 
important it was for the person with the condition to first seek emotional support for 
themselves before they could focus on the implications of the diagnosis for others. I 
think these findings are likely to be generalizable across conditions but the time taken 
to adapt to the diagnosis will vary between individuals, therefore any supportive 
intervention would need to be flexible and adjusted to the needs of each patient.    
While it is probably inevitable that our understanding of how information is shared in 
families focusses on the patient or proband, characterising them as the key actor in 
this process, the culture of their family and the perspectives of other relatives will 
have a major impact on how such information is disseminated in the family (Ersig, 
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Hadley & Koehly, 2011; Koehly et al., 2009; Koehly et al., 2003; Peters et al., 2011). 
Koehly and colleagues (Koehly et al., 2003) used random graph techniques and social 
network analysis to explore the relationships within five families with LS. They 
described how those relationships impacted on the way genetic counselling and 
testing was discussed within those families. Data were drawn from interviews with 36 
people from the five families and described 783 dyadic relationships. They found that, 
in these families, two relatives were more likely to discuss genetic counselling or 
testing if they were closely related (first degree relatives or partners); either relative 
had the familial gene variant; or their relationship was marked by ‘positive cohesion’, 
‘leadership’ or ‘lack of conflict’ (Koehly et al., 2003).  
The same research group (Koehly et al., 2009) then went further to understand and 
describe the aspects of family functioning and communication that could impact on 
disclosure of genetic test results using ‘Coloured Eco-Genetic Relationship Map’s 
(CEGRM) to analyse the relationships and personal support networks to 183 women 
(Koehly et al., 2009). Using this method of analysis they characterised the behaviour 
of different people within these 124 BRCA gene identified families, describing 
‘gatherers’, ‘disseminators’ and ‘blockers’ to the process of sharing health information. 
Data were collected through semi-structured interviews where participants reflected 
on the different roles and emotional support provided by different people in their 
network. The researchers then looked for associations and characteristics associated 
with these different roles. Frequently ‘gatherers’ were also ‘disseminators’, and 
typically ‘disseminators’ were female close relatives who had a personal history of 
cancer and provided emotional or tangible support. In contrast information ‘blockers’ 





The CEGRMs provided a way of looking at these family interactions and relationships 
over time and were used to further investigate the role of blockers in this population 
of women from families with BRCA gene variants (Peters et al., 2011). A weakness of 
the 2009 study was the fact that all participants who informed the CEGRM were white 
women, 91% of whom had experienced higher education. The relationships 
represented on the CEGRM are described from the perspective of that one informant, 
so they might not have been truly representative of the situation in the family. 
Although probably not generalizable across other populations, the roles provided by 
certain individuals in these families are still the social reality for those women who 
Figure 2.1  Example of CEGRM map 
Taken from Koehly, L. M., Peters, J. A., Kenen, R., Hoskins, L. M., Ersig, A. L., Kuhn, N. R., Loud, J. T. & 
Greene, M. H. (2009) 'Characteristics of health information gatherers, disseminators, and blockers 
within families at risk of hereditary cancer: implications for family health communication 
interventions'. 
 American Journal of Public Health, 99 (12), pp. 2203-2209 
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reported them. Also, these findings do concur with conclusions drawn from other 
studies (Patenaude et al., 2006; Young et al., 2017) with respect to the sort of relative 
who is most engaged with the task of gathering and sharing information about the 
genetic condition. These individuals are often ‘pivotal’ in the process of passing on 
information, they are typically women, and often older women such as mothers or 
grandmothers (Keenan et al., 2005). 
Extrapolating findings from a different type of adult onset genetic disorder, 
Huntington disease (HD), Forrest Keenan et al  (Forrest Keenan et al., 2009) 
investigated the experiences of young people at risk of HD and how they had learnt 
that they were at risk. Their research in Scotland involved interviewing 33 children, 
adolescents or young adults (12 males and 21 females) who ranged in age from 12 to 
28 years old, all of whom were at risk of HD. Semi-structured interviews were used to 
explore the process of disclosure and the results make poignant reading at times. 
Their analysis showed that there were four types of disclosure, which varied from 
open discussion (termed ‘having always been told’) through gradual disclosure, to the 
diagnosis being kept a secret, and when the diagnosis was new to the family. The 
findings support the view that the communication norm in the family is likely to be 
more influential that any information that is provided by an outside agency such as 
the genetics services (Forrest Keenan et al., 2009). These authors also found that 
women were often the ‘gatekeepers’ of the genetic information. However, rules of 
authority within families influenced disclosure and led in some circumstances to 
collusion where secrets were kept across generations or people lacked authority to tell 
others, such as cousins. This emphasises the impact of pre-existing patterns of 
communication within families for disclosure when new information comes into the 
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family (Forrest et al., 2008). The evidence from Forrest and colleagues on this topic 
also demonstrated the temporal nature of disclosure; revealing how patients first seek 
support for themselves immediately post diagnosis by sharing information with close 
friends and family and it is only later when they are able to consider the implications 
for others (Forrest et al., 2008). Their findings further support the importance of 
providing information in a format that can be revisited or referred to, as it could then 
be used at whatever time is most appropriate for that person to support their 
disclosure. 
Since 2012 the Memorial Sloane Kettering Cancer Centre Clinical Genetics Service 
have been providing annual educational workshops to families with LS (Corines et al., 
2017). Recently reporting the results of their pre and post workshop participant 
surveys over that time they indicated how they decided on the range of topics covered 
at these meetings and the preferences of attendees. While the most frequently 
requested topics were cancer screening options and chemoprevention, strategies for 
family communication was a common suggestion as a topic for future lectures. 
(Corines et al., 2017). In addition to this, they reported that the majority of their survey 
respondents would like to use online methods of communication but they also wanted 
more teaching in simple principles of genetics. While clearly beneficial to attendees, 
with high levels of satisfaction post workshop, it was evident that only a minority of 
those invited were able to or chose to attend (on average only 24%) with peak 
attendance at 75 people in the first year. The gender of attendees is not given but the 
majority the group (57%) had attended a previous workshop, so the responses may 
not be representative of their LS patient population as a whole and so may not be 
generalizable. The authors noted that they wished to conduct further research to 
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quantify the effect of the workshops on family communication. They anticipated that 
the knowledge gained through the workshops could assist and empower patients. 
They realised that there is a potential wider benefit to such events, as such workshops 
could enable family members who might be planning to have genetic testing to be 
better informed and also help them to understand and support those relatives already 
living with a diagnosis of LS (Corines et al., 2017). 
2.5 Motivations for sharing information with relatives 
When a patient tells a health professional that their relative “would not want to know” 
about the diagnosis, this could be true but it could also stem from that individual 
feeling protective of themselves and their relatives. Of course it is very difficult to 
ascertain whether someone would not want knowledge of a disease risk without 
asking them directly. However a research group at Sheffield University (Heaton & 
Chico, 2016) attempted to do this amongst students and staff at the University using 
vignettes to illustrate different hypothetical scenarios. They conducted an online 
survey of 955 people to investigate attitudes of the public to disclosure of unsolicited 
information about a genetic condition to those who may be at risk following genetic 
testing in a relative. A range of 54 vignettes were developed with the help of focus 
groups and then each participant was presented with four vignettes to consider, these 
were selected at random. The key issues were: whether an at risk relative would wish 
to be contacted about their risk, whether the at risk relative’s interests should override 
patient confidentiality in this circumstance and whether, if they had been tested, they 
would be willing to give up their confidentiality to inform their relatives.  Likert-type 
scales were used to measure attitudes. Vignettes were designed to represent a range 
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of disease severity, disease preventability and comparative risk in order to allow 
comparison about what factors might influence a decision to inform relatives.  
What the researchers (Heaton & Chico, 2016) found was that people wanted to be 
contacted for conditions where there was something that could be done to avoid 
illness (the majority 91% (CI 88-94%) wanted to know if they were at risk of a fatal 
disease which was preventable) . Even for less serious diseases the majority indicated 
that they would like to be informed. However, if a condition was not preventable then 
25% to 40% would not want to receive genetic information, however serious the 
condition.  Although the data were derived from a survey of university students and 
staff, in their analysis the authors reweighted the data demographically to reflect the 
general population. Using this reweighted data they concluded that the majority of 
the public would want to know about a condition if some preventative action was 
possible, overriding the patient’s confidentiality if necessary (Heaton & Chico, 2016). 
Respondents to this survey did not alter their views generally whether they considered 
the scenario from the perspective of a relative or as a patient. A small proportion 
would not wish to lose their confidentiality in any circumstance (1% for a fatal and 
preventable condition). While it would be valuable to have such a survey repeated in 
another, non-academic environment in case the results were biased by this 
population, it does provide insight into the factors influencing people’s views on 
disclosure. These survey results do support the view that most people would want to 
know about their risk, at least if there was some action they could take to ameliorate 
the risk of illness.  
This pragmatic stance to what motivates patients to inform relatives was already 
evident from the findings of a review by Bleiker et al (Bleiker et al., 2013) which 
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focussed on the psychosocial issues associated with LS. Those authors synthesised 
the evidence from studies since 1993, when genetic testing for this condition first 
became available. They reported that the primary motivations for having genetic 
testing in people at risk of LS were: ‘early detection of cancer’,  ‘reduction of 
uncertainty’, ‘information on whether (continued) screening is necessary’ and ‘knowledge 
of one’s children’s risk’ p327 (Bleiker et al., 2013). Against these incentives to be tested, 
there are other factors, such as concern about impact on health insurance or insurance 
costs, that are frequently cited by patients as reasons not to have testing, despite 
changes in law to protect against discrimination of this kind (Wauters & Van 
Hoyweghen, 2016). 
2.6 Information needs of relatives 
Undoubtedly, many different variables can influence how and when information is 
shared within a family. Broad estimates have been made regarding the proportion of 
relatives informed of a genetic diagnosis and they indicate that from 20% to 40% of 
relatives remain unaware of a diagnosis (Gaff et al., 2007).  In their exploration of the 
ethical and professional dilemmas around enhancing family communication, Hodgson 
and Gaff (Hodgson & Gaff, 2013) state that communication within families cannot be 
forced, but needs to happen at the pace which is appropriate to the proband, or 
whichever individual has received the new information. If third parties, such as genetic 
counsellors, try to persuade someone who is reluctant to contact their relatives, they 
are no longer supporting that person’s autonomy. 
Returning to the evidence provided by Hodgson and colleagues (Hodgson et al., 2016) 
from their RCT of an intervention using non-directive follow-up telephone calls, they 
found that even in families with a diagnosis of genetic disease, only a minority (25.6% 
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intervention vs 20.9% in control group) communicated with their relatives in such a 
way as to prompt them to seek genetic advice themselves (Hodgson et al., 2016). 
Even in the group of patients with the greatest increase in contact (those with 
treatable disease) only 39% of relatives contacted genetics services within 18 months 
of the proband being given their diagnosis. It was a key element of this intervention 
that would infer that either relatives were choosing not to seek genetic advice within 
this time frame, or the process of adjustment within the family is a slow process for 
many families. However, it is only possible to speculate as to the motives of someone 
who does not respond or participate in the research. 
One aspect that may influence how families perceive the condition in their family is 
their comprehension of which relatives are at risk and which are not (Forrest et al., 
2003).  A family tree, or ‘pedigree,’ is a visual tool well recognised and utilised by 
clinicians but also by patients and their families (Bennett, 2012). Skirton (Skirton, 
2001) suggested that using the patient’s own pedigree would help them comprehend 
the inherited nature of their condition better than the use of diagrams. Thus, by 
visually placing the patient within the context of their family, they may understand 
the implications for themselves but also be better able to identify through the family 
tree which other relatives are at risk too.  
How information is communicated in families also requires further analysis.  Metcalfe 
et al (Metcalfe et al., 2011) explored how parents and children communicate about the 
genetic condition in their families. In the 33 families studied (affected by a range of 
genetic conditions) children (from aged 8), their siblings and parents were all 
interviewed, but separately. This study included families at risk of adult onset 
disorders (Huntington disease and familial adenomatous polyposis).  Amongst their 
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findings, Metcalfe and colleagues found that young people had difficulty 
understanding genetic risks and statistics so they suggested that such figures could be 
represented graphically to facilitate understanding.  In addition, their research found 
that there was a gender difference around which family members shared genetic 
information, with mothers often playing a key role in disseminating information. The 
family members involved agreed that children should usually be informed about the 
diagnosis by their parents. Many of the young people interviewed in this study 
thought parents should receive help from health professionals to support their 
disclosure to their children. 
In an extension of the study cited above, Metcalfe et al (Metcalfe et al., 2011) have 
taken their findings and have sought to develop an intervention to try and help 
families that are experiencing particular difficulties adjusting to their diagnosis and 
communicating about it. Their collaborative group (The Socio-Psychological Research 
in Genomics SPRinG Collaboration) (Eisler et al., 2016) carried out a series of focus 
groups with families affected by a range of genetic conditions and health 
professionals in clinical genetics. Using the data from those, they then set up and 
tested a pilot intervention called multi-family discussion groups (MFDGs) where 
several families came together with a trained facilitator (a genetic counsellor with 
additional training) to discuss and explore the impact of the condition on themselves 
and the function of their families (Eisler et al., 2016). Following the pilot MFDGs the 
participants were very enthusiastic about their experience and what they had gained 
from it. The facilitators were also excited by the success of the method having 
witnessed the benefit to families who had participated. The families themselves 
reported several benefits, these included how helpful it was to explore the common 
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issues experienced by families with genetic conditions and realise that they were not 
disease specific. One grandmother who described previously feeling stigmatized said 
“I was able to talk about things I have not disclosed to anyone else. It felt a lot had been 
taken off my shoulders and I can go forward with a much more positive view on life.” p7 
(Eisler et al., 2016). I would not wish to detract from the success of the project and the 
potential benefit that such MFDGs might provide. However, it is perhaps an inevitable 
limitation of this type of study that the people who came forward to participate, while 
acknowledging that they had problems, may have been the families already willing to 
take steps to resolve those problems. The challenge would be to get effective 
assistance to the families who were really struggling to cope with the issue.  
The common difficulty faced by the families involved in the above research (Eisler et 
al., 2016) was the problem of how to talk about the inherited genetic condition with 
their children (Metcalfe et al., 2008). The MFDG approach appeared particularly apt 
since it allowed children and young people of similar ages to interact while 
participating in activities and sharing experiences with each other and also with their 
parents, other parents and caregivers. This approach has been used in other settings, 
with chronic diseases affecting families such as diabetes, eating disorders and mental 
illness and also investigated by a Portuguese group who used this approach to try to 
help families affected by hereditary colorectal cancer (Mendes et al., 2013). The 
Portuguese investigators perceived the MFDG approach as working well alongside the 
delivery of genetic counselling to specific individuals, drawing attention to how the 
threat posed by a diagnosis of an increased risk of cancer is likely to have 
repercussions throughout the family; testing resilience, coping mechanisms and the 
family’s ability to adjust to the threat. They set up four semi-structured meetings of 
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up to two hours held on Saturday mornings for one combined group that was made up 
of 19 people (ranging in age from 14 to 56) from four families. The success of the 
programme was then assessed during a focus group of participants one month later. 
The structure of the meetings had been predetermined with a mixture of education 
about the medical implications and management of the genetic vulnerabilities (LS and 
familial adenomatous polyposis) plus support related discussions focussing on a 
selection of themes such as disclosure, emotional reactions, coping strategies and 
how to maintain family identity (Mendes et al., 2013).  
I would agree with the conclusions of Mendes et al (2013) that since a genetic 
diagnosis does not only affect the individual in whom it is made, but also has 
implications for their relatives, there is a need to augment existing genetic counselling 
provision. Currently this is largely focussed on the individual, but it may be necessary 
to improve long term post-test follow-up and support adjustment within affected 
families to what is inevitably a chronic health threat. The results of the post 
intervention focus groups in Portugal highlighted the benefit felt by participants to 
the opportunity to share experiences and gain support from other people who were 
experiencing a similar situation. In fact their participants wanted longer sessions in 
order to have more time to talk with the other people there. The authors (Mendes et 
al., 2013) do not comment on the availability of patient led support groups in their 
area, which might have met this need, but since the MFDG placed emphasis on 
developing both intra familial and inter familial coping strategies, it could be argued 
that families could benefit from both types of support and they shouldn’t be mutually 
exclusive. However, the authors did recognise the potential bias within their sample 
towards people who were positively motivated to take part. 
64 
 
These initiatives then draw into focus how and what guidance should be given to 
patients and their families to understand and adjust to the familial diagnosis.  
Meanwhile Otten (Otten et al., 2014) has described how patients expected a variety of 
information sources to be available, at a range of complexity that should be tailored to 
the patient's particular needs. This finding (from their focus groups of patients and 
genetics health professionals) is now informing the development of a web-based 
‘recontact-app’ to facilitate re-contacting genetics patients in Groningen in the 
Netherlands (Halbersma-Konings, 2018).  
2.7 Barriers to communication within families 
As standard clinical practice is to encourage and support patients to inform their 
family members, sometimes described as a ‘family-link’ approach (Mesters et al., 
2005), it is important to understand the barriers and facilitators to this method. 
Research has in the past focussed on the accuracy of the information a proband will 
take away and potentially pass on to their relatives (Esplen et al., 2014). Several 
studies have focussed on recall of risk information both for the benefit of the patient’s 
own understanding but also making the point that this is an important indicator of the 
success of genetic counselling.  In addition, a patient’s knowledge about their 
condition has implications for their compliance with medical advice but also their 
ability to convey appropriate information to their relatives (Wiens et al., 2013). 
However, other evidence indicates that the type of information communicated may 
be quite limited. Mesters (Mesters et al., 2005) found that usually only the key 
concepts were passed on to relatives, that there was a hereditary “danger” in the 
family and that there was an opportunity to have a genetic test to determine personal 
risk (Mesters et al., 2005).  
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Another complicating factor is the patient’s own personal theories of inheritance (PTI) 
as described by McAllister (McAllister, 2003) These may contradict or deviate from the 
Mendelian pattern of inheritance described by their health professional (Henderson & 
Maguire, 2000). If the patient’s personal theory of inheritance does differ significantly 
from accepted Mendelian inheritance then I would argue that it is likely to influence 
their attempts to forewarn their at risk relatives, as they may perceive some relatives 
as less vulnerable than they actually are.    
However, more pertinent evidence emerged from the Dutch study by Mesters and 
colleagues (Mesters et al., 2005). Their interview based study with 30 people (8 men, 
22 women, average age of 53 years) explored patient perspectives and experiences of 
sharing information within their family. Participants were selected at random from a 
registration database of people at risk of hereditary cancers. The authors found that 
not only was the concept of ‘family’ really confined to a nuclear family, but if patients 
had a bad initial experience of attempting to explain the implications of the diagnosis 
to their relative, this inhibited them in any further attempts to inform other people in 
the family. Although the findings in this study may have been influenced by recall bias 
(because the interviews were capturing retrospective experiences) their conclusions 
are in agreement with my own clinical experience. Previously, patients have described 
a reluctance to inform relatives where they have anticipated that their message would 
be rejected (Koehly et al., 2003). Conversely, if patients are endorsed in their efforts 
and gain sympathy and support from other family members then they are likely to 
persist in attempting to inform everyone in the family (Gaff et al., 2007; Mesters et al., 
2005). These findings have reinforced my conviction that health professionals need to 
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be alert to those families where difficulties in communication may occur and try to 
provide support that is tailored to the needs of those patients and their relatives. 
2.8 How information sharing can be facilitated  
In a study where patients were interviewed about what motivated them to tell their 
relatives about their diagnosis (Mesters et al., 2005), they described a sense of a moral 
obligation, with the additional spur of anticipated regret if a family member were to 
develop a cancer that could have been prevented. If such motives were found to be 
endorsed by health professionals, this gave patients an additional stimulus to attempt 
contact and disclosure (Mesters et al., 2005). This then provided evidence that how 
health professionals encourage or indicate to their patients that they should talk to 
their relatives about the familial diagnosis is also important, as well as what they say. 
Unfortunately there are situations where the support of health professionals or the 
provision of written information may be of negligible use because significant barriers 
to communication exist in families (Chivers-Seymour et al., 2009). For example, where 
relatives have lost touch with each other over time there may be ways of assisting or 
encouraging family members to overcome such difficulties to make contact again. 
However, where a family rift has occurred it is unlikely that outside encouragement 
will be sufficient for relatives to put aside their differences. Some barriers can be 
explored with patients with the potential to overcome them. This could occur when 
people feel torn between the competing demands of their responsibility to tell their 
relatives and their desire to protect them from distress and anxiety (Hallowell et al., 
2003). Chivers-Seymour (Chivers Seymour et al., 2010) characterises the feelings felt 
in response to a need to communicate risk information to relatives as ‘reactions to the 
role of informant’(p.335), drawing attention to this emotionally demanding task. They 
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detail feelings of burden and isolation; the anticipated (unpleasant) reactions of 
relatives; concern about passing on technical information accurately; and worry about 
being the bearer of bad news (Chivers Seymour et al., 2010). I think, given the anxiety 
that many patients experience over this task, it remains important that healthcare 
professionals assist and support them where they can.  
A recent randomized controlled trial (RCT) conducted in Australia (Hodgson et al., 
2016; Hodgson et al., 2014) was designed to give patients the opportunity to consider 
and explore the barriers to communication within their families through telephone 
follow-up with genetic counsellors (Hodgson et al., 2014). Using techniques of non-
directive counselling, the counsellors sought to explore with the participants their 
experience to date of communication in their family about the diagnosis, what their 
intention was in terms of contacting relatives, and what future plans they had for 
further communication. It was essential that counsellors avoided trying to persuade or 
advise participants as this would undermine their autonomy (Gaff & Hodgson, 2014). 
This complex intervention study was based on the Reciprocal Engagement Model 
(REM) (Veach, Bartels & LeRoy, 2007) which postulates that genetic counselling is 
made up of a dynamic series of interactions between different elements. The 
interrelationship of three key tenets around a central concept, that the relationship 
between counsellor and client is integral, and recognises that:  
 genetic information (hence education) is vital, 
 patients are resilient, need support and their emotions matter, 
 outcomes from counselling should enable the patient to manage their 
condition, adapt to their situation and make decisions appropriate for 
themselves and their families (Veach, Bartels & LeRoy, 2007).  
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Part of the argument put forward by Gaff and Hodgson (Gaff & Hodgson, 2014) is that 
the patient themselves may have valid reasons for non-disclosure. These could include 
actively attempting to protect a vulnerable relative from bad news or as a defence 
mechanism protecting themselves emotionally from the repercussions of the 
diagnosis. Either way, it may be detrimental for the family for a health professional to 
try to overrule these reasons by persuasion. However, if the counsellor comes 
alongside the patient empathically and explores the difficulties or obstacles to 
disclosure this can promote the self-efficacy of the patient and in the long term is 
likely to be more effective as a strategy for facilitating information sharing (Gaff & 
Hodgson, 2014; Hodgson et al., 2014). I think this is a very cogent argument; however, 
the results of the RCT that this group reported in 2016 were not as significant as 
anticipated. The intervention for the study (Hodgson et al., 2014) was telephone 
follow-up by specially trained genetic counsellors at 3, 6 and 12 month intervals post 
clinic who delivered the intervention in accordance with the REM model. One of their 
primary outcome measures was the proportion of at risk relatives who contacted the 
Clinical Genetics Services in Victoria, Australia within 18 months of the participant’s 
recruitment to the trial (Hodgson et al., 2016). Starting with n=95 proband 
participants, the overall difference between the control group and the intervention 
group was 20.9% (112/536) of control group at risk relatives compared to 25.6% 
(142/554) of intervention group relatives contacting genetics. Taking account of the 
clustering effect within families, the adjusted Odds Ratio (OR), was 1.30; and the 95% 
Confidence Intervals (CI) were 0.70–2.42, giving a non- significant result of p= 0.40. 
However, the group were using contacting genetics as a proxy for communication 
within the family which makes the assumption that relatives would wish to seek 
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further professional advice soon after learning about their risk. For this reason the trial 
would have benefited from a longer follow-up. Added to which, not all at risk relatives 
might live within the State of Victoria or they might have chosen to seek advice from 
other sources such as via the Internet or from their general practitioner. Therefore 
their results could underestimate the actual numbers of relatives contacted and 
seeking information.  
This trial (Hodgson et al., 2016) did find a greater difference between rates of contact 
in families with conditions which gave a high risk of illness to offspring (such as in X-
linked conditions such as Fragile X syndrome and Duchenne muscular dystrophy or 
chromosomal anomalies such as translocations) with an adjusted OR 24.0, 95% 
confidence interval 3.4–168.5, p=0.001. However, the actual number of contacts for 
this cluster of families was relatively small, so they were comparing twelve out of 
nineteen relatives (63.2%) with four out of sixty relatives in the control group (6.7%), 
which further emphasises the need to replicate or continue this type of trial to give 
more robust results. Another possible weakness in their trial design was that genetic 
counsellors did not appear to have provided other tangible supporting information to 
assist probands when they were communicating with their relatives. Since the 
purpose of the research was to investigate a method of follow-up and support that 
could be delivered through existing genetics services in that part of Australia, it is 
possible that their standard care included the provision of leaflets or other educational 
resources, but that was not stated. The authors found that the highest level of contact 
happened following diagnosis of a condition where treatment or active surveillance 
was available, such as in familial cancer syndromes. For this category of patient 
around a third of at risk relatives contacted genetics services with only slightly more 
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from the intervention group compared to the control group: 30.3%  (108/356) versus 
28.0% (85/304) OR 1.12 (0.50–2.50). This result possibly reflected the greater 
emphasis that genetics professionals put on informing relatives in these families at 
the proband’s consultation (Hodgson et al., 2016). It may also demonstrate the 
participant’s own motivation to warn their relatives and help give them access to 
potentially beneficial medical treatments or screening (Heaton & Chico, 2016). 
2.9 Some relatives choose not to know 
While providing support to those who are attempting to inform their relatives is 
important, it is also necessary to accept that some relatives may choose to ignore or 
avoid engaging with genetic services. Cowley, an experienced genetic counsellor who 
interviewed 15 members (out of 50) from one extended family with LS (Cowley, 2016), 
found that only people in that family who had received testing would agree to be 
interviewed. The topic of her research was how people experience genetic testing and 
whether that influenced family relationships. She found that the interviewees spoke in 
terms of a genetic test being “common sense” and framed it as a moral imperative. 
When discussing their untested relatives, they talked about them in negative terms, 
describing them as “selfish”, “silly”, or “stupid”; that they were “cowardly” or “fearful 
of the truth” p.631 (Cowley, 2016); so apparently viewing them as imprudent or 
morally lacking. Cowley concludes that by promoting genetic testing as a logical way 
to protect and promote health there is a danger of creating a ‘genetic underclass’ of 
those who decide not to participate in genetic investigations. She does also recognize 
that since she was known to be a genetic counsellor by her study participants this may 
have influenced the way they presented their opinions. Most critically, the views of 
the untested relatives were not heard because they did not participate in the research 
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(Cowley, 2016). While it is important to acknowledge the potential to negatively 
impact the lives of family members by seeking to disseminate information about the 
familial diagnosis, there is also a responsibility for health professionals to improve 
health where possible.  This is an important issue where more research is needed to 
look for practical, pragmatic improvements to the problem of how best to support 
patients and their families dealing with the implications of a new genetic diagnosis in 
the family. 
2.10 The value of information provided in different formats 
Without providing some documentation of the detailed information given at the time 
of diagnosis, it is reasonable that many probands would find it difficult to recall and 
pass on information with confidence. The importance of educational materials and 
how they were used in communicating about a diagnosis of LS was investigated in the 
USA by Dilzell (Dilzell et al., 2014). The research showed that those relatives who 
received written information about the condition were significantly more likely to 
seek further advice. Seventy-four participants (50 of whom were the first person in the 
family to be tested and 24 who were either their first or second degree relatives) 
completed online anonymous questionnaires: different questionnaires were used for 
probands and for relatives. In this group, the probands’ reported a high level of 
disclosure, saying they had informed 88% of first degree relatives and 64% of second 
degree relatives. The material they used to support this was mainly the letter they 
received after their genetic counselling (53%) but other material such as letters, 
personal notes, laboratory details, support group information or online resources were 
provided to a third of relatives. More of the relatives who were given educational 
material sought advice from a health professional compared to those that received no 
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material (74% versus 22%, p<0.001). However this difference could not be 
corroborated as none of the relatives who did not seek advice or testing were 
represented amongst the study participants (Dilzell et al., 2014). This demonstrates a 
weakness in their study in this respect. It is likely to illustrate the possibility that 
people who took part in the research were the more proactive patients, already 
receptive to health information and therefore presenting as more engaged with 
genetics services than might apply to the wider patient population. The study was also 
retrospective and self-reported so liable to error of recall. However these authors 
(Dilzell et al., 2014) do detail what types of educational material were shared and what 
proportion of recipients were thought to have responded to that information, which 
adds to evidence regarding the utility of providing a post clinic or family letter to 
relatives. Although this study does provide evidence of an association between 
receiving educational material and seeking genetic advice, it is not sufficient to 
determine what benefit relatives got from the material. 
2.11 The use of technology and online Personal Health Records (PHRs) to share 
information 
Written information such as letters or leaflets are most commonly provided in clinical 
practice (Forrest et al., 2010) but making specialist information available online could 
be considered a logical step, and an economically feasible way to provide information 
to a greater number of people. It is not unusual for family members to be widely 
geographically dispersed which, it might be argued, could compromise sharing of 
information but this could be mitigated against by using online technology.  
Although Internet access is not universal and could disadvantage some patients, 
providing information online could be a practical solution to the need to educate and 
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inform about genetic disease (Kardashian et al., 2012). Providing information that can 
be tailored to the patient has been found to be particularly beneficial and more likely 
to be seen as relevant (Bental, Cawsey & Jones, 1999; Jacobs et al., 2016; Neuhauser & 
Kreps, 2008). This could be viewed as an appropriate use of technology and one not 
constrained by the relatively limited availability of genetic counsellors or other trained 
health care professionals. The application of new technology to the advantage of 
patients affected with inherited conditions could also be an important and appropriate 
development in service provision. Alongside such changes, it would be necessary to 
ensure that those patients without access to the appropriate technology are not 
disadvantaged (Huxley et al., 2015). Nonetheless, current evidence indicates that the 
vast majority of the population do regularly use the Internet (ONS, 2014) and this is 
predictably higher in the young who increasingly use texting, direct messaging, social 
media and email to communicate (Duggan, 2015). Also, widespread use of mobile 
technology such as smartphones, tablets and laptops can enable people to access 
these forms of communication throughout the day and avoid the need to carry 
printed documents with them (Poushter, 2016). Indeed, some studies have indicated 
that the opportunity to email general practitioners was particularly valued by some 
otherwise marginalised groups, such as people who work shifts, those with mental 
illness, the physically disabled and caregivers (Huxley et al., 2015). While not 
suggesting that men are a marginalised group, there is evidence that indicates a 
gender difference in the utilisation of electronic communication with healthcare 
providers.  
In a large European study (Newhouse et al., 2015) seeking to describe the 
characteristics of people using email to communicate with general practitioners and 
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other healthcare organizations, their findings indicated that more men than women 
had used email ((29.11%, 2099/7210 versus 21.42%). They also found that the largest 
proportion of users was in the 16-24 age group, but the most frequent users were 
those who reported bad health or who had several health problems (Newhouse et al., 
2015). Therefore the opportunity to use email or online communication is likely to 
particularly appeal to those groups of people who might have more difficulty 
communicating with their relatives. 
An additional point to consider is that of sustainability and ease of data sharing. 
Reducing the use of paper alongside increased use of information technology (IT) 
within the NHS has been a goal for over ten years, although with only limited success 
to date (Cresswell et al., 2011).  While government strategy had focussed national 
implementation of IT improvements across hospital trusts, this has proved unwieldy 
and ultimately difficult to achieve (Greenhalgh & Keen, 2013). In the interim, different 
hospitals and primary care trusts will have had to seek their own solutions, leading to 
a varied provision of electronic records and paperless solutions. Despite these 
challenges, sustainability is recognised within healthcare as an important aspect of 
procurement (Grose & Richardson, 2013) so the need to provide information in 
electronic format instead of paper documents is something that is supported in 
principle, but not necessarily carried out in practice. 
When considering the specific example of patients’ opportunity to access their own 
information and health records, the technology has been developed and provided 
through a range of platforms or Personal Health Records (PHRs) (Prey et al., 2016). 
These provide a secure platform for sharing information digitally, which can be viewed 
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through any device connected to the Internet. This means that information stored in 
this format could be retrieved much more easily than if it is provided in paper format.  
It is some time since evidence emerged from a randomized trial of information 
provision to patients with cancer indicated that giving patients’ access to their own 
personal information reduced their anxiety and facilitated them showing the 
information to others (Jones et al., 1999). Unfortunately the initiatives to introduce 
PHRs in the UK have not all been successful, with both NHS HealthSpace and 
GoogleHealth withdrawn in 2012 (Davies, 2012). Archer et al (Archer et al., 2011) in his 
scoping review of what contributes to a successful PHR, described how the functional 
utility and security of the system is important. However, he also emphasises that the 
purpose of the PHR and its perceived benefits need to be appreciated by patients and 
health professionals alike, as their acceptance of the technology is key to its adoption 
(Archer et al., 2011; Nazi, 2013). Consequently, within an already overstretched NHS 
where clinical and administrative staff are under pressure to provide high quality 
clinical care to more people with fewer clinical staff, it is important to recognise that 
the motivation of health professionals to learn new skills and adopt novel technology 
may be reduced.  
However PHRs such as ‘My Health Record’ and ‘Patients Know Best’ (PKB) would 
provide the opportunity for patients to control and share medical information and 
evidence of their diagnosis with their relatives, if they wished to do so (Bidmead & 
Marshall, 2016).  This facility of PHRs has not yet been tested, although the use of 
PHRs and their effect on patient empowerment was investigated at a children’s 
hospital in the UK. The hospital used PKB to encourage participation in health 
management and share test results with the parents of children with chronic 
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conditions. (Schneider, Hill & Blandford, 2016). The researchers used a semi-
structured qualitative field study approach and they identified four styles of use 
amongst the families observed and interviewed: ‘avoiders’, ‘co-operators’, 
‘collaborators’ and ‘controllers’. The authors (Schneider, Hill & Blandford, 2016) used 
self-determination theory to guide their analysis and they argue that the provision of 
a PHR does not necessarily empower patients, as predicted, but may be helpful for 
those with certain coping styles. Although their research looked at PHR use by parents 
of sick children rather than adult patients seeking information to inform their own 
care, the issue of coping styles and motivation for accessing health information is 
something to be considered in the design of any system to promote information 
sharing (Al-Busaidi, Gray & Fiddian, 2006; Schneider, Hill & Blandford, 2016). 
At the moment PHRs are not widely available across the UK, with only a minority of 
trusts using them (de Lusignan et al., 2014; Mold & de Lusignan, 2015). Despite this, 
the opportunity to utilise sharing genetic information online through PHRs has not yet 
been investigated to my knowledge. The creation of comprehensive PHRs would 
require collaboration with large health institutions so that lies outside the scope of a 
PhD. However, investigating the acceptability and feasibility of sharing information 
online using a more modest platform, such as a website, would be possible. 
2.12 Websites to support families at increased risk of cancer 
Ongoing research at MD Anderson in the USA by Peterson and colleagues has created 
‘HEALTH4Families’ (Peterson, 2017). This website is part of an initiative to develop an 
eHealth weight management intervention for people at increased risk of cancer 
(currently families with known BRCA gene variants or Lynch syndrome). The 
intervention is intended to promote healthy behaviour to help both patients and their 
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relatives who are overweight (Body Mass Index greater than 25) to reduce their weight 
and get more exercise using online weight monitoring, an online social network, and 
coaching by E-mail or via the telephone (Peterson et al., 2017). This programme allows 
online communication between participants to encourage and provide peer support, 
so although not directly intended for communication between family members, 
HEALTH4Families does utilise information technology to optimise health benefit 
using communication within ‘family teams’ (Peterson et al., 2014; Peterson et al., 
2017). 
More specifically targeted at assisting communication, at least one website exists in 
the USA for the purpose of supporting families at increased risk of cancer (Myers, 
Conrad & Terdiman, 2014). It was created at the University of California, San Francisco 
to encourage and support their families with an inherited risk of cancer to share 
information about the diagnosis using an online platform called ‘Kintalk’ 
www.kintalk.org (Myers et al., 2013). The researchers have attempted to measure 
satisfaction with the website through an online survey with users but so far have not 
published any results (Myers, personal communication July 2016).  
An alternative approach, also in the USA, has been the development of a web-based 
intervention called the Family Gene Toolkit (Katapodi et al., 2018). This intervention 
has been designed to provide genetics education about hereditary breast and ovarian 
cancer (HBOC), coupled with skills building around coping, decision making and 
family communication. Thus far a prototype of the intervention has been tested with 
12 dyads of women (each dyad comprised a woman with a BRCA gene variant and her 
untested relative). In addition, the authors reported the results of focus groups (n=11) 
to discuss the two live webinar sessions and follow-up phone call delivered by the 
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project. Although this research is still ongoing, participants to the pilot study found 
the intervention acceptable, delivery was feasible and they were ‘highly satisfied’ with 
it overall. However, the focus groups valued the content of the modules but thought 
the live delivery difficult to accommodate in their schedules (Katapodi et al., 2018). 
2.13 Conclusions 
 
In this chapter I have considered different aspects of communication in families 
affected by genetic conditions. The issue of disclosure of a genetic diagnosis with 
relatives for whom it may have implications is something that could be discussed with 
patients either during their preparation for genetic testing or in follow-up. Topics that 
might help determine the patient’s perspective around this and any likely barriers to 
communication include: the family norms of communication around health issues,  
their emotional and geographical distance to relatives,  the appropriate timing of 
disclosure and what role health professionals can play supporting the process of 
information sharing (Chivers Seymour et al., 2010). I suggest that in seeking to 
facilitate family communication health professionals first need to understand the 
unique circumstances that their patient or client is facing and their perspective about 
the urgency of the task. With insight about the potential barriers or obstacles that 
someone is likely to face, and whether their patient feels ready to pass on information 
to their family members, we are then better placed to help them both practically and 
psychologically. With new digital technologies and changing norms of communication 
in families it would be timely to investigate what methods of information provision 
would be welcomed and feasible. In the next chapter I describe the systematic review 
that I conducted to find out what evidence had accrued about existing types of 
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A systematic review of literature around the use of email or 
websites to facilitate communication about a health issue 
 
3.1 Introduction 
Electronic methods of communication are now ubiquitous in everyday life but utilised 
less often to communicate between healthcare professionals and their patients 
(Newhouse et al., 2015). In order to better understand the efficacy and potential 
pitfalls of using electronic communication to share information about a genetic 
diagnosis I carried out a systematic review. This was to capture and synthesise 
research evidence that existed about the issue in order to inform the development of 
an innovation. In this chapter the rationale, method and results are presented, with a 
discussion of how the findings informed the subsequent phases of this research. 
3.2 Background and rationale 
With increasing demands and limited resources in the provision of healthcare, it could 
be argued that the opportunity to provide information and respond to queries from 
patients efficiently and sustainably would be desirable. Using electronic methods of 
communication could enable this increased efficiency as such communication would 
not be limited to a clinic setting and would not use administrative time or printed-
paper.  However doctors, nurses and other health professionals fear that responding 
to emails from patients will adversely impact on their time, and they are also 
concerned that emails are less secure when sending sensitive, confidential 
information (Sawmynaden et al., 2012).  However, with improving technology 
providing greater security for the use of email in healthcare (Newhouse et al., 2015) 
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and alternatives in the form of password protected patient portals and websites 
(Ammenwerth, Schnell-Inderst & Hoerbst, 2012), such security issues are gradually 
being addressed.  
On the basis that emails can be forwarded and links to websites can be shared, these 
forms of electronic communication could provide an opportunity for family members 
to share information that has been provided by their healthcare professional. Given its 
widespread use, it is credible that some studies have found that patients would like 
email contact with their doctors (Peleg & Nazarenko, 2012), although in practice the 
email provided may be used infrequently (Andreassen, 2011).  The opportunity to send 
information by email, or make it available on websites, could be particularly relevant 
in genetic healthcare where a diagnosis made in one individual very often has 
relevance to other people in their family (Dheensa, Lucassen & Fenwick, 2017; 
Wiseman, Dancyger & Michie, 2010).  
Although a systematic review and meta-analysis of email for health promotion or 
disease prevention concluded that the benefits of using email against standard mail 
were not clearly demonstrated, the reviewers considered the quality of the evidence 
to be low (Sawmynaden et al., 2012). However, none of the studies included in that 
review had attempted to measure the impact or ease of transmission of information 
between relatives that could be facilitated by the use of email or websites.   
More positively, the potential benefits to greater utilisation of information and 
communication technologies (ICT) was investigated within the context of the Cancer 
Genetic Services in Wales, with over 80% of the 225 patient respondents to their 
online survey indicating that having an email facility for queries would be “highly 
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acceptable”. In addition, the use of “email and text messaging services” was the most 
common suggestion in an open-ended item regarding which initiatives should be 
prioritized by the service (Hilgart, Hayward & Iredale, 2012).  
In order to optimise the health benefits to families where there is a shared genetic 
vulnerability to disease, health professionals (such as clinical geneticists or genetic 
counsellors) try to provide accurate information and support (Dheensa et al., 2015; 
Edwards et al., 2008) . This is because there are potential significant health benefits to 
the relatives from doing so, such as symptom awareness, access to targeted 
screening, treatment and consideration of reproductive options (Menko et al., 2013). 
Consequently, the issue of how to harness new technology to facilitate 
communication in families where there is genetic diagnosis or shared genetic 
vulnerability has implications for many people (Chivers Seymour et al., 2010; Edwards 
et al., 2008; Gaff et al., 2007). 
In practice there are many barriers that can influence and negatively impact on 
communication between relatives about a health issue.  Most of these barriers are 
unlikely to be influenced by the method of information provision. However, it could be 
argued that providing information in a digital file (that can be shared electronically) 
could help facilitate communication where the barrier is one of relatives being 
emotionally or geographically distant. This would be particularly beneficial if people 
live in different time zones where the cost or convenience of a phone call could be an 
issue. Another barrier to communication exists if the patient has difficulties in 
approaching someone with whom they are in only sporadic or infrequent contact, or if 
the relationship is dysfunctional in some way, for example following a divorce in the 
family (Chivers Seymour et al., 2010; Mendes et al., 2017). In both these situations, it 
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could be postulated that if information was available online or via email that might 
help facilitate the communication by making the process less intrusive. 
Within the context of families with an inherited vulnerability to bowel cancer, it was 
found that the provision of educational materials led relatives to seek further advice 
about their own risk of cancer and the opportunity for cancer surveillance (Dilzell et 
al., 2014). It is understandable that providing timely, appropriate and accurate 
information about a diagnosis is likely to be important to ensure that correct 
information is given to relatives.  However, balancing the privacy and autonomy of the 
individual against the need to prevent harm in their relatives remains a dilemma in 
genetics (Dheensa, Fenwick & Lucassen, 2016; Lucassen & Parker, 2004; Lucassen & 
Parker, 2010). In the UK, issues of information governance in health are guided by the 
2013 Information Governance (or ‘Caldicott’) Review  (Caldicott, 2013). Within that 
document a new seventh principle is stated: “that the duty to share information can be 
as important as the duty to protect patient confidentiality” (p.119 (Caldicott, 2013)). This 
draws attention to the need to balance the confidentiality of the individual against 
their relative’s risk of harm when a potentially treatable or preventable condition is 
known in the family. 
I was already aware that Personal Health Record (PHR) systems such as Patients Know 
Best (PKB) could enable health professionals to provide patient’s access to 
information specific to them and allow it’s onward transmission (Prey et al., 2016). In 
addition, at least one health care provider was using a purpose built website 
(www.Kintalk.org) to facilitate information sharing, but to date they had only 
published conference abstracts regarding the purpose and development of the 
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website without any data about the efficacy of this approach (Myers et al., 2013; 
Myers, Conrad & Terdiman, 2014).  
Without evidence of the efficacy of using email or interactive websites as a means of 
sharing health related information in families it is unlikely that such methods would be 
adopted by healthcare professionals. Therefore it was considered appropriate to 
conduct a systematic review to determine what peer reviewed published evidence 
existed regarding the impact of using email or interactive websites as alternative ways 
of providing information to patients and their families, when a diagnosis had been 
made that was of relevance to more than one individual. 
3.3 Aims and objectives of the systematic review 
 
The aim of the systematic review was to investigate what methods of electronic 
communication were being used by health professionals, in order to support families 
communicating information about a shared diagnosis or health issue.  
The main objectives were to:  
 Understand what had already been done in order to identify gaps in 
knowledge around this topic. 
 Gather evidence of the use of electronic communication methods in 
healthcare in order to inform the development of an innovation. 
 Appreciate the potential benefits and barriers to this type of communication. 
This led to an overarching question:  
86 
 
‘What is the impact of information provided by health professionals either by 
email, or via interactive websites, on communication within the family about a 
familial diagnosis or other health care issue?’ 
3.4 Design 
 
A systematic review is a method of identifying, analysing and synthesising the 
available evidence on a particular topic. I used the method described by the Centre for 
Reviews and Dissemination to search, select and analyse the relevant papers (Reviews 
& Dissemination, 2009). The aim of the search was to identify any peer reviewed 
empirical published research evidence, which was either qualitative, quantitative or 
mixed methods. The issues communicated needed to be health related, or a familial 
diagnosis. The communication was between relatives, so within families, or from a 
health care professional to their patient and then on to a third party of the patient’s 
choice, but the use of email or a website needed to be assessed within the study.   
3.5 Search methods 
 
The first systematic search and review was conducted from January 1990 to January 
2015 across ten electronic databases (Cochrane Library, AMED, CINAHL, EMBASE, 
ERIC, MEDLINE, PsycINFO, SocINDEX, Web of Science (Core Database) & EThOS). 
These databases had been recommended by the health faculty librarian at the 
University of Plymouth and although there was overlap between them this ensured a 
thorough approach. The search was limited to peer reviewed published evidence and 
not extended to ‘grey literature’, such as book chapters, reports or commentaries. 
This was because the grey literature was not considered as academically robust and 
trustworthy as peer reviewed evidence. 
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This search was repeated in December 2017 in order to ensure that the review was 
comprehensive over the period of January 1990 to December 2017. The process of 
systematic appraisal and rejection is illustrated by a PRISMA diagram (Moher et al., 
2009) for the combined search and review (Appendix 1). The syntax of the search 
terms varied according to the syntax proscribed by the different databases (Figure 3.1 
is an example of the syntax used in EBSCO).  
The syntax given below is an example of the search terms used in EBSCO for the 
systematic search of 10 databases. 
I combined terms for digital communication such as “Email*, electronic 
communication, information technology, social media, Facebook, web-based, online 
mail, web#site, web#based OR interactive web-site”, plus “Health, healthcare, health 
care, diagnos*” with terms for “Family, siblings, children*, relatives, relations, at-risk 
relatives” or “Famil* disclosure, famil* communication, famil* discussion, famil* 
discourse, communicat*, inform* relatives, tell* relatives, facilitate communication, 
shar* information, support tool*, communication* tool, enhance communication, 
discussion*” The resulting nested groups were combined with AND to link the four 
concepts of (i) ‘family’, (ii) ‘communication’, (iii) by ‘email or social media’, (iv) within 
‘healthcare’. 
Figure 3.1 Example of syntax used as search terms 
 
Articles were searched by abstract or topic only, in English, and full text articles were 
obtained for papers that were likely to meet the inclusion criteria, plus manual 
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ancestral searching was carried out for completeness. All searches were saved and the 
results imported into an EndNote X8 citation manager (Clarivate Analytics, 2016).  
 
3.6 Inclusion and exclusion criteria 
 
Studies were included if they were:  
 focussed on the issue of communication of information regarding a familial 
diagnosis or shared health issue; 
 involved some form of information exchange where information provided by a 
health professional could be passed on to a third party; 
 empirical studies, including observational studies, surveys or trials; 
 published in English. 
 
Studies were excluded if they were: 
 papers describing communication which was exclusively between healthcare 
professionals or professionals and hospitals or primary care, and without 
comment or opportunity to forward that communication to a patient or 
relative;  
 papers that involved relatives or carers in the receipt of information about their 
unwell relative (the patient) where the information itself had no relevance to 
the health of that relative or carer; 
 papers where the electronic communication under investigation was not using 
email or access to a website (for example: text messaging, or social media, as 
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these were unlikely to be used in a clinical context for confidential 
information); 
 papers that provided clinical or professional guidelines on the use of electronic 
communication within healthcare, or made recommendations for practice; 
 conference abstracts, commentaries, literature reviews or systematic reviews 
which did not contribute any new primary data. 
3.7 Search outcome 
 
The process of screening, eligibility and exclusion identified 3587 (2247 articles in the 
first search, 1340 in the second search) of which 105 were assessed in full text.  
Table 3.1 Systematic search outcome by database 
Database Articles retrieved 
EMBASE (OVID) 2037 
PsycINFO 296 













Only one article was identified that met the criteria:  
 'Communication Among Melanoma Family Members' (Bowen et al., 2017). 
 
3.9 Quality appraisal 
 
Since there was only one article (Bowen et al., 2017) which met the search criteria it 
was concomitant that it would be included in the review. Nonetheless the quality of 
the above article was reviewed and scored independently by two researchers and was 
scored at 75% on the criteria described by Kmet (Kmet L M, 2004). I had anticipated 
finding articles with different methodologies, either qualitative, quantitative or mixed 
methods approaches in the search and Kmet’s approach to quality appraisal would 
have been useful in that situation. This is because it allows the internal validity and 
comparison of studies with disparate designs (Kmet L M, 2004). However, one 
criticism of their checklists are that they give equal weight to a variety of factors (such 
as study design, methodology, sample size, reporting of results) so it would remain 
important to comment on overall quality. 
3.10 Study findings 
The initial search in 2015 did not yield any eligible evidence. One article  (Crotser & 
Dickerson, 2010) identified nearly met the eligibility criteria but an email 
correspondence with the authors revealed that the information shared by family 
members had not been provided by a health care professional. In their study they 
investigated the experiences of eight women from families with a diagnosis of 
hereditary breast and ovarian cancer who had been recruited to the study via a 
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website (FORCE, 2016) and also learnt more about their risks of cancer via the same 
website (Crotser & Dickerson, 2010).  
The only article that met the search criteria provided evidence from a randomized 
controlled trial of a web-based intervention to promote communication and support 
in families affected by malignant melanoma, the ‘Suntalk Study’ (Bowen et al., 2017; 
Bowen et al., 2014; Bowen et al., 2012; Harris et al., 2010). The authors of the article 
'Communication Among Melanoma Family Members' (Bowen et al., 2017) presented 
quantitative data relating to the frequency of communication about family history of 
cancer and level of agreement about specified topics between different family 
members. In this study, communication between individuals who had been diagnosed 
with melanoma (‘cases’)was compared with either a first degree relative of theirs 
(‘FDR’) or another relative who was the parent of a child (aged under 18) described as 
‘parents’. The family triads (n=313) were either given access to the web-based 
intervention over the period of a year (intervention group) or given access to the same 
website at the end of a year (control group). Data were collected via surveys at 
baseline and at one year follow-up. Frequency of communication was assessed using a 
Likert scale but simplified to a dichotomized response of either ‘frequent’ or 
‘infrequent’, thus losing some of the nuanced differences between cases, FDRs and 
parents. Their data did show an increased frequency of communication at 12 months 
and a significant difference between the intervention and the control groups. 
Agreement within pairs (case/FDR and case/parent) regarding a series of statements 
was measured again at baseline and follow-up with comparison between the level of 
agreement about statements in the intervention group and control group. A 
significant alteration in agreement was in response to the statement: “It is important 
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to check their skin for signs of melanoma” which rose from 30% to 78% agreement in 
the intervention case/FDR pairs (p=.001). However, the statement: “tanning lamps are 
a good way to get a tan” also showed a rise in agreement from 24% to 81% (p=.001) in 
the case/parent pairs of the intervention group with no significant difference in the 
control group. Although the authors interpret their data to support the efficacy of the 
web-based information and communication aid, the fact that the frequency of 
communication data is self-reported and only distinguishes between frequent and in-
frequent weakens this argument. The increase in agreement between family member 
pairs does appear to support the inference that the health advice and information on 
the website is being shared between relatives. However, participation in the study 
could prompt further information seeking behaviour by participants, so might not 
solely reflect the impact of the website intervention. 
3.11 Discussion 
 
This systematic search and review elicited only very limited evidence regarding 
studies where information about health issues had been provided to patients and their 
families via electronic means of communication. The data from the Suntalk study did 
indicate that receiving personalised health information via a secure website, coupled 
with emailed prompts to view new information on the website, had a significant 
impact on family members discussing their risk of melanoma. They also found an 
increase in agreement about statements of belief and what action to take to 
ameliorate that risk between baseline and follow-up in the intervention group 
compared to the control group.  
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No synthesis was possible since only one article was identified that provided empirical 
evidence of this issue. However, Bowen and colleagues did emphasize the need for 
further research to more fully understand the processes involved in communicating 
about a familial diagnosis or shared risk. They drew attention to the importance and 
potential to alert family members to a health threat that would enable relatives to 
make appropriate choices for themselves and seek further advice should they wish to 
do so.  
3.12 Limitations 
 
The inclusion criteria were specific to evidence of health professionals’ provision of 
information via methods of electronic communication, where the recipient had the 
opportunity to share or pass on that information to others. The specificity of the 
eligibility criteria meant that only one study fulfilled the criteria. The strict inclusion 
criteria meant that several studies where information was provided to parents or 
carers about their child’s condition (Brown et al., 2016; Hopkins et al., 2016; Osara et 
al., 2017) were not included, although they did investigate the acceptability of using a 
secure website to communicate about health issues. 
Conducting a systematic review was considered the most rigorous approach and 
necessary to identify empirical evidence. However, a realist review or scoping review 
that included ‘grey literature’ might have found more examples of the use of 







With only one relevant article to review, the search clearly indicated the dearth of 
evidence around this topic. It would therefore have been premature to draw any 
conclusions regarding the efficacy of providing more extensive and specific health 
information online and whether this could help those seeking to understand the 
impact of the diagnosis on themselves and their families.  Although it has been 
recognised for some time that giving cancer patients online access to information that 
was specific for them reduced anxiety (Jones et al., 1999) it may also assist those 
patients who wish to accurately inform their relatives.  Indeed, evidence suggests that 
families who talk more openly about health issues appear to cope better with the 
diagnosis and experience less detrimental effect on family functioning (Metcalfe et al., 
2008).  Nonetheless, I did not wish to make assumptions about what patients might 
want, or attempt to provoke change without valid empirical evidence. I concluded that 
it was important to investigate the opinions and preferences of people who were 
themselves living with a health threat. This was necessary in order to meet their needs 
when designing an innovation to support communication with their relatives.  
Although there are now projects focussed on the development of online tools 
specifically designed for information sharing (Anderson, 2016; Harris et al., 2010; 
Myers, Conrad & Terdiman, 2014) or risk assessment (NIH, 2014) there is still very little 
published data to demonstrate their utility.  It has been observed that in countries 
where government funding and infrastructure has supported national 
implementation, such as Portugal, Austria and Australia (Prey et al., 2016), PHR 
systems have been more widely adopted. Therefore, I hoped that my research in this 
area, combined with that of other researchers, might contribute to our understanding 
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of how digital technology can help facilitate disclosure in families with genetic 
conditions and attract support for such systems at national or international level. The 
next chapter describes my aims and objectives based on a culmination of the evidence 
described in the preceding three chapters. In Chapter Five I set out the methods I used 










The evidence presented in the first two chapters indicated to me that there was more 
work to be done to help people understand and come to terms with the implications 
of a genetic diagnosis in the family. It could also be argued that further investigation 
and innovation is needed to improve services and promote healthy behaviours in 
individuals living with an increased risk of cancer. Furthermore, the systematic review 
(Chapter Three) indicated that there was very little evidence relating to the 
acceptability, functionality and application of using either email or websites to 
facilitate communication in families with a shared health threat. 
Enabling those people living with an increased risk of cancer to better understand 
their condition and share that knowledge with their relatives was the focus of my 
research.  Looking for original ways to facilitate information sharing in a manner that 
is appropriate to current and future generations necessitates exploiting new 
technology. In the previous chapter (Chapter Three) I explained how I reviewed 
current evidence of health professionals providing health related information in a 
digital format that was then shared between relatives. 
4.2 Aims and objectives 
Motivated by the evidence presented in Chapters One and Two, and the limited 
evidence found in the systematic review, the aim of this research was to investigate 
whether a secure website could support families with an increased risk of bowel 
cancer to share information with their relatives. 
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The research question was therefore:   
Can a secure website support families with an increased risk of bowel cancer to 
share information with their relatives? 
In order to achieve this aim my objectives were to: 
1. Explore the perspectives of patients, including their experiences of how they 
received information about the familial diagnosis themselves. 
2. Invite patient’s suggestions for improvement (if needed) in the way they were 
told about the familial diagnosis. 
3. Investigate patient’s preferences for information topics and also how they 
would like to receive information, including whether these varied by age or 
gender. 
4. Explore patients’ views about a secure website that provided a platform for 
patients to share documents about their diagnosis with their relatives. 
5. Create a secure website in accordance with the suggestions of participants. 
6. Investigate the acceptability and feasibility of sharing electronic documents 
regarding a familial diagnosis securely online using the purpose built website.   
7. Test the website’s function and acceptability with research participants.   
4.3 Conclusions 
The problems addressed within this research have already been recognised, and the 
importance of addressing the apparent lack of information dissemination was 
summarised by Bleiker and her co-authors: “Without success in these efforts, needless 
deaths will continue to occur despite our knowledge of the genetic aetiology” p.331 
(Bleiker et al., 2013). I acknowledge that there are likely to be limitations to the utility 
of providing information to families, whatever the format. However, I considered it 
both necessary and timely to investigate new ways of supporting families who were 
grappling with these challenges.  In the next chapter I present the methods used to 






In the preceding chapters I have provided the background to my research and given 
the context from which I have approached the issue of communication in families 
about a genetic susceptibility to bowel cancer. In this chapter I will give a brief 
background to mixed methods in healthcare research and explain why I thought it was 
an appropriate method to use in this context. I will present my perspective, how this 
informed my research questions and what methods I have used to answer those 
questions.  
5.2 Strategy 
I have taken a pragmatic approach, both in a practical and a philosophical way 
(Cherryholmes, 1992) to investigate the factors that influence communication in 
families about a genetic diagnosis. Realising at the outset that I was examining the 
issue with the perspective of a health professional, I decided that I needed to learn 
from people who had greater insight than I did, the patients themselves. In order to 
help guide any new development I first wanted to know more about the particular 
difficulties patients had encountered and conversely what approaches had been more 
successful. This realisation indicated to me that I needed to use an inductive approach. 
I considered that a qualitative interview based design for at least part of the study 
would be the most informative way to capture the complex personal perspectives that 




I wanted to know what research had already been done about how helpful it would be 
to share digital documents provided by health professionals. It was also necessary to 
find out more precisely what evidence already existed to inform the method of 
sharing information electronically I would investigate. Consequently I carried out the 
systematic search and review of peer-reviewed published literature (Reviews & 
Dissemination, 2009) already described in detail in Chapter Three. The review was 
quite specific, looking for evidence about the use of electronic communication (email 
or websites) to provide information to families regarding a familial diagnosis, where 
the information had first been provided by a healthcare professional.  
In addition to identifying existing evidence regarding the use of digital communication 
to disseminating health information, I wanted to capture a broad range of different 
patient views. I also wanted to invite as many patients as possible to comment on the 
use of information technology (IT) as a potential vector for receiving and sharing 
health information. Since evidence (Newhouse et al., 2015) has indicated that men are 
more frequent users of email to communicate with healthcare providers than women, 
I was interested in whether there were any differences in attitude to this use of IT 
between the genders. I was also wanted to know if there were variations in 
perspective across different age groups, since younger people have been recognised 
as using more IT for communication than older people (Duggan, 2015). I concluded 
that these questions would be most clearly answered through a quantitative cross-
sectional survey (Colton & Covert, 2007). An added advantage to starting my data 
collection with a survey was that it could be made available online and in a hard copy 
(Braithwaite et al., 2003). The strategy of making the survey available online was 
intended to increase awareness about the research (O'Connor et al., 2014). Based on 
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my clinical experience I also anticipated that I might have difficulties recruiting to my 
research if I was solely reliant on busy NHS health professionals to introduce the study 
to patients within their clinical time.  
Therefore this combined complementary strategy appeared the most appropriate, 
combining both post-positivist and constructivist views and using a combination of 
deductive and inductive approaches (Johnson & Onwuegbuzie, 2004). Combining 
quantitative with qualitative methods of data collection sat within the increasingly 
used pragmatic approach (Borglin, 2015; Collins & O’Cathain, 2009; Mayoh, Bond & 
Todres, 2012) to health care research into complex interventions and was aligned with 
the Medical Research Council (MRC) Guidance (Craig et al., 2008). The table below 
(Table 5.1) gives a summary of the pragmatic perspective, illustrating that this 
approach encompasses different views.   
Table 5.1 Overview of the pragmatic world-view (taken from Borglin, p.34 2015) 
 
Pragmatism  
Methodology Mixed- methods design 
Ontology Multiple ways of viewing, hearing and understanding the world. 
Epistemology Knowledge is not neutral as influenced by human interest. 
Hence knowledge is formed by both objective and subjective 
values. 
Rhetoric Meta-inference, inference quality and inference transferability. 
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I subscribe to the argument that mixing approaches to health sciences research can 
give rise to a more holistic understanding of the phenomena under scrutiny (Ivankova, 
Creswell & Stick, 2006; Tashakkori & Teddlie, 2010). However I am aware that others 
would argue that it is not possible to successfully combine approaches that stem from 
very different research paradigms, since they arise from contrasting sets of 
assumptions about what reality and knowledge really are (Guba, 1990). Mixed method 
research runs the risk of being muddled in its approach by seeking to assimilate the 
opposing ideas of the positivist scientific paradigm of quantitative research and the 
interpretivist or constructivist paradigms of qualitative research (Mayoh, Bond & 
Todres, 2012). Clearly there are many different ways methods can be mixed. However 
it should be possible to remain mindful of the tension that exists between these 
paradigms in order to apply the alternative approaches as complementary 
contributions to understanding the research question within a single study (Sale, 
Lohfeld & Brazil, 2002). Pluye and Hong (Pluye & Hong, 2014) describe the breadth of 
the discipline of mixed methods research, encompassing as it does many 
combinations of approach, and they proposed the following definition:  
“Mixed methods research is a research approach in which a researcher or team of 
researchers integrates (a) qualitative and quantitative research questions, (b) qualitative 
research methods and quantitative research designs, (c) techniques for collecting and 
analyzing qualitative and quantitative data, and (d) qualitative findings and quantitative 
results” p. 30 Pluye & Hong 2014. 
This definition makes the distinction that the different approaches should be applied 
to different and appropriate aspects of the research question, forming a kind of 
‘jigsaw’ of interconnected parts rather than an undisciplined amalgamation of merged 




5.3 Design  
In order to investigate my research questions as stated above in Chapter Four (Section 
4.2) I anticipated that the integration of different methods of enquiry would also 
provide more scope for an iterative process of development of the innovation. This is 
where the design of the project would allow for feedback loops where there was 
sufficient flexibility for emerging insights to be incorporated into the investigation. 
This would also link the process of testing feasibility with development and vice versa 
as described in the MRC guidance (Craig et al., 2008). The intention was to gather 
information with both depth and breadth in order to more fully investigate such 
complex phenomena (Mayoh, Bond & Todres, 2012). This type of convergent mixed 
method design was utilised by Mayoh et al (Mayoh, Bond & Todres, 2012) when they 
used a questionnaire to gather broad quantitative data concurrently alongside 
qualitative interviews conducted with a group of participants drawn from their survey 
respondents.  
Previous studies which have sought to investigate patient experiences and 
satisfaction with health care have concluded that quantitative survey measures are 
sometimes insufficiently sensitive to measure small changes or variability in quality of 
care experienced by patients (Andrew et al., 2011). In the context of this investigation 
into patient views of how they would like information provided, quantitative data was 
necessary to distinguish some of the differences in attitudes between different 
groups. However a cross-sectional survey was unlikely to provide sufficient insight 
into the direction needed for improvement and therefore integrating qualitative data 
was necessary to provide that understanding (Andrew et al., 2011) 
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In conclusion, the design of this research project was a pragmatic mixed methods 
study (Ivankova, Creswell & Stick, 2006). In order to capture the views and 
experiences of a range of individuals and achieve triangulation (Creswell & Clark, 
2007) I combined both a quantitative approach and a qualitative approach in the 
different phases of the research. Through triangulation I sought to achieve 
consistency and convergence of the conclusions reached. I applied these methods in 
order to attain some complementarity (Borglin, 2015) as the different approaches of 
the questionnaire and interviews were intended to investigate different aspects of the 
problem of sharing information in families and thereby lead to deeper interpretations 
and conclusions (Farquhar, Ewing & Booth, 2011).  
5.4 Methods  
The first phase was a cross-sectional survey (Colton & Covert, 2007)of individuals who 
were already aware that they were at increased risk of bowel cancer. The 
questionnaire was self-completed with a mixture of closed and open questions. I 
sought to elicit the experiences of participants about how they had learnt of their risk; 
what information they had received at the time; what further information they had 
looked for and how they felt this process should be improved. In addition, participants 
in the survey were asked to reflect on alternative methods of information provision 
and how they themselves might communicate with their relatives about such issues. 
The survey consisted of 20 questions, which included six optional open questions with 
free text boxes which invited participants to comment or suggest improvements to 
the situation they had experienced. Hence these open questions were intended to 
capture qualitative data to supplement responses to the multiple choice questions. 
The survey was launched online via a link on the charity website Lynch syndrome UK 
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in December 2015. More advertisements were placed online via other organisations in 
January 2016, which are described in more detail below in section 5.8.3.   
The second phase of the Family Web study was gathering qualitative data about the 
same issues through semi-structured telephone interviews with a purposive sample of 
survey participants who had volunteered to help with further research. These 
interviews commenced in April 2016 while the Phase 1 survey was still ongoing. This 
allowed a convergent approach to the data collection with adaptation of the interview 
questions to further investigate issues that were emerging from the survey data. 
The third phase was development of the website innovation with recently diagnosed 
patients (diagnosed within two years of receiving their invitation to participate). 
Guided by the data gathered through the survey and telephone interviews, website 
content was written to meet the needs of this patient group. The website was then 
tested through a series of Think-Aloud interviews with twelve participants, allowing 
an iterative process of data collection, analysis and adaptation of the website. The 
people who participated were either patients recruited through the clinical genetics 
services or respondents to the survey who had volunteered for interview and were 
diagnosed less than two years before their participation in the survey. The criteria of 




Figure 5.1 Illustration of the interaction between the different phases of the study 
See the Family Web Study timeline (Appendix 9) for illustration of the timing of 
recruitment and data collection across the three phases of the study. 
In order to facilitate contact by potential participants a generic email address was set 
up (familyweb@plymouth.ac.uk) and a mobile phone was purchased. Both the mobile 
phone number and email address were on the advertisement (Appendices 10 and 13) 
and Participant Information Sheet (PIS) (Appendix 15) to give a choice of contact 
method. 
5.5 Patient involvement 
I wished to involve a group of individuals who were from families with a genetic 
diagnosis or who had a personal diagnosis of an increased risk of bowel cancer. This 
was in order to ensure that the study was aligned to the needs of the patient group it 
was intended to investigate. Therefore an appeal for volunteer patient advisors was 
displayed at a national meeting of the support group ‘Lynch Syndrome UK’ in 
Birmingham in April 2015. This was a printed notice with a sign-up sheet briefly 
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describing the study and requesting help which was displayed near the coffee area at 
the conference. Slips with my contact details were also made available and I had been 
introduced to all participants at the event to encourage those who might want to 
approach me for more information about the study. Eight people signed the sheet, 
providing their telephone numbers and email addresses and indicating that they 
would be interested in being patient advisors. I contacted these people by telephone 
or email to discuss how best to proceed. Six people agreed to review the draft survey 
questionnaire, patient information sheets and consent forms, providing advice about 
the wording of these documents and the questions in the questionnaire. These same 
six people then completed two questionnaires each of the final version of the 
questionnaire to enable validation of the online versus the paper copy questionnaire. 
In addition to the patient volunteers recruited through Lynch Syndrome UK, the study 
was registered on the National Institute for Health Research INVOLVE database 
[http://www.invo.org.uk/]. This public access database was seen as a way of 
encouraging public involvement in the research (Appendix 2). Providing details of the 
study on this platform (Goodman, 2015) was intended to broaden the opportunity for 
people who had an interest in this issue to become involved as lay advisors to the 
project, however no approaches were received via INVOLVE. 
5.6 Approvals process 
5.6.1 Ethical approval 
Application for National Health Service (NHS) ethical approval was submitted on 3rd 
August 2015, presented to the Health Research Authority (HRA) South West Research 
Ethics Committee (Appendix 5) on 3rd September 2015 and full HRA ethical approval 
granted on 8th October 2015 (Appendix 6). 
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Initially twelve different clinical geneticists had been approached by letter (Appendix 
16) or email as potential clinical collaborators, with later face-to-face discussions. 
Verbal and written agreement was reached with clinicians who were going to be 
principal investigators (PI) for the study at West Midlands Regional Genetics Service in 
Birmingham, All Wales Medical Genetics Service in Cardiff, Peninsula Clinical Genetics 
Service in Exeter, North West Thames Regional Genetics Service and the Guy's 
Hospital Department of Clinical Genetics in London, plus the Colorectal Surgery and 
Endoscopy units at Plymouth Hospitals NHS Trust in Plymouth. Plymouth University 
ethical approval was granted in October 2015 (Appendix 4) on Chairman’s action 




Figure 5.2 Diagram giving a timeline of the NHS ethical and research 




5.6.2 Application and amendments 
Approval for local site specific research and development (R&D) was obtained on 18th 
January 2016 at the lead site of Plymouth (Appendix 7). Subsequent applications to 
the other local sites were made with supporting localised documentation in 
accordance with HRA guidelines. The site specific forms were submitted via the IRAS 
online platform. Due to local variations in requirement, approval was obtained across 
the different recruitment sites between January 2016 and September 2016. An 
additional application to the Health and Care Research Wales Permissions office was 
made in order to have authorisation to recruit via the All Wales Clinical Genetics 
Service (Appendix 8).   
A letter of access (LoA) was provided by Plymouth Hospitals NHS Trust in January 
2016 to allow me to visit the site and assist clinical staff in their decisions about which 
patients were eligible and should be approached about the study. This was used by 
me to assist staff in the Endoscopy unit where eligible patients were not necessarily 
known to the Peninsula Genetics Service. Subsequently I was granted a Research 
Passport on 8th February 2016 which allowed me to visit clinical units if necessary to 
assist local research teams in any of the six recruitment sites.  
A substantial amendment to the HRA ethical approval was submitted in November 
2016 (as previously arranged with the HRA ethics committee). This amendment 
(Appendix 22) provided more detailed information regarding the content of the 
Family Web website and was necessary prior to commencing recruitment to Phase 3. 
A non-substantial amendment was made in June 2017 (Appendix 23) to extend the 
period of recruitment to 30th September 2017 as the projected 14 months of 
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recruitment was due to expire at the end of June 2017 and more volunteers were still 
needed at that stage. 
5.7. Recruitment 
5.7.1 Amended recruitment criteria 
The amendment to the HRA ethical approval described above also included a change 
to the protocol (Appendix 3) that allowed broader opportunities for recruitment to 
Phase 3. This change allowed for the recruitment of people who had already 
completed the Phase 1 survey, as long as they were diagnosed within the last two 
years and had indicated that they would be happy to be interviewed. 
Recruitment to the study was either online or through NHS clinical centres. More 
detailed descriptions of each part of the study are given below within the relevant 
section for each phase. 
5.7.2 Participants 
The study sought to capture the views, opinions and experiences of family members 
living with a genetic susceptibility to bowel cancer. Therefore the inclusion criteria 
were that participants were over the age of 17 years and also one of these below. 
• Part of a family which was deemed to have an increased risk of bowel cancer 
due to their family history, or where a genetic vulnerability to bowel cancer 
had been found. 
• Had themselves been recommended to have bowel screening by colonoscopy 
on the basis of their family history of cancer, or where they were from a family 
where regular colonoscopy has been recommended for this reason. 
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• Or had been diagnosed with cancer, which they had been told was due to an 
inherited vulnerability to bowel cancer, such as Lynch syndrome, where their 
close relatives had been recommended to have regular colonoscopy. 
 
Participants needed to have had time to adjust to their diagnosis so they were only 
eligible if their diagnosis (genetic or cancer) was made three or more months before 
recruitment. All participants had to be competent in reading and speaking English to 
take part in the study. 
Anyone eligible for this research would have already been given a recommendation to 
have regular bowel screening on the basis of their increased risk of bowel cancer. 
Since the criteria for eligibility was that they should be aware of their risk, the concept 
should not have been novel or alarming to them. However, prior to potential 
participation in the study, patients were provided with information sheets explaining 
whether they were eligible and what the study involved. Every information sheet 
included my telephone number and email address should participants have any 
questions. I had expected that potential participants might have had questions about 
their risk, their eligibility or the study in general. In fact over the course of the study, 
only six potential participants contacted me by telephone, two to clarify if the survey 
was still open and four to discuss what would be required in order to take part in the 
Think-Aloud interviews. 
Patients were excluded from taking part in the study if they were receiving active 
treatment (radiotherapy or chemotherapy) for any cancer or were diagnosed with any 
cancer within the previous 3 months. However, patients who were considered in 
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remission or who were taking maintenance medication were considered eligible to 
take part as long as they were diagnosed at least three months previously. These 
criteria were to avoid giving greater burden to cancer patients while they were 
experiencing an acute phase of their illness. 
5.8 Phase 1 anonymous cross-sectional survey 
5.8.1 Phase 1 Design 
In Phase 1, a cross sectional survey design was used (Morris, 2004) administered both 
online (using SurveyMonkey https://www.surveymonkey.com/) and in paper format 
(Stern, Bilgen & Dillman, 2014). The questionnaire was designed to elicit the views of 
a broad cohort of individuals. The paper copy version was an eight page A4 booklet 
and is reproduced in Appendix 18. The overarching objective of the questionnaire was 
to assess participants’ experiences and attitudes to different types of communication 
both within the family and with health professionals; what information they had 
received and whether this was all they wanted. I was also interested in participants’ 
views on what could be improved and the topics where they felt they would like more 
information. 
I wanted to look at the influence of gender as my own clinical experience and 
published evidence both indicated that women are more likely than men to talk about 
the genetic diagnosis in their family (Bartuma, Nilbert & Carlsson, 2012; Chivers 
Seymour et al., 2010; Koehly et al., 2009). In addition, men and women have been 
found to use IT differently to communicate, with men being more task focussed in 
their communication (Kimbrough et al., 2013). Also men have been found to use email 
more frequently to contact their GP (Newhouse et al., 2015) therefore I was 
particularly interested in any gender differences in responses. 
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Younger people are recognised as being more frequent users of the Internet, email 
and social media for communication (Newhouse et al., 2015; Poushter, 2016). In order 
to investigate novel methods of providing information about a genetic diagnosis I had 
envisaged that younger participants to the survey would indicate a preference for 
receiving information by email, a website or via social media.  
I was also aware that by making the survey available online this might have attracted 
responses from people who were more confident or comfortable with digital 
communication (Sax, Gilmartin & Bryant, 2003). The questionnaire was also available 
in a paper copy format in order to try and elicit the views of all eligible patients. 
However, I expected that there might be differences in response to questions about 
preferences of mode of information provision between those who responded online 
and those who responded via the paper questionnaire. 
Participants were asked if they had been diagnosed with bowel cancer, any other 
cancer, or no cancer, as I expected that the information needs might be different 
between these groups. Evidence has shown that people diagnosed with cancer have 
less anxiety when given information that is personalised or specific to themselves 
(Jones et al., 1999). Also, relatives who are living with the knowledge of their risk of 
cancer, but currently well, might have different needs and interests from those people 
already diagnosed with cancer. 
The questionnaire was available online to reach respondents across a wide 
geographical distribution, to reduce costs and facilitate completion (Fink, 2012). The 
target for recruitment was 300 participants to the survey phase of the study. I had 
calculated that if half of the projected sample of 300 were to give clear preferences, 
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for example for information provided by email, this would give a 95% confidence 
interval of 44% to 56% for that estimate. This was an acceptable level of precision for 
the study. 
The concurrent triangulation design of this study allowed for data collection from the 
questionnaire responses to continue while some participants were taking part in the 
Phase 2 telephone interviews and Phase 3 Think-Aloud interviews.  
5.8.2 Phase 1 Participants 
Patients were considered eligible if they had already been advised to have regular 
bowel screening by colonoscopy to prevent or detect cancer in accordance with 
guidelines (Cairns et al., 2010). The criteria are described above in Section 5.7.2 so it is 
not necessary to repeat them here in detail, apart from noting that patients were 
eligible because of their relationship to someone who had been diagnosed with a 
genetic vulnerability to bowel cancer, whether or not they had chosen to have a 
molecular genetic test to find out if they had inherited the familial genetic variant. The 
key aspect of eligibility was whether they or their relative had been advised to have 
regular bowel screening by colonoscopy. In this phase of the study the experiences of 
being informed of the diagnosis and sharing information about that in the family was 
sought from participants. Therefore research teams and clinicians at the recruitment 
sites were encouraged to approach patients who had been given their diagnosis over 
two years previously. 
5.8.3 Phase 1 Recruitment 
Potential participants from across the UK were approached through online 
advertisements (Appendix 10) and links on the charity websites of:  
116 
 
Lynch Syndrome UK (https://www.lynch-syndrome-uk.org/research) 
(Appendix 12) 
 
Bowel Cancer West (http://bowelcancerwest.com/),  
Beating Bowel Cancer via their online community forum 
(http://community.beatingbowelcancer.org/forum/research-and-media-
opportunities/) 
FAP Gene Support Group (http://www.fapgene.com/phdsurvey.html)   
Also cancer charity Macmillan through ‘Macmillan Evidence’ tweeted a link to the 
survey (https://twitter.com/mac_evidence?lang=en as @Mac_Evidence)  
In accordance with the planned process for recruitment (Appendix 11) A4 printed 
advertisements (Appendix 13) were put up and information leaflets were distributed in 
the endoscopy clinic, in colorectal surgical outpatients’ clinics and the Macmillan 
Centre in the local recruitment centre in Plymouth NHS Hospital Trust.  In addition, 
locally headed copies of the PIS (Appendix 15) and invitation letters (Appendix 17) 
were distributed to eligible patients through the approved recruitment sites at five 
NHS clinical genetics services in England and Wales. I was recruiting through different 
regional genetic services, plus online, in order to involve participants from different 
geographical areas.  
Potential participants who were considered eligible by clinical staff after checking 
against the checklist (Appendix 14) were approached during their clinic visit, posted 
information about the study with their post clinic letter, or approached by letter via 
the research administrators at each recruitment site. A reply paid envelope was 
provided for those participants who used the paper format questionnaire.  
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The survey questionnaire concluded with an invitation to take part in further research. 
If participants, having read and understood the PIS and consent form, wished to be 
interviewed they were asked to contact the research team or provide their contact 
details on a separate sheet or via a different webpage, thus ensuring participant 
anonymity was preserved. 
5.8.4 Phase 1 Data collection methods 
Data were collected through completion of the survey questionnaire, either online or 
in paper copy. Nominal categorical data were collected using fourteen multiple choice 
questions.  There were also six open questions with free text boxes inviting more 
detailed responses or elaboration to some answers. In addition, one question had a 
Likert type scale giving a range of options between “very unhelpful” and “very helpful” 
to different formats for receiving information (see questionnaire in Appendix 18). The 
items on the questionnaire were divided into sections. The reliability of the 
questionnaire was only assessed in terms of the variation in responses by the patient 
advisors who answered both a paper copy and an online copy of the questionnaire. No 
attempt was made to assess internal consistency or construct validity of the questions 
prior to data collection. 
5.8.5 Phase 1 Data analysis methods  
The data collection strategy allowed for a responsive dynamic and evolving 
interpretation of the qualitative data in conjunction with the process of gathering 
more quantitative data. This was a nested analysis (Lieberman, 2005) which utilised 
the benefits of both methods of data collection simultaneously and allowed for the 
investigation and interpretation of this complex issue. Qualitative data from free text 
responses were coded and analysed for recurrent themes (Joffe & Yardley, 2004; 
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Leech & Onwuegbuzie, 2011) using NVivo qualitative data analysis Software (QSR 
International Pty Ltd. Version 11, 2015). The quantitative data from the cross sectional 
survey (Colton & Covert, 2007) was analysed using descriptive statistics in Microsoft 
Excel (2016 version) and using SPSS software (IBM SPSS statistics version 22).  
The majority of the questions in the survey elicited nominal categorical data, with only 
two questions having ordinal responses and the remainder being free text. 
Consequently the statistical tests that were appropriate were bivariate analysis 
through contingency tables and non-parametric tests. Pearson’s Chi Square or Fisher’s 
exact tests were used to give a measure of association between categorical variables. 
Since Chi Square is calculated based on the sum of the differences between the 
observed and expected counts in each cell, it is less accurate for small samples where 
the cell count falls below 5. Therefore when tables contained cells with small values 
the Fisher’s exact test was used to calculate association between variables. These 
calculations were done using either Excel or SPSS software.  
The responses to the Likert type questions were analysed as ordinal data using 
descriptive statistics to show central tendencies and Chi-squared as a measure of 
association (Boone & Boone, 2012). In addition, the Likert type responses to question 
10 were coded numerically. Then the mean scores for each different part (paper 
leaflet, follow-up appointment, etc) of the question were calculated. This made it 




5.8.6 Phase 1 Research rigour 
Validation was carried out of the online questionnaire versus the paper copy 
questionnaire with the help of six Patient Advisors, all of whom had a diagnosis of 
Lynch syndrome. Each patient advisor was sent a paper copy of the questionnaire and 
the link to the online questionnaire by email. They were equally divided so that half 
received the online version first and half received the paper copy questionnaire first. 
Their responses were received and collated to allow comparison in December 2015.  
5.8.7 Phase 1 Ethical issues  
Phase 1 Freedom from coercion 
The survey was designed to avoid being intrusive as it was optional and anonymous. 
The survey could be completed at a convenient time to participants and they could 
stop after partial completion of the survey and return to it later. Participants had the 
option of completing the survey online or via a paper copy (supplied with reply paid 
envelopes). Survey questionnaires were given out in clinics with a PIS and an invitation 
letter or alternatively these were sent out by post. These strategies were designed to 
avoid any coercion to participate and the optional nature of the survey was stressed in 
supporting information. 
Phase 1 Consent 
The act of completing the anonymous survey questionnaire and returning it was taken 
as assent to taking part, therefore explicit consent was not required prior to 
completion of the survey. 
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Phase 1 Confidentiality 
The confidentiality of participants was maintained throughout the survey. No clinical 
details were required for participation in the survey and participation was anonymous. 
Participants who wished to volunteer for further involvement with the research had a 
separate form or tear off slip in order to maintain the anonymity of their responses 
and participants could choose to give a pseudonym. Completed questionnaires were 
kept in a locked filing cabinet in a secure room in the University and online responses 
were password protected and only accessed by me in order to ensure the 
confidentiality of participants. 
Phase 1 Emotional reactions 
It was anticipated that some participants might experience emotional reactions to the 
survey. These might be feelings of guilt or an increased concern regarding their 
susceptibility to cancer. The survey questions could have evoked latent cancer fears as 
participants were reminded of their own increased risk. However, evidence from 
genetic counselling, and experience from my own clinical practice, suggested that 
such psychological distress would usually be short lived following genetic counselling 
or genetic testing (Burton-Chase, Gritz & Peterson, 2013) and to my knowledge there 
was no evidence to indicate that questionnaires would cause more distress.  
Participants might have experienced feelings of guilt in relation to their fears for the 
health of their children or grandchildren (Chivers Seymour et al., 2010). In addition, 
these feelings could also have arisen because taking part in the study reminded 
participants that they had not communicated with all their relatives about the shared 
risk of cancer. Evidence (Lucassen & Parker, 2010) indicates that people with a genetic 
vulnerability to cancer do realise that they have a duty to warn their relatives, but they 
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can experience a conflict between the desire to protect their family from anxiety and 
distress and the knowledge that their relatives could reduce their risk of cancer 
through regular screening, taking medication and symptom awareness.  
5.9 Phase 2 telephone interviews 
5.9.1 Phase 2 Design 
This part of the study was conducted using qualitative methods, more specifically a 
thematic analysis (Boyatzis, 1998; Braun & Clarke, 2006; Vaismoradi et al., 2016) to 
enhance and provide more in depth information about participants’ experiences and 
their needs in relation to sharing health information in the family. 
5.9.2 Phase 2 interview participants 
Participants for the telephone interviews were drawn from people who had already 
responded to the survey, who had indicated that they were willing to take part in 
further research and who had provided their contact details. The eligibility criteria for 
this phase was the same as for the survey detailed above in Section 4.8.2 (Phase 1 
participants). A purposive sample of respondents to the survey, with maximum 
variance for age and educational qualification and with equal numbers of men and 
women (Bryman, 2006) was selected by anonymously sorting the list of interview 
volunteers using an Excel spreadsheet, sorting by gender, age and qualification. 
5.9.3 Phase 2 Recruitment strategy 
This phase of the study used a nested sampling design (Onwuegbuzie & Collins, 2007) 
where participants for the telephone interviews were recruited via an invitation to 
take part in further research at the end of the survey questionnaire with an optional 
tick box and tear off slip. These slips were laid out so that they could be separated 
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from the questionnaire and returned using the Freepost address. This meant that 
participants in Phase 2 could have known about their diagnosis, or the diagnosis in the 
family, for some time and were therefore drawn from the same population of patients 
as for Phase 1. 
Participants in Phase 1 who volunteered for Phase 2 were sent an email 
acknowledgment indicating that their offer to take part in further research had been 
received. If they had only provided a telephone number then a telephone message 
was left giving the same message. If they were selected for interview they were 
approached either by telephone or email (dependent on their preferred method of 
contact) and given more information about the study and the interview process. If the 
participant decided that they wished to take part they were asked to give a telephone 
number and then a mutually convenient time for the interview was agreed. 
5.9.4 Phase 2 Data collection methods 
Semi structured telephone interviews were used to collect data from a purposive 
sample of respondents to the survey, with maximum variance for age and educational 
qualification and with equal numbers of men and women (Bryman, 2006). The digital 
recordings of the interviews were then transcribed to allow coding and subsequent 
analysis by content and theme (Joffe & Yardley, 2004). Data were collected from 
fourteen interviews in order to better understand the difficulties encountered and 
preferences for information of people of different ages and both sexes. Fourteen 
interviews (six men and eight women) were sufficient to reach saturation of themes 
(Ponterotto & Grieger, 2007; Vaismoradi et al., 2016). 
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5.9.5 Phase 2 Data analysis methods 
Phase 2 data analysis was based on a qualitative thematic analysis approach using 
both deductive and inductive coding (Boyatzis, 1998; Joffe & Yardley, 2004; Strauss & 
Corbin, 1998). This was done in order to define concepts of interest or concern and 
develop information most suited to the needs of the potential recipients. Primary 
analysis was deductive using descriptive coding and content analysis, focussing on 
how the participant had been informed of their risk, how health issues were 
communicated in the family and which topics they would like more information 
about. Secondary analysis was inductive and sought to develop theory regarding what 
facilitated or impeded communication in the family over health issues.  
A coding frame was developed specifically looking at signs of adaptation (Biesecker & 
Erby, 2008) and was applied to the data then there were a range of signs detectable in 
what participants said. The coding frame (Chapter Seven, Table 7.3) gives some 
examples of adaptation. Features that were considered key to demonstrating 
personal adaptation were included, such as: whether the participant spoke positively 
about the diagnosis; referring to the benefits of knowing; but also whether they 
communicated with their relatives or others about it; sought additional information or 
took action to adjust to the new ‘threat’.  
 
5.9.6 Phase 2 Research rigour  
Following each interview I wrote reflective notes which captured my thoughts about 
the experience of the interviews. Although my positioning as a female genetic 
counsellor (coming with the perspective of a health professional) remained the same, 
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the way the interaction had gone with the interviewee and any technical problems 
they had encountered were noted. These notes contributed to the reflexivity of the 
analysis (Berger, 2015). 
5.9.7 Phase 2 Ethical issues  
Phase 2 freedom from coercion 
In order to avoid coercion, eligible patients were either sent or given information 
about the study as a PIS. They were provided with consent forms that they could sign 
at a later date having had the opportunity to consider what participation might 
involve and discuss this with me. Prior to starting each of the interviews participants 
were reminded that they are free to be involved and could stop the interview at any 
time without compromising their care.  
Phase 2 consent 
At the beginning of each telephone interview, before recording began each 
participant was asked about the different aspects of the consent form. This was done 
to ensure that they were completely happy with taking part and aware that the 
interview was going to be recorded. They were invited to ask any questions they 
might have about the study and if they were happy to proceed, also being reminded 
that they could withdraw and stop the interview at any time. Their permission to have 
the interview recorded was checked. 
Phase 2 confidentiality 
Maintaining the confidentiality of participants was very important so I was the only 
person conducting the interviews in Phase 2 and had access to the participants name 
(or pseudonym) plus their email address or telephone number in order to set up the 
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interview at a mutually convenient time. The names of participants were changed in 
the transcripts of the interviews to protect their identity.  
Participants who completed the online or paper survey did have the opportunity to 
contact me directly to express their interest in taking part in an interview before they 
made a decision about whether to do so. Although some survey respondents were 
then identified to me by this their responses were not linked to their names so they 
remained anonymous. When participants indicated that they were willing to be 
interviewed they provided their preferred method of contact (email or telephone) 
using the tear off slip at the end of the questionnaire. These personal details could 
then be posted or sent separately from their survey responses in an additional reply 
paid envelope. Those participants that said they were happy to be contacted about 
being interviewed were able to choose to use an alias, pseudonym or username to 
conceal their identity. Participants’ data remained confidential at all times. Consent 
forms and all data generated by the study were kept in a locked filing cabinet within a 
secure office. 
Phase 2 emotional reactions 
I had anticipated that the interview process could provoke unpleasant emotional 
reactions in some participants. These would be the same emotional reactions 
described in Section 5.8.7. Therefore I was prepared for them experiencing a 
heightened anxiety in relation to cancer, and also possible feelings of guilt or remorse 
if they had been reminded about how the inherited risk of cancer could affect the 
health of their descendants or other relatives.  
Although it would not necessarily be obvious at the time of interview, if any of the 
participants had become very distressed during their telephone interviews they would 
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have been asked if they would like the interview to be suspended. This was a planned 
strategy in order to minimise their distress. As a Registered Genetic Counsellor my 
clinical experience talking to people about these issues in a sensitive way gave me 
confidence to respond appropriately if a participant did become upset. 
In addition, had any of the participants experienced distress or voiced concern they 
would have been encouraged to seek the advice of their GP (if they had any physical 
symptoms that gave them concern).  Alternatively, I would have advised them to 
contact their genetic counsellor or colorectal specialist nurse. If someone had 
experienced profound and intrusive feelings of guilt, or other negative emotions, they 
could have sought appropriate referral through their GP for supportive care.  
5.10 Website development 
5.10.1 Identifying web designers  
Six web-development companies (ICO3, Modern websites, Robert Stillwell, Live IT 
Solutions, Papertank and Kevin Hamer at University Hospital Southampton) were 
identified either by personal recommendation or links via NHS websites. 
Invitations to quote for the contract to create a website were sent by email to the 
above companies in October 2015. Attached to the email (Appendix 40) was a 
PowerPoint file ‘Family Web planning’ (Appendix 41) which explained the 
requirements of the planned website and included hyperlinks to other sites which 
might be relevant such as Kintalk.org and Patients Know Best.  From these web 
development companies Modern Websites https://www.modernwebsites.co.uk/p-
website-design-services was selected because they provided the most competitive 
estimate for the work, they also engaged with the concept and the developer had 
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previous experience working on academic projects. Partial funding for my research, 
which included funding for the website development, had been secured through a 
research grant awarded by the charity ‘Bowel Cancer West’. The funding provided by 
the charity limited the cost of website development to £4,500.  
5.10.2 Initial development stages 
Initially it was necessary to create a domain name that was registered and therefore 
could not be used by any other organisation or individual. We agreed that this would 
be www.familyweb.org.uk rather than www.familywebstudy.org although both were 
available. Registering the domain name incurred a small annual cost and the process 
was managed by the web developer. 
In order to guide the developer regarding the requirements of the website it was first 
necessary to map out the different ways information could be provided to the patient 
users and how they might distribute it. This was a visual way of representing the 
underlying function of the website. Initially we worked from the PowerPoint slides I 
had provided initially that specified the brief and then I created an image representing 
the function. 
Discussions with the web developer allowed me to emphasise the key issue of data 
security and confidentiality. Once the quote for work had been accepted and an initial 
fee paid Modern Websites provided a link to their account at ‘Shutterstock’ © which is 
a company providing licenced images. We had email correspondence and some 
telephone calls to discuss how the website would be structured (examples of an email 
in Appendix 42). At the recommendation of the webdeveloper we created an initial 
stage, ‘Stage I’ as a mock up of the website using dummy data. The Patient Advisors 
were then given the opportunity to comment on the appearance of the Stage I 
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website. Subsequently a ‘Stage II’ live website was set up to reflect the comments of 
the Patient Advisors. At all stages of the development the content was written by me 
with the exception of brief functional commands, such as “Click here for more 
information”, which were written by the webdeveloper. 
A feature of the website that was necessary to enable it to be viewed on different 
devices was that it was ‘responsive’, this meant that the style elements of the website 
would adapt to a given screen size. For example, the images would be proportionately 
smaller if viewed on a smartphone, allowing more room on the screen for the written 
content to be viewed. This was achieved by the developer through an instruction in 
the software (a script) which checked what type of device the website was being 
viewed on and changed some of the functionality accordingly. 
5.10.3 Testing the prototype website  
The developer and I had agreed that to achieve sufficient security it would be 
necessary to have a free membership system where users created their own login. 
This represented the ‘front end’ and would be preceded by a short explanation about 
the purpose of the website. In addition to the document sharing function I wanted to 
provide freely available generic information. The choice of information that appeared 
on the website in the open access pages was determined by the results of the Phase 1 
survey and the Phase 2 interviews. I organised this content using a life course 
approach entitled ‘Your Journey’ (see PowerPoint slides (Appendix 43)). I shared and 
discussed this approach with the developer by telephone and email. The final version 
of the text on each page of the website was written by me and emailed as Word files 
to the developer to insert into the various webpages. I also suggested which images 
should accompany each of the different passages of text. 
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The priority was to create this front end before going on to Stage II which would be 
the core functionality of the system with file sharing between health professionals, 
their patient ‘users’ and the patients’ relatives. We agreed that it was important to 
keep the amount of personal data required by the system to the absolute minimum. 
He explained that part of the security would be achieved through the site creating 
unique passwords to protect digital files in folders. At each point of the process people 
viewing files would only be able to do so if they had received an encrypted password 
created by the system which could not be shared with third parties. We acknowledged 
that once a file had been downloaded from the site by the user (or their relative) then 
it was up to that person how they protected the confidentiality of their documents.  
The purpose of the site was intended to be equivalent to sharing an information 
leaflet or clinical letter in hard copy but being able to do so in a digital format. The 
resulting structure of the website was in effect a very secure database with multiple 
levels of encryption (Appendix 35) which meant the security of documents was well in 
excess of that prescribed by the NHS (Appendix 34).  
The function of the Stage II website was subsequently tested with volunteers of 
various ages who were happy to test the role of the Patient User with dummy 
documents. The web developer had already tested the function with his own selection 
of alternative pseudonyms but he needed to check that he had not missed anything.  I 
created a login for myself as a ‘health professional’ member and also as a ‘patient’ 
user. This enabled me to see the email invitations that the website generated when a 
health professional was inviting their patient to access the documents they had 
uploaded. I was also able to see the invitation emails that a patient would generate 
when sending an encrypted link to their relatives by using my own personal email as if 
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I were a relative. We amended the wording of the invitation email slightly and some of 
the volunteers sent me screenshots of what they saw on their computers at each 
stage to check that it was as planned. 
One initial change that we made at this stage was the choice of banner images. The 
developer had set up the Stage II website with a series of changing images on the 
banner at the top of the page. I thought this was distracting from the written content 
so I asked that he make the banner a still image as I thought it would be better at 
orientating the reader to the different ‘pages’ of the website. I also chose which 
images appeared on each page using a selection of images suggested by the 
developer. 
5.10.4 Stage III website testing and iterative development 
The ‘Family Web’ website www.familyweb.org.uk/ (Appendix 26 screenshot of the 
homepage) was intended to function as an alternative means of sharing health 
information with at risk relatives. Since the website would enable health professionals 
to upload documents we made it flexible to allow a range of file formats (e.g. word 
files, pdfs, jpeg, etc). I intended that this might facilitate sharing health information by 
patients with their relatives. In order to test the function I created documents in 
different digital formats (mostly pdfs and word documents) that I could use as dummy 
documents to upload and share in my tests or to demonstrate the website function 
with volunteers. 
5.10.5 Timescale of development 
Although agreement was reached commissioning Modern Websites to build the 
Family Web website in October 2015, work on it did not start in earnest until June 
2016. Over 150 emails were exchanged with the web developer during the course of 
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creating the website between June 2016 to the end of November 2017 discussing all 
aspects of the process. My academic supervisors proof read the content and made 
suggestions for improvements both in the function and content of the website during 
this period. A more detailed description of the process of website development in 
response to the Think-Aloud interview data is given in Chapter Eight and a timeline 
illustrating the iterative process of development is given in Figure 8.7.  
5.11 Phase 3 Think-Aloud interviews 
5.11.1 Phase 3 Study design 
Phase 3 was guided by the results of the survey and interviews in Phases 1 and 2.  The 
Family Web website was developed and tested with eligible participants through an 
iterative series of twelve Think-Aloud interviews (McDermott et al., 2010). These were 
semi-structured interviews conducted through an online video conferencing platform 
called GoToMeeting (LogMeIn, 2017) where the participant navigated through the 
website and voiced their thoughts about the website during the recorded interview.  
5.11.2 Phase 3 Participants 
The participants in Phase 3 were patients who had been given a diagnosis of an 
increased risk of bowel cancer and advised to have regular bowel screening by 
colonoscopy. The criteria for eligibility was as quoted above (Section 5.7) but in 
contrast to Phases 1 and 2 the people who were eligible for Phase 3 were more 
recently diagnosed. I was looking for people who knew about the risk of cancer in their 
family but I hoped they might still be trying to share information with their relatives. 
Interviews were conducted at a mutually convenient time but I first clarified if the 
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participant was recently diagnosed (at the time of invitation to participate they were 
between three months and two years post their diagnosis).  
5.11.3 Phase 3 Recruitment strategy 
Eligible patients were approached through their clinical genetics service, either during 
their clinic appointment (if they were being seen again post-diagnosis) but more often 
with an invitation letter and PIS (Appendix 24) sent out later. In addition to this some 
participants were selected from the volunteers who had completed the Phase 1 survey 
and who had been diagnosed within the last two years. These participants were 
contacted by telephone or email to ask how long ago they were first diagnosed. If 
they were recently diagnosed they were sent and invitation letter by email with a PIS 
and consent form. I contacted anyone who responded positively to explain in more 
detail what the Think-Aloud interview would entail. Signed consent forms were then 
returned to the researcher by post or scanned copies sent by email. 
5.11.4 Phase 3 Data collection methods 
The website was further developed and refined using a series of Think-Aloud 
interviews (McDermott et al., 2010). In these interviews the participant talked to me 
via an online link, while the participant explored the website and voiced their 
thoughts. 'Think-Aloud' interviews were used because they are a method for 
recording the dynamic interaction of a participant with a computer programme 
(McDermott et al., 2010; Sadasivam et al., 2011). I used this type of interview in order 
to find out how participants explored the website while talking about their thoughts 
and actions (Appendix 25). The activity of the computer and their associated 
verbalisation was recorded for analysis. The recordings were done remotely following 
the method of moderated remote usability testing (Barnum, 2010; Wozney et al., 
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2016) where the participant and interviewer/moderator can be in different locations 
but the interviewer can talk to the participant, viewing what the participant is seeing 
on their computer and recording their dialogue. These moderated remote usability 
interviews were recorded using GoToMeeting online video conferencing software 
(LogMeIn, 2017) which created a video, linking the participants’ comments to what 
they were viewing in the website at the time. Initially four interviews were conducted 
with participants who had no prior contact with the website. Subsequent interviews 
were carried out after the participants had been given time to explore the website in 
their own time.  In total 12 participants were recruited to this phase of the study.   
5.11.5 Phase 3 Data analysis methods 
The video recordings were played over several times, so that I was able to view them 
repeatedly while taking notes about the participant’s reactions and comments to 
different aspects of the website. Phrases were transcribed verbatim to provide 
illustrative quotes. For each participant a matrix was constructed so that their 
comments were linked to the context of the relevant part of the website. An 
anonymised copy of one matrix is presented as an illustration in (Appendix 27). At 
each iterative stage, themes within the interviews were developed and analysed to 
guide changes to the website.  
5.11.6 Phase 3 Research rigour 
Participants to this phase of the research were invited to take part through the 
recruitment sites in clinical genetics services or via the option to volunteer for 
interview at the end of the Phase 1 survey questionnaire. In order to maximise the 
variability in perspective of participants a purposive sample of varied age and sex was 
selected from the interview volunteers. The only other details recorded about the 
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participants was the time since their diagnosis in order to confirm eligibility to this 
phase. This design was intended to minimise bias in the selection of participants to 
this phase of the study. 
Since the Think-Aloud interview took place via an online platform (GoToMeeting) this 
necessitated access to the Internet. The link to GoToMeeting was sent by email so 
only patients who had access to email were able to participate. These issues were 
explained to volunteers who had only provided a contact telephone number. 
However, the fact that the interviews were recorded on video provided the 
opportunity for independent researchers to check the validity of the findings against 
the raw data if necessary. 
In common with Section 5.9.6, reflective notes were written after each Think-Aloud 
interview, noting issues that had arisen during the course of the interview and any 
technical problems that may have influenced the continuity of the interview and 
recording. 
5.11.7 Phase 3 Ethical issues  
Phase 3 freedom from coercion 
I provided eligible patients with written information and consent forms. The PIS and 
consent forms were sent by email to potential participants if they had not already 
been sent these by the NHS recruitment site. The method of recording the Think-
Aloud interview was explained to interested patients over the telephone and via 
email. No pressure was made to try and persuade patients to take part. 
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Phase 3 consent  
Consent forms were distributed with the invitation letter and PIS sent out by 
recruitment sites. These were either returned in paper copy or scanned and returned 
by email before the interviews. Any participant who had volunteered for interview 
following completion of the survey questionnaire was contacted by the researcher. 
Before starting the Think-Aloud interviews participants were again asked if they were 
happy to take part and reminded that their participation would be anonymous and 
would not affect their treatment. Their permission to record the interview was 
obtained and their right to stop the interview at any time was repeated. 
Phase 3 confidentiality 
In Phase 3 of the study, participants’ details were only passed on by clinical staff with 
the verbal or written consent of the participant. No details about participants’ health 
or treatment were taken prior to contact. Research or clinical staff provided the 
researcher with a contact telephone number or email if patients expressed interest in 
the study in order for the researcher to explain the study in more depth. All 
information pertaining to participants (name, contact number, email) were kept 
securely in accordance with data security guidelines from the HRA. 
Phase 3 emotional reactions 
Just as for the Phase 2 telephone interviews described above (Section5.9.7) it was 
anticipated that the content and purpose of the website might potentially distress 
participants if it was reminding them about their increased risk of bowel cancer. 
However, the structure of the Think-Aloud interviews was focussed on eliciting 
participants reactions to the website itself and for them to suggest ways to improve it. 
This was therefore not considered as sensitive to participants as the more in depth 
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telephone interviews, but the researcher was still alert to the vulnerability of 
participants during the Think-Aloud interviews. If participants wanted to explain their 
circumstances and how they had learnt of their own risk time was given in the 
interview for this. 
5.12 Conclusions 
In this chapter I have described the pragmatic mixed methods approach I have taken 
to the issue of how to investigate communication of a genetic diagnosis within 
families affected by a susceptibility to bowel cancer. This is a complex issue requiring 
a range of methods to elucidate it. These data were used to inform the development 
of an innovation intended to facilitate communication. The novel function of the 
website was investigated for its feasibility and acceptability with potential users. In 
the following chapters, I will give the results of the first two phases of the study, 





Results of the cross-sectional survey in Phase 1 
 
6.1 Introduction 
In this chapter I will describe the results of the first phase of data collection, where 
responses to the survey from across England and Wales provided both breadth and 
depth of data regarding patients’ experiences. These data were analysed using 
descriptive statistics and calculations of association using Chi square and Fisher’s 
exact tests. Participants did not disclose their identity, so where quotes are given in 
the text the quotation is followed by a letter and a number (either ‘O’ for online or ‘P’ 
for paper questionnaire, followed by a number) providing a unique identifier. 
6.2 Data collection and analysis 
The first phase of data collection was a mixed methods survey collecting anonymous 
data via a questionnaire. The objectives and methods are described in detail in 
Chapters Four and Five respectively so will not be repeated here. The first part of the 
questionnaire, questions 1 to 8 (Appendix 18) were intended to elicit information 
about the participant’s experience of what happened to them, how they themselves 
learnt about the diagnosis of increased risk of bowel cancer in their family. The 
following questions related to areas of information provision the participant thought 
should be changed or improved, such as what other information they would like and 
how they might like to receive that information. The analyses were focussed on 
aspects that may have influenced participant’s responses: gender, age, cancer 
diagnosis, education, who informed them about their risk and whether a paper or 
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online version of the questionnaire was used. The data derived from responses to 
question 10, using the Likert type scale of preferences, were coded numerically and 
mean scores for different parts of the question were calculated to allow comparison of 
means and the ranking of preferences. 
6.3 Demographic characteristics of the survey participants 
6.3.1 Response rate 
I recruited to the survey through online links posted on charity websites and also 
through six NHS clinical services. Recruitment sites did not provide data on the 
number of eligible patients they had approached due to the different strategies used 
by clinicians (Chapter Nine, Section 9.10.1) so it was not possible to calculate the 
response rate for the survey. 281 participants gave their postcode, but only 150 could 
be linked geographically to one of the recruitment sites (Figure 6.1). The results for 
Plymouth and Exeter were merged under ‘Peninsula’ due to shared postcodes. 
 
Figure 6.1 Comparison of number of survey responses received by area (n=150)  
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The demographic characteristics of the 286 participants who took part in the survey 
are described below, using the variables of gender, age, cancer diagnosis, education 
and response type. 
6.3.2 Gender 
The majority of participants were women, 217 (77%) with 66 (23%) male participants; 
only three participants did not state their gender.  
6.3.3 Age of participants 
Participants ranged in age from a minimum of 17 -19 years to a maximum of 80 -84 
years (two participants did not give their age). Since age was given in age groups, a 
mean was not calculated, but the mode was 50-54 years of age.  
From the age distribution (Figure 6.2) it was calculated that 139/284 (49%) of 
participants were less than 50 years old and 145 (51%) were 50 years or over.  The 
differences in responses between younger and older participants was of interest, 
however only 22 (8%) people under the age of 30 participated in the survey, 68 (24%) 
were under the age of 40 years and in the oldest group, only 14 (5%) were 70 years or 
over. Therefore, in order to compare younger and older participants’ responses, 





Figure 6.2 Age distribution of participants (n=284) 
6.3.4 Cancer diagnosis 
Of 284 participants who responded to this question, over half had not been affected 
by cancer 165/ 284 (58%) but 87 (30%) reported that they had been diagnosed with 
bowel cancer and 32 (11%) reported being diagnosed with another type of cancer.  
6.3.5 Educational qualifications 
 
Figure 6.3 Participants' highest reported educational qualifications (n=285) 
The participants to the survey were an educationally diverse group (Figure 6.3). The 
most frequently reported qualification was “first degree”, 73/285 (26%) which included 
graduate membership of a professional institute. The next most frequent category 
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When the data were divided into those participants with or without a degree or higher 
qualification, 109 (38%) had a first degree or higher degree qualification.  
6.3.6 Response type – online or paper questionnaire 
Of 286 responses,183 (64%) were made online via a SurveyMonkey link and 103 (36%) 
were made via the paper copy questionnaire.  
 
6.4 Participants’ experiences 
6.4.1 Who first informed participants about their risk of cancer 
Figure 6.4 Question 1 from the questionnaire 
 
When asked who had first told the participant about their risk of cancer (Figure 6.4), 
the largest proportion, 124 (43%) were told by a relative (Table 6.1), most often by 
their mother. While broadly equal numbers learnt of their risk either through a 
genetics professional, 79 (28%) or another health professional, 69 (24%) (Table 6.1). 
  
Firstly, please can you think back to how you first found out about the increased 
risk of bowel cancer in your family.  
1. Who first told you that there was a risk of bowel cancer in your family?  
Please tick one: 
□ Your doctor (General Practitioner “GP”) 
□ Specialist doctor (e.g. surgeon, gastroenterologist, oncologist, etc.) 
□ Genetics specialist (e.g. medical doctor or genetic counsellor)  
□ Another healthcare professional  
□ Your relative, can you tell us who? (e.g. mother, brother, cousin?) 
□ Other person, please tell us who? (e.g. friend or charity advisor?)  




Table 6.1 Who first informed about the risk of cancer (n=286) 
Who first informed Number % 
   
Doctor (GP) 8 3% 
Specialist doctor 56 20% 
Genetics specialist 79 28% 
Another health professional 5 2% 
Relative 124 43% 
Other person 12 4% 
Can’t remember 2 1% 
Total 286 100% 
 
6.5 Family awareness of the increased risk 
6.5.1 Proportion who were the first to know 
Of 286 respondents, 88 (31%) reported they were the first person in their family (to 
their knowledge) to be told that there was an increased risk of cancer in the family. In 
clinical genetic terms, this meant that they were the ‘index case’ and therefore the 
onus of responsibility to inform other relatives would rest initially with them.  
 
Participant’s responses in the free text box (question 13 see Appendix 18) that invited 
them to provide more detail about any difficulties they had encountered when sharing 
information had some recurring themes of difficult family dynamics, loss of contact 
with relatives and family members not wishing to accept the diagnosis, which are 
summarised in the quote below: 
“Lost touch with cousins.  Some relatives putting their heads in the sand. Not 
wanting to have the test.” O10 
While another participant just said:  
 “Delivering bad news is difficult” P28 
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In addition, some participants mention the length of time to get a diagnosis, problems 
with getting referral to a specialist, needing written information to explain the 
diagnosis, or relatives being too young to be informed. These themes were ones that 
recurred, some having already been mentioned in responses to questions 2 and 3. 
 
6.5.2 What proportion of participants’ relatives were aware of the risk of cancer 
When asked how many of their relatives were aware of the increased risk of cancer in 
the family, the most common response was “Most” 116/286 (41%).  
Comparing the responses from those participants who were the index case in their 
family to other participants, there were no significant associations in terms of what 
proportion of relatives were aware of the risk.  Of the 88 people who were the ‘index 
case’ in their family: 29/88 (33%) said “All” were aware, while 33/88 (38%) said that 
“Most” were aware (Table 6.2).  
Table 6.2 Participants' estimates of the number of their relatives who were aware of the risk 
 All Most Some None TOTAL 
Index 29 (33%) 33 (38%) 21 (24%) 3 (3%) 88 
Non index 71 (37%) 83 (42%) 36 (18%) 4 (2%) 198 
All 100 (35%) 116 (41%) 57 (20%) 7 (2%) 286 
 
However, level of educational attainment was associated with whether participants’ 
relatives were aware of the diagnosis. Comparing participants with a degree or a non-
degree level qualification (Table 6.3) participants educated below degree level more 
frequently believed that their relatives were aware of the diagnosis (39% vs 28%) 




Table 6.3 Participants' estimates of the number of their relatives who were aware of the risk 
by participant education level 
 
Participants’ estimate of what proportion of the family 
were aware of the familial risk 
 
Total 
Education All Most Some  None 
 
degree or above 31 (28%) 52 (48%) 22 (20%) 3 (3%) 108 
below degree 69 (39%) 64 (36%) 35 (20%) 4 (2%) 172 
 100 116 57 7 280 
 
These two groups (education at degree level or above and below degree level) were 
also compared to see if there were associations between educational level and 
receiving information about the diagnosis. More participants educated below degree 
level received no supporting information at the time of their diagnosis (Fisher’s exact 
10.24; p<.05.). Conversely, participants educated to degree level or above more often 
searched for additional information on the Internet (Fisher’s exact 11.64; p<.01). There 
were no associations between education level and preference for receiving 
information either via email, a website or a follow-up appointment. 
6.5.3 Genetic testing in the family 
Most participants 249 (87%) indicated that genetic testing had been done in their 
family but nine people did not know if a test was available. I interpreted genetic 
testing taking place as a proxy indication that a genetic diagnosis had been made in 
the family. Although potentially inaccurate and dependent on participants’ 
understanding of the outcome of the genetic testing, I considered this the best 
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indication of a genetic diagnosis in the circumstances and while maintaining 
participant anonymity. Where a genetic test was available, this would then imply that 
most respondents should have had access to some specific information about the 
diagnosis, however I did not know if this was necessarily the case. Therefore questions 
five and six in the questionnaire were intended to probe the issue of what written 
information participants had received when they first learnt about the risk in their 
family (Figure 6.5).  
Figure 6.5 Question 5 wording from the questionnaire 
 
The type of information received could then be linked back to the role of the person 
providing that information, whether they were a health professional or a family 
member. My expectation was that when people were informed by their relative they 
might only receive information verbally or have quite general information. However, 
where families have been provided with a letter specifically designed to be passed to 
relatives, a ‘Dear Relative’ or ‘To whom it may concern’ letter, this was likely to be 
used. Such letters usually provide practical details about how to access referral to 
Information you received 
5.   Please can you tell us what written information you received when you were told 
about your risk of cancer? Tick all that apply 
□ None received 
□ General information about the condition 
□ Specific information about your family 
□ A copy of your family tree indicating who had cancer 
□ A copy of your family tree showing who could have bowel screening 
□ A ‘Dear Relative’ or ‘To Whom it May Concern’ letter to give to your relatives 




specialists and screening and give reference numbers that could assist GPs when they 
are making referrals. 
6.5.4 Information received at the time of their diagnosis 
Figure 6.6 Number of participants who had received specified types of information at the time 
of their diagnosis (n=283)  
 
Those that received information at the time of their diagnosis most often received 
some general information, 140/283 (49%), or a ‘Dear Relative’ letter, 67/283 (24%). 
However, of the 124 participants who first learnt about their risk from their relative, 
40/124 (32%) received no written information at all at that time. Types of written 
information received at the time of diagnosis (Figure 6.6) were all noted, with 
opportunity for other types to be given in free text.  
The types of written information received were analysed against the role of the 
person who had first informed the participant of their diagnosis. Distinguishing 
between those participants who had first been informed by a genetics health 
professional (geneticist or genetic counsellor) or another type of health professional, 
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likely to give no information at all (8%) than for the other groups of informants 
(Fisher’s exact 23.54;p<.0001) (Table 6.4). However, there was weaker association 
between learning of the diagnosis from genetics professionals and receiving a ‘Dear 
Relative’ letter (37%) (Fisher’s exact 10.21; p<01). 
Table 6.4 Type of information received by person who informed (n=214) 
Who informed What type of information was received (multiple 
responses allowed per participant) 
 















26 (21%) 48 (39%) 21 (17%) 40 
(32%) 
124 
Total 54 95 65 72  
 
No associations were found between being told by another health professional and 
the type of information received. However if participants’ learnt of their diagnosis 
through their relative they were more likely to receive general information (Pearson’s 
Chi Square = 9.19 with 1 df ; p<.01). 
6.6 Participants’ views of the support they had received 
6.6.1 Was the written information received considered sufficient at that time 
The question that followed asked participants to reflect on what they had received 
and whether this was sufficient for them at that time.  Being informed by a genetics 
health professional was found to be associated with receiving sufficient information 
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(Fisher’s exact  18.25; p<.001) (Table 6.5). However, being informed by a relative or by 
another type of health professional were not found to have any significant 
associations with these variables. 
Table 6.5 Whom informed of increased risk of cancer with whether participants thought they 




Did participants get all the information they wanted? 














19 (17%) 32 (28%) 46 (40%) 18 (16%) 115 
Total 63 62 93 38 256 
 
 
6.6.2 Support received from health professionals 
In addition to their information needs, participants were asked to say whether they 
had received sufficient support at the time of their diagnosis. The responses of those 
participants who had been informed of the diagnosis by a health professional (general 
practitioner, specialist doctor, genetic specialist or other healthcare professional) 
were grouped together. Out of those, the majority 104 /148 (70%) indicated that they 
had felt well supported at the time they learnt of their increased risk of cancer. 
However, 24 (16%) said they had not and 17 (11%) indicated that they were “Not sure”. 
Many participants who did not feel well supported at the time they learnt about their 
risk provided a free text response to the next question, where they were invited to 
give suggestions about what could have been done better.  
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Some suggestions on how to improve support to people at the time of their diagnosis 
were made, but the responses mainly provided insight about what participants felt 
was bad or lacking in support (Figure 6.7) with some of these issues apparently 
interacting and contributing to each other.  
 
Figure 6.7 Map of themes developed from Phase 1 survey responses (n=286) regarding how 
support could be improved. Interrelationships between identified themes of: information needed 
by patient (green), HPs lack of knowledge (orange), problems in process (red) and the impact on 
the patient’s mental state (purple)  
 
The data revealed a sense that people’s expectations in the care they would receive 
through the NHS had been disappointed. Many participants reported experiencing 
delays at each stage of the process; such as when they were being referred to 
screening or to clinical genetics services; having testing; receiving test results; or 
receiving screening for cancer. These problems in the process of care appear to have 
been compounded by a lack of information, leading to uncertainty and confusion 
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about what they should do themselves to mitigate their risk. The contribution and 
interaction between the deficiencies in information, lack of support from health 
professionals, delays in referral and test results were described as impacting on their 
mental state, as represented in the map of themes above (Figure 6.7). 
Some excerpts from the responses are quoted below. In one case the participant 
described their experience and how they felt isolated after initially experiencing good 
care: 
“I felt well supported during the process of diagnosis which took several months 
but I was completely unsupported thereafter without any communication at all 
until I requested it.” P49 
 
Another participant stressed the importance of being kept informed: 
“It is absolutely essential to explain testing timescales to patients and to keep 
them fully informed every step of the way. Being given bad news and left to rot is 
a really bad experience.” O72 
 
This participant wanted a better understanding and more realistic expectations: 
“A simpler way of explaining it and a realistic time frame to get conclusive results 
would have benefited me” O163 
 
While this participant also wanted practical guidance: 
“It would have been helpful to be given some guidance of the questions/tests I 
should be now be asking my doctor for.” O116 
 
The emotional impact of the genetic diagnosis, or just the awareness that they might 
have an increased risk of cancer, was described by some as “shocking” or “stressful” 
and one woman wrote: 
“I was confused and mainly angry with my diagnosis (and still am).” P52 
 






6.6.3 What other information would have been helpful at the time of diagnosis 
 
Participants were asked to suggest what additional information they thought might 
have been helpful at the time of their diagnosis. About a quarter, 66/286 (23%) said 
how they had received all the information they needed at that time but many others 
described their uncertainty about what to do next and how to manage their increased 
risk. The quote below describes how that person sought more information to better 
understand their situation: 
“There seemed to be very little information available, and I was only Googling. I 
found a mix of social media posts and scientific papers. I would have liked 
something clearly written by health professionals for the lay person.” O148 
One participant wanted advice about how to approach their relatives, saying:  
“Informal advice about how to broach this subject with relatives, some of whom I 
do not see often and who are not local to my area. The 'To Whom it May concern' 
letter is rather too formal in my opinion”. P49 
While another participant noted that they might have made different decisions had 
they been better informed at the time: 
“More information to make better choice instead of being told this is the only 
way. Knowing what I know now I would have made a different choice”. P29 
The following comment echoed a recurring problem of insufficient knowledge 
amongst health professionals about their condition: 
“What screening was available and how to get it when even your own doctor 
hasn’t heard of Lynch syndrome”. P09 
Some of the same themes emerged from a question later in the survey (Figure 6.14) 
when participants were asked what issues about which they would like more 
information. These are described in more detail below in Section 6.9. 
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6.7 Differences and associations between groups 
6.7.1 Gender differences in responses 
 
Differences between the male and female participants were significant in how they 
had responded, online or via the paper questionnaire (Table 6.6) as more women than 
men had responded online (67% vs 52%) (Fisher’s exact  6.58;p<.05). 




Total   
female male 
 
Type Online 146 34 183   
(67%) (52%) (64%)  
Paper 
questionnaire 
71 32 103 
  
(33%) (49%) (36%)  
Total 217 66 286 
 
Bowel cancer effects both men and women, but in Lynch syndrome women also have 
a high risk of developing endometrial cancer (Ryan et al., 2017b) so I was expecting 
that there would be more women in the group defined as “Yes, another cancer” 
(Table 6.7). This association between gender and cancer diagnosis was significant with 
many more female respondents having cancer but not bowel cancer (88% vs 9%) 
(Fisher’s exact  14.47; p<0.05).  











female 130 28 58 216  
(79%) (88%) (67%) 
 
male 33 3 29 65  
(20%) (9%) (33%) 
 




Another potential difference between male and female participants was regarding the 
choice of topics where they wanted more information.  Since information about a 
‘healthy lifestyle’ was a popular topic across the entire sample of responses, with 140/ 
286 (49%) indicating that they wanted information about this, associations between 
gender and topic were examined. However no significant association was found 
between the topic of ‘healthy lifestyle’ and gender.  
Other topics where respondents wanted more information were ‘genetic testing’ and 
‘talking to children’. There was no association between gender and ‘genetic testing’, 
with 44% of both men and women wanting information on this topic. However 
‘talking to children’ was of greater interest to women than men (39% vs17%)(Fisher’s 
exact 11.84;p<.005). 
Participants were invited to consider the different ways they could envisage receiving 
information about the familial diagnosis (Figure 6.8). They were asked to rate 
different forms of information provision between “very unhelpful” to “very helpful” on 
a Likert type scale. It was of interest whether there were any gender differences in 
these responses, particularly if preferences for email or websites were expressed as 




Figure 6.8 Question 10 from the questionnaire 
Responses were coded between 1 and 4, with 1 being ‘very unhelpful’ and 4 being 
‘very helpful’. 
  
Figure 6.9 Ranking of question 10 responses by gender (n=283) 
 
Figure 6.9 above illustrates how the preferences for different methods of 





















FU appt email website leaflet FU phone call
Average scores for 'helpfulness' of 
different communication methods
Women Men
10. Please indicate how helpful you think this would be for the different ways getting 
information by making a cross on each of the scales below: 
(Likert type scales removed) 
a.  A paper leaflet which has general information about an increased risk of bowel cancer, 
the implications for relatives and the screening available? 
b.  A secure email which has more specific information about your increased risk, the 
implications for your relatives and the screening advised? 
c.  A password protected website which has more specific information about your 
increased risk, the implications for your relatives and the screening advised ? 
d.  A follow-up appointment in the hospital clinic where you are given specific information 
about your increased risk, the implications for your relatives and the screening advised? 
e.  A follow-up telephone call where you are given specific information about your 
increased risk, the implications for your relatives and the screening advised? 
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women, with more women indicating that each of the different methods would be 
helpful than the responses given by male participants.  
Although the coding of the responses equated ‘helpful’ to 3 and ‘very helpful’ to 4, it is 
only possible to rank this ordinal data, giving relationship to these different 
preferences but not to equate the numerical means to actual responses. However, it is 
possible to infer that the majority of participants of both sexes considered all methods 
‘helpful’ or ‘very helpful’. The exception was a follow-up telephone call, which was less 
often thought to be ‘helpful’, particularly by male participants. 
6.7.2 Age differences in responses 
There was a broad range of ages represented among participants to the survey. The 
modal age group was 50 -54 years (Figure 6.2).  When the age distribution was 
subdivided by response type there was evidence that participants between the ages of 
30 and 60 had responded more often online (Figure 6.10) but this difference was not 
tested statistically.  
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Participants who were eligible to take part in the survey did not have to have a specific 
genetic diagnosis to be eligible but the commonly identified conditions which resulted 
in an increased susceptibility to bowel cancer were familial adenomatous polyposis 
(FAP) and Lynch syndrome (LS).  Since these conditions typically give rise to cancers 
occurring at young ages (mid 30s and mid 40s respectively) differences in responses 
were examined between the under 40 year old age group and the 40 years and above 
group. It was also expected that there would be an association between age and 
cancer diagnosis amongst respondents. 
 
 
Figure 6.11 Ranking of question 10 responses by age (n=283) 
 
The ranking of preferences did not change between the two age groups (40 years and 
above and below 40 years) with a follow-up appointment the most popular option for 
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6.7.3 Differences between groups with and without cancer diagnoses 
 
Table 6.8 Participants’ cancer diagnosis by age group (n=284) 
 
  









106 77 31 216 
  





59 8 1 68 
  
87% 12% 2% 
 
  
165 85 32 284  
Total 58% 30% 11% 
 
 
It was more common for the older participants to have been diagnosed with cancer 
(50% vs 13%) (Table 6.8) (Pearson’s Chi Square 30.75; 4 df; p<.0005). This is expected 
(Torre et al., 2016) but there was also a significant association between having had 
cancer and being the first person in the family who knew about the risk (the index 
case) ( Chi Square 35.47; 9 df; p<.0005).  As reported above in Section 6.7.1 (Table 6.7) 
male gender was also significantly associated with having a cancer diagnosis.   
Looking at the data for other associations with cancer diagnosis there was a 
significant association between wanting to receive information through a follow-up 
appointment and having had cancer (Pearson’s Chi Square 16.69; 6 df; p<.05). In 
contrast, there were no associations found between having cancer and wanting to 
receive information either by email or through a website. In addition, there was no 
significant association between wanting information about a healthy lifestyle and 





6.7.4 Differences between responses from the online and paper questionnaires 
 
Age distribution by response types (online or paper questionnaire) (Table 6.9) 
appeared to show that more of the younger participants had responded online but no 
significant association was found between responding online and being under 40 
years old.     
Table 6.9 Frequency of response by age group (n=284) 
 
However, when sources of additional information (Figure 6.12) were considered, 
participants could tick as many options as they chose to indicate where they had 
found additional information after learning about their risk of cancer. 





Total   
Online Paper 
 
Age group over 40 136 (63%) 80 (37%) 216  
under 40 45 (66%) 23 (34%) 68 
Total 
 
181 103 284 
7. If you have found additional information about the shared risk of cancer in your family, 
who provided that information? Tick all that apply 
□ Your doctor, surgeon or other health professional 
□ Other relatives 
□ Friends 
□ Support group or charity meeting 
□ Internet website 
□ Social media 
□ Library 
□ Other source of information – please give details 
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This allowed comparison between different groups of participants (Table 6.10) and 
showed that those participants who responded online were much more likely to look 
for more information on the Internet (Fisher’s exact  205.5; p<.0005) or via a support 
group (Fisher’s exact  308.6; p<.0005). 
Table 6.10 Sources of information post diagnosis by response type (n=286) 
  
Sources of additional information  
support group Internet website other relatives Total 
Online 45 (25%) 102 (56%) 33 (18%) 183 
Paper 8 (8%) 33 (32%) 36 (35%) 103  
53 135 69 286 
 
In contrast, those participants who responded via the paper questionnaire were more 
likely to have found additional information from a relative (35% vs 18%) (Fisher’s exact 
260.0; p<.0005). 
6.8 Receiving information about the condition in other formats 
Looking at other ways of receiving information, much of the survey was seeking to 
elicit data regarding participant’s preferences for future methods of communication 
and topics where more information was desired.  Following the questions about what 
information they had received when they learnt about their risk of cancer (questions 5 
to 8) participants were asked if they would like to receive information in other ways 
(Figure 6.13).  
Figure 6.13 Question 9 from the questionnaire 
9.  Would you like to receive information in other ways? Yes / No / Don’t know 
o If yes, would this be  
□ Via a website 
□ By Email 
□ Social media 
□ In a follow-up appointment 





Table 6.11 Whether information was desirable in other formats 
 
Receiving information in other ways 
Yes No Don’t know Total 
Responses overall 182 (76%) 34 (14%) 24 (10%) 240 
 
The responses to this question (Table 6.11) indicated that the majority of 
participants would be interested in receiving information in other formats, such as by 
email or in a follow-up appointment. Since there were more responses to the survey 
made online, 183/ 286 (64%), different options for receiving information were 
analysed by response type. Associations were found between responding online and 
wanting to have more information in a follow-up appointment or via a website. This is 
described in more detail below in Section 6.10 (Figure 6.18). 
6.9 Topics where more information was wanted 
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Participants were given a list of topics (‘talking to children’, ‘healthy lifestyle’, ‘helping 
relatives who live abroad’, ‘genetic testing’ and ‘other’) where they might have want 
more information and asked to tick all that applied. Most participants 140/286 (49%) 
indicated that they wanted more advice on how to have a ‘healthy lifestyle’ (Figure 
6.14).  In addition to providing answers to the closed question using the predefined 
topics, 122 participants completed the free text box giving details about other issues 
that were of concern. The results are presented in a word cloud (Figure 6.15) which 
illustrates how concerns about cancer screening were frequently cited.  Many 
participants expressed their wish to know how screening was determined, what 
national guidelines were and whether there was screening for cancers other than 
bowel cancer. One participant described the need for practical advice on this: 
“Regular screening, how often and what it involves and contact names for 
arranging the screening.” O08 
 
Figure 6.15 Word cloud illustrating the most frequently cited words in the free text responses 




A variety of perspectives were voiced in the free text responses regarding what 
information would be helpful and indicated many different aspects of how the 
condition affected people. In addition to questions about screening, a common issue 
concerned informing other family members about the familial diagnosis, including 
advice on how to broach what was considered a difficult subject, to not knowing what 
advice to give about the next steps: 
“I have found that relatives want to know about various treatments and always 
the same question is “What happens next?”” P67 
Another person also had a practical request for information to support their 
conversations with their relatives: 
“I would like some written information, maybe a letter or email which I can give to 
interested relatives. I feel frustrated by the way some them seem to think that 
they do not need to listen, as if I am exaggerating the risks, having told them 
verbally. Maybe a letter would be more official and they would read it, then make 
an informed choice on proceeding to get tested or not.” P75 
 
Many of the participants stated that they had Lynch syndrome and wanted to know 
more about their risk of cancers other than bowel cancer. Other practical concerns 
given were: the impact a genetic diagnosis would have on health or life insurance, 
what symptoms of cancer they needed to be alert to and how they might ameliorate 
their risk of cancer through changes to their lifestyle, particularly diet. This is 
illustrated by the quote below from one participant: 
“Information about talking to children that will have to be tested by a genetics 
specialist. What eating habits could help you decrease your chances of your 
illness turning to cancer e.g. what to eat more of and what to avoid. More in 
depth exploration about genetics testing.” P83 
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However other issues included starting a family, management of their condition and 
updated information or research, encapsulated in these three quotes: 
“family planning and fertility treatment options” O65 
“Who should co-ordinate family screening” P51 
“Any breakthrough or what is happening going forward”. O12 
 
6.10 Different methods of information provision 
To investigate the ways that information could be provided, a Likert type scale was 
used where several possible options for different methods of receiving information 
could be classed as “very unhelpful” to “very helpful” (Appendix 18, p.383). 
 
Figure 6.16 Preferences for each method of providing information (n=286) 
This question was intended to invite participants to consider how they would prefer to 
receive “more specific information” about their increased risk. The responses from all 
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the options were either “helpful” or “very helpful” (Figure 6.16). In order to allow 
comparison of each preference type between different groups of participants, the 
responses were changed into a numerical value to allow each preference type (paper 
leaflet, secure email, etc.) to be compared through calculating the mean score for 
each type.  These mean scores were then ranked and the ranking compared between 
different groups of participants. 
Using this method of comparison, it was shown that across all age groups what was 
considered the most helpful sources of information were: 
 A follow-up appointment 
 Secure email   
 Password protected website.   
As stated earlier, there was no change in the order of ranking when the data were 
analysed by gender (Figure 6.9) or by age group (Figure 6.11). 
The option of receiving a ‘follow-up phone call’ was less popular across several groups; 
receiving a telephone call to explain specific information about the diagnosis was 
more often considered “unhelpful” or “very unhelpful” by men, those under 40 years 




Figure 6.17 Comparison of information preferences according to type of questionnaire 
response (n= 286, online = 183, paper questionnaire = 103) 
It was important to compare responses between the participants who responded 
online with those who used a paper copy questionnaire, as this could give some 
indication as to whether the sample was biased in this respect. Using the comparison 
of mean scores showed how similar the responses of the two groups were to this 
question (Figure 6.17).   
Since the preferences expressed on the Likert type scale by men and women ranked 
so closely (Figure 6.9), this created a ceiling effect which was not particularly 
informative. However, the preceding question (Figure 6.13) provided indications for 
the popularity of different ways of receiving information, such as by email, via a 
website or through a follow-up appointment.  
The proportion of men and women who wanted to receive information in other 
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Table 6.12 Preferred methods of information provision by gender (n= 282) 
 Preferred method of information provision 
 email follow-up website Social 
media 
Total 
Women 93 (43%) 96 (44%) 70 (32%) 31 (14%) 216 
Men 29 (44%) 27 (41%) 27 (41%) 12 (18%) 66 
All 122 (43%) 123 (44%) 97 (34%) 43 (15%) 282 
 
Although a follow-up appointment was the most frequently cited preference by 
women (96/216, 44%), and an email was the method most often preferred by men 
(29/66, 44%) (Table 6.12) there were no significant differences in responses between 
men and women regarding their preferred methods of information provision.  
5.10.2 Preferred methods of receiving health information 
When the data from question 9 (Figure 6.13) were analysed for associations according 
to whether participants answered the survey online or via a paper questionnaire, some 
differences were observed (Table 6.13). 
Table 6.13 Preferred methods of information provision by survey type (n=286) 
 
 Method of information provision preferred  
(multiple responses possible) 
Survey type Email FU appointment Website Denominator 
Online 79 (43%) 91 (50%) 74 (40%) n=183 
Paper 43 (42%) 34 (33%) 25 (24%) n=103 
Total 122 125 99  
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Correlations between response type and preferred method of receiving information 
were calculated. 
 
Figure 6.18 Frequency of preferred method of receiving more information by response type, 
online or via paper questionnaire 
 
It was found that wanting a follow-up appointment was significantly associated with 
responding online (Fisher’s exact 202.2 ; p<.0005). A significant but less strong 
association was found between online responses and wanting to receive information 
via a website (Chi Square 7.61; 1 df; p<.01). No association was found with wanting 
information provided via email. 
6.10.3 Where additional information had been found 
In order to further investigate if there were any other associations with response type, 
Question 7 (Figure 6.12) responses were compared from those people who had 
responded online to those who had responded on paper.  
Searching for information on the Internet and responding online to the survey were 



















information from a relative was considered, there were significantly more participants 
who responded via the paper questionnaire who reported receiving more information 
about their diagnosis from a relative (Chi Square 9.17; 1df; p<.005).  
6.11 Conclusions 
The Phase 1 cross sectional survey was completed by people with a broad range of 
ages and qualifications. The results of the survey indicated that the majority of 
participants did feel well supported at the time of their diagnosis or when they first 
learnt about the risk of bowel cancer in their family. However, there was a desire for 
more information and support, with certain topics being of particular interest. The 
free text responses provided a more detailed view of the range of topics where 
participants wanted specific information, key issues being: screening for cancers and 
how to reduce their risk of cancer through changes in their lifestyle or diet. 
These data therefore gave evidence that this group of patients and their families 
would also consider receiving or sharing information about their familial susceptibility 
by email or through a website.  
In the next chapter (Chapter Seven) I will set out the results of the second phase of 
data collection. Qualitative data, gathered through telephone interviews with a 
purposive sample of volunteers, were interpreted using thematic analysis and the 





Results of Phase 2 Qualitative telephone interviews  
 
7.1 Introduction 
In this chapter I will present the results of my qualitative analysis of the semi-
structured telephone interviews conducted in Phase 2 of the study. These interviews 
were carried out to inform the development of the proposed website innovation. It 
was anticipated that the interview data would add to our understanding of 
participants’ experiences of learning about their risk of bowel cancer; how information 
was shared in the family; what methods of communication they used and what 
aspects of the condition they would have liked to have more information about. These 
qualitative data were therefore building on the data collected through the preceding 
survey in order to enhance and deepen my understanding of what a website might 
contribute to communication within families. I also wanted to improve the 
trustworthiness of the findings through triangulation between the survey data and 
interview data.  
The thematic analysis (Boyatzis, 1998; Braun & Clarke, 2006) was carried out using the 
software package NVivo, version 11 (QSR International, Pty Ltd) which facilitated the 
identification of multiple codes, amalgamation of codes into themes and enabled data 
sources to be indexed for retrieval. This process revealed fifteen themes which 
coalesced into four major themes. Some themes were around participants (the impact 
of the diagnosis and people’s adaptation to it) while others were specific to the 
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concept of the website. It was key to the development of the website that I captured 
participants’ views about what content they wanted and how they might envisage 
using the website in order that it aligned with their needs.  
All names given are pseudonyms in order to preserve participant anonymity. 
7.2 Demographic characteristics of participants 
 
All interviewees had already completed the anonymous survey questionnaire. Many 
participants had been recruited to take part in the survey via the Lynch syndrome UK 
support group website, which hosted a link to the online survey with information 
about the research study (Appendix 15). At the end of the survey there was a request 
for volunteers and a tick box so that participants could indicate if they were willing to 
be interviewed.  In total 291 people completed the questionnaire, of which 187 (64%) 
volunteered to be interviewed. Interview volunteers were selected from this group of 
187 using purposive sampling to obtain a maximum variance sample (Teddlie & Yu, 
2007) based on gender, age and educational attainment.  
Demographic characteristics of the interview participants are presented below in 
tabular form (Table 7.1). The participants were six men and eight women, ranging in 
age from 20 years to 68 years  (this range of ages broadly reflects the characteristics 
of patients referred to clinical genetics services for assessment of risk of bowel 
cancer). Educational attainment was varied amongst the participants, although the 
majority had a degree or higher degree. Twelve out of the fourteen participants had a 
diagnosis of Lynch syndrome, of which five had been tested and found to have a 
pathogenic gene variant following their diagnosis with cancer.  Six participants had 
been diagnosed following a pre-symptomatic test (PST) and three had no proven 
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molecular diagnosis but they had been given a diagnosis of either Lynch syndrome or 
a high risk of bowel cancer based on their family history of cancer.  
Table 7.1  Demographic characteristics of participants in Phase 2 interviews.  















Emma 20 Female none PST uncle Lynch 
syndrome 
Robin 27 Male none PST sibling Lynch 
syndrome 




Sandra 55 Female endometrial Diagnostic children Lynch 
syndrome 




Fiona 43 Female bowel Diagnostic sibling Lynch 
syndrome 
Anne 64 Female bowel & 
endometrial 




Bob 36 Male none PST none Lynch 
syndrome 








Kay 48 Female none Not 
available 
NA High risk 
of bowel 
cancer 
Gina 39 Female none Not 
available 









7.3 Summary of the four major themes identified  
 
Each of the interviews provided an opportunity for the participants to tell their story. I 
encouraged them to reflect on what could have been improved in terms of supporting 
information at the time of their diagnosis. This approach may have encouraged a 
critical perspective on their experiences. What I found striking was the profound, 
mostly negative, effect the diagnosis had made to their lives. This led to me 
identifying the first major theme as the impact of the diagnosis. The evidence for this 
was in the descriptions given by some participants of the shock, a sense of burden and 
the feelings of isolation they had experienced since their diagnosis. Some spoke of 
having to become self-reliant, for example: having to keep reminding clinical services 
about their need for regular surveillance by colonoscopy. 
The second major theme was that of adaptation; it was evident to me that lack of 
adaptation to the diagnosis had affected some participants’ ability and inclination to 
share information about the implications of the diagnosis with their relatives. 
Conversely, those participants who appeared to have adjusted and adapted to their 
diagnosis were more accepting and also more engaged with their sense of 
responsibility to their relatives. The participants wanted more practical information 
to augment their understanding of the familial diagnosis, this was the third major 
theme. Descriptive coding identified what information they would have liked to 
receive (and what topics they would want covered on the proposed website). This 
revealed that advice on how to reduce their risk of cancer through a healthy diet and 
changes to their lifestyle was most commonly mentioned. Other frequently cited 
topics were: risks of different cancers and the relevant screening for them, how to 
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spot the early symptoms of cancer, how to explain the diagnosis to children, where to 
go for support, and finding advice specific to their particular mismatch repair gene. 
The fourth major theme identified was using appropriate communication with 
relatives. Those participants who had shared information about the diagnosis with 
their family members used ways to contact them that were feasible and that they 
thought would suit that person. This meant that using a secure website to share 
information in the family could be utilised as one of several ways of communicating 
with their relatives. 
Table 7.2  Summary of main themes and subthemes identified in Phase 2. 
Theme Subthemes Examples 
Impact of the diagnosis  
 Emotional burden Role of being informant; fears for self and others 
 Initial understanding Shock or some expectation 
 Feelings of isolation Self-reliance, fight for treatment, ignorance of GPs 
 Practical implications of 
diagnosis 
Colonoscopy screening, responsibility to family, 
aware of symptoms of cancer. 
Adaptation  
 Acceptance, coping & self 
esteem 
Adjusting to things unable to change, positive 
perspective, forward looking. 
 Social integration Closer to loved ones, joined support group 
 Regaining control Taking action, role of family co-ordinator, 
information seeking, sharing information 
 Family adjustment Family talk about diagnosis, relatives access 
screening 
 Lack of adaptation Denial, avoid talking about diagnosis 
Practical information  
 Information to support 
understanding 
Written in plain language, education for GPs and 
other health professionals 
 Information that gave hope Less clinical and more positive 
 Website content 
requirements 
Healthy lifestyle advice, gene specific risks, talking to 
children 
Appropriate communication  
 Using existing methods of 
communication 
Different methods for different relatives; Facebook, 
email, telephone. 
 Positive attitudes to 
website idea 
Could access information at anytime; store screening 
reminders; ideal for younger relatives. 
 Limitations of information 
via a website 




7.4 Impact of the diagnosis 
 
7.4.1 Initial understanding 
 
Most of the participants either learnt about their risk of cancer through their parents, 
often their mother, or through their own diagnosis of cancer. Several had experienced 
multiple relatives being affected with bowel cancer or other cancers.  This was the 
case with Sandra, who was not surprised by her diagnosis:  
“my maternal grandmother had cancer of the womb and then she had bowel 
cancer twice. My mum had cancer of the womb. (Sandra, S6 line 11). 
This indicated to Sandra that she was likely to develop cancer too:  
So I always expected..it” (Sandra, S6 line 12 ).  
The exception to this was Robin, who in his early 20s realised that his father’s 
diagnosis with bowel cancer at 40 years was unusual.  He sought the advice of his GP, 
which eventually resulted in his father being tested and found to have a pathogenic 
gene variant, giving him a diagnosis of Lynch syndrome. Robin appeared to have had 
a key role in his family regarding the diagnosis. Nonetheless, he did not know whether 
his aunt had talked to his cousin about the diagnosis: 
“her daughter is obviously aware of that operation and whether she's tested I am 
not sure, and she has kids and I am not sure if they are [aware] either” (Robin, S4 
line 158).  
Quite unusually Fiona (S8) learnt about the condition in the family through a letter 
from her genetics service, which she found profoundly shocking:  
“I knew nothing about that at the time. And so it was, you know, it was a real 
shock” (Fiona, S8 line 62)  
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However, all other participants were told either in person or over the telephone by 
their relative or a health professional.   
Thinking beyond the mechanism of how people found out, the way that participants 
described their experience of learning about their familial risk of cancer indicated the 
profound effect it had on them.  
7.4.2 The profound effect of the diagnosis 
None of the participants reported regretting having a pre-symptomatic test or being 
given a diagnosis. However, the data revealed what a major impact the diagnosis had 
made on the participants’ lives. The need to adjust and come to terms with their 
increased risk of cancer appeared to have had a profound effect on them. Some 
participants emphasised the role chance played in their diagnosis, and this appeared 
to reinforce their sense of uncertainty. Some reported that their cancer was only 
detected by chance or was entirely unexpected. For others, the participant or their 
family had realised that there was some genetic predisposition in their family, but this 
had not been recognised before by health professionals. 
Some of the participants found the diagnosis frightening or shocking initially. This is 
most evident for Fiona who did not have contact with her late mother’s family and 
learnt of the familial diagnosis by letter from her genetics service: 
“a complete bolt out of the blue really” (Fiona, S8 line 59).  
Several participants felt it was better to know of the risk and benefit from regular 
screening. However in almost all, the diagnosis led to concern and the burden of 
responsibility of having to inform their relatives. In addition, there was anxiety that 
their attempts to inform other people in the family might be met with indifference or 
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negative reactions. Anne explained how difficult it was when her son was tested 
following her own diagnosis: 
“it was a really horrible thing to go through to see the devastation with my son, 
when he realised he had it. It was very traumatic” (Anne, S9 line 285) 
Some participants alluded to the emotional burden they felt by being constantly 
aware of the condition. Others described the trauma they experienced through 
witnessing the effects of cancer on people they cared for. 
7.4.3 Feelings of isolation  
 
Feelings of isolation appeared common and were expressed by the majority of 
participants; Fiona said:  
“I feel that nobody is looking after me” (Fiona, S8 line 531).  
While Anne reflected that after her genetic counsellor retired she felt unsupported: 
“I felt like a little bit abandoned” (Anne, S9 line 199)  
These feelings were compounded by her GP retiring: 
“he was absolutely amazing but he's retired now and I don't feel that there is 
anybody that's left” (Anne, S9 line 209).   
Responses from Bill and Fiona reflected their pain and sense of powerlessness; Bill 
described how he felt his cancer could be worse if it recurred: 
“I have got these thoughts, you know, of the ..you know, the death sentence and 
that type of thing and the thoughts of if it does came back, you know, it's going to 
be a lot more difficult to manage, the consequences are going to be worse and that 
type of stuff” (Bill, S2 line 321).  
Another common issue reported by participants was having to be self-reliant, 
particularly needing to be the expert patient because the health professionals may 
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know less than the patient. Diane, Robin, Dave and Fiona all described how they have 
to “push and push” to get the appropriate treatment or screening. Dave reported:   
“it seems to be all the time I am battling to (get) my colonoscopy, colonoscopies 
done yearly rather than three yearly.” (Dave, S7 line 127).  
Similarly, Diane believed that her cancer would not have been found but for her 
persistence:  
“I had to push and push and push each stage of the way” (Diane, S11 line 73)  
and  
“I would possibly be dead by now or had a really serious, you know, end stage 
cancer before they got to me. I don’t think I would have been taken seriously. ..I 
have had to really, really push…particularly about my bowel screening.” (Diane, 
S11 line 158). 
Several participants spoke of their frustration and dismay that very few health 
professionals they met had heard of their condition; some suggested that they felt it 
was important that GPs, in particular, received education about LS. The difficulties of 
having to be self-reliant and become an expert patient appeared to add to the burdens 
experienced by participants. 
7.4.4 The burden of the diagnosis 
 
Some participants voiced a sense of burden associated with the diagnosis.  There was 
an emotional burden sometimes described in terms of a fear for themselves: 
“..sometimes it does feel as though there is a bloody sword hanging over your 
head” (Sandra, S6 line 175) 
The emotional burden was sometimes expressed as feelings of guilt, and the trauma 
of watching loved ones suffer: 
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“it is the watching people with it, or er, the predation of people um ..through 
cancer, which is probably the most painful thing” (Bob, S10 line 152). 
Bob also described how he felt he had become a burden to others when he tried to 
talk about his condition; this may have contributed to his feelings of isolation: 
“I get the sense, that you know, I'm becoming a burden, I am becoming boring. I 
know I shouldn't be, but it is just something that gets glazed over really and I don't 
actually know why. Because it is quite a big deal, I would have thought” (Bob S10 
line 183) 
Other aspects of the diagnosis that created a sense of burden were their efforts to 
inform relatives, their anticipation of negative reactions in relatives and how 
participants expressed feeling a responsibility to others. These feelings were most 
frequently voiced in relation to children, so they appeared fearful about their own 
health and the health of their family members. In addition, there were also the 
practical burdens of taking time off work to have screening or prophylactic surgery: 
“It was a complete waste of time because they didn’t actually pass any of the 
information on.  Yes it was a complete waste of time and effort. And then because 
when I have to go for these appointments I have to take time off work” (Kay S12 
line 214) 
‘Access to information’ was also a recurring minor theme where lack of access to 
information was a factor that inhibited communication, like the condition not being 
openly discussed in the family, having insufficient knowledge to be confident 
explaining the diagnosis to others, or having problems being referred to genetics 
because of inadequate information to support that with the GP. However, some 
positive experiences were described by participants such as: access to genetics follow-
up or information found through a support group, also greater awareness of research 




7.5 Theme 2 - Adaptation to the diagnosis 
 
7.5.1 Adaptation was associated with sharing information 
Moving beyond the manifest to the latent meaning of the interviews, secondary 
analysis of the data indicated that coming to terms with, and adjusting to, the 
diagnosis was likely to be necessary before patients could fully engage with sharing 
information about the diagnosis with their relatives. The coding frame (Table 7.3) 
provides some examples of adaptation taken from the data from seven of the 
fourteen interviews. The signs that I took to indicate adaptation also appeared to be 
associated with how engaged participants were communicating with their families 
about their test result or diagnosis.  
7.5.2 Lack of adaptation 
Amongst the participants in this study, two people stand out as lacking peace of mind 
and did not appear well adapted to their diagnosis, these are Bill (S2) and Bob (S10). 
Bill had spoken to his sons about the diagnosis of Lynch syndrome but could hardly 
contemplate attempting to speak to one brother and had no intention of trying to 
contact his other brother. He returned repeatedly to his complaint that his family 
received very little psychological support 20 years earlier when he was diagnosed with 
cancer. He also admitted to feeling troubled by his more recent diagnosis of LS:  
“I guess I come up with trying to make sense of nonsense, you know, and just try to 
make what is going on a little bit more manageable” (Bill S2, line 282).   
Bill was also fearful for his own future:  
“on me bad days, it is like um.. a death sentence” (Bill S2, line 247).  
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Bob presented a different perspective but with only tentative signs of adaptation. He 
sounded isolated and was the only person in his family to be tested; he was still 
struggling to come to terms with his positive pre-symptomatic test eight years earlier: 
“I have not got any family. I mean, you know, I am not going to lie to you, since I 
was diagnosed it has totally affected my interaction with other people, forming 
relationships” (Bob, S10 line 114).  
While showing some indications that adjusting to their situation was still difficult,  
Bill’s and Bob’s involvement in this study could be interpreted as demonstrating a 
degree of adaptation.   
7.5.3 Signs of psychological adaptation 
In contrast to Bill and Bob, all the other participants appeared to demonstrate more 
signs of psychological adaptation to their diagnosis and some were actively engaged 
in trying to inform and support their relatives about aspects of the familial diagnosis. 
One of the commoner signs of adaptation noted in this group was actively seeking 
information about the condition. For example, John and Gina both described looking 
on ‘Google’ for more information, while Fiona, Emma, Robin and Natalie all sought 
information and support through the Lynch syndrome UK Facebook group and 
website.  
Another aspect that comes across in some of the data is the positive view of their 
circumstances that some participants appeared to have. A few of the participants 
described how their familial gene variant was in some way advantageous compared to 
other mismatch repair gene variants. They regarded their particular gene variant as 
being, as Dave says: “probably one of the better ones to have” (Dave S7 line 186). 
Dave (gene variant in MLH1) shared this perspective with Robin (gene variant in 
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PMS2) and Sandra (gene variant in MSH6) and this optimistic view was interpreted by 
me as evidence of coping efficacy.   
7.5.4 Which relatives are informed 
 
The closeness of family members seemed to have a bearing on how likely they were to 
be informed or share information, although this may not hold true for some families 
with dysfunctional relationships. For most participants the people they talked about 
as ‘family’, and for whom they felt a responsibility, were their children or siblings.  
The younger participants who didn’t have children, such as Emma, Natalie and John, 
were all recipients of information provided by their parents and appeared not to have 
felt a responsibility to share any information with relatives. In contrast, it was Robin, 
who at age 27 years and married, did encourage his brother to seek genetic advice and 
have testing, despite his brother’s apparent indifference:  
“he’s had the test. Er he was very.. not reluctant, but not bothered is probably too 
strong a word, but it wasn’t something that he was particularly interested in. But 
he has had the test and luckily he hasn’t got it..” (Robin, S4 line 123).  
Initially Robin had recognised the pattern of cancers in the family as unusual. 
Subsequently he appeared to adopt the role of a family co-ordinator regarding the 
diagnosis, following the instigation of genetic investigations in his father.  
Other participants with adult children (George, Gina, Kay, Anne, Bill, Diane, Dave, 
Anne and Sandra) focussed on the importance of protecting their children from cancer 
and supporting their children through genetic testing. This is illustrated by Sandra 
who had children ranging in age between 36 and 22 years:  
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“that’s where I think .. ..it’s alright supporting them, ‘cause I …I.. I …for me, I 
knew about me, that wasn’t my issue, the issue now is that I have got four 
children” (Sandra, S6 line 64).  
 
7.5.5 The role of family co-ordinator – taking action 
 
Another aspect of adaptation was the type of actions participants described following 
their diagnoses. In response to questions about how they had shared information 
about the diagnosis, most indicated that they had talked to their close family but few 
mentioned relatives in the wider family.  One clear exception was George, who had 
taken it upon himself to be a family co-ordinator and had created a spreadsheet where 
he logged what testing or screening each relative had received:  
“I do check up to make sure that the colonoscopy teams in their local hospital are 
responding and that there’s no delays.” (George, S1 line 680).  
Diane’s behaviour also illustrates that she took this role with regard to sending 
information to her relatives, asking other family members to send on information to 
those for whom she lacked contact details:  
“..getting people to share stuff and sending information and you know, if I haven’t 
got an up to date address its getting someone else and they have to send it off” 
(Diane, S11 line 414).  
Diane also went with her sister and son to their genetic counselling appointments, 
which was a supportive strategy also used by Sandra. 
 
Emma mentioned how her uncle looked into the family history first following her 
mother’s diagnosis and Fiona described how she was asked by the genetics service to 
inform her brother and to make sure he had screening. Natalie had a different 
perspective, mentioning several times the importance of her partner having access to 
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information about her diagnosis. She wanted him to have information from which he 
could draw his own conclusions and not be influenced by her interpretation:  
“I felt it was very important for my partner to know about Lynch syndrome, 
because I didn't know um about Lynch syndrome because I didn't um, I was not 
sure if I was explaining it well enough to him , so I felt that reading the letters 
would be a good way for him to um, to have a better insight” (Natalie, S5 line 54) .  
 
7.5.6 Family adjustment interacts with personal adaptation 
 
Assessment of family adjustment was through indicators such as how openly the 
condition was discussed in the family and whether relatives were reported as having 
testing or screening. This revealed that some families did not appear to have adjusted 
to the diagnosis, even when the diagnosis had been known for several years. Most 
notably, Bill did not appear to have adapted to his genetic diagnosis and there was 
little evidence of adjustment in his family, with his sons both struggling with the 
diagnosis and Bill estranged from his brothers.  
In contrast, Emma, Natalie and Dave all had supportive families with open 
communication around the diagnosis and they themselves appeared to have adapted 
to the diagnosis. Passages of each of their dialogue could be interpreted as showing 




*Adaptation domains taken from Biesecker et al 2013 “Development and validation of the Psychological Adaptation 
Scale (PAS): use in six studies of adaptation to a health condition or risk”  
 Table 7.3 Evidence of participants' adaptation coding 
Adaptation 
domain* 
Indicated by these 
aspects 
 






Acceptance of diagnosis, 
positive perspective, or 
appears forward looking 
“Technically your kind of.. safer having it, and 
getting the regular screening and the regular tests, 
than… not knowing and not getting that help, then 
if they can catch it early then that’s amazing..” line 







“..a lot of my concerns I have brought up with my 
mum prior to going anyway, because we have a.. a 
very good relationship” line 50, S5 Natalie 
Joined support group “ the genetic side of it and emotionally I go on the 
Lynch syndrome UK Facebook” line 52  S4 Robin  
Aware of support available 
from others 
I still call mum like er..for three times a week, 
because I don’t know, because I think we are as a 
family quite used to it now I’m in which it needs talk 
about it that much says there is anything like 
worrying me then I would just call her and tell her. 
Line 162 S3 Emma 
Informing relatives about 
diagnosis 
“I said “Take my letter with you because it will 
explain it easier than you trying to explain it”, so I 
had to give him my personal clinic letter to take to 
his GP and his GP, did refer him” line 291 S8 Fiona 
Raising awareness of the 
condition 
“If I am telling someone, I do tell a lot of people 
about it, because I would rather them know about 
it, so if they say if someone in my family had it 
young, and my brother had it young, then it raises 






Information seeking “I did a kind of Googling it in the early days I think 
when my mum had first given me the information I 
sort of started to dig around to find what is it what 
does it mean” line 204 S14 John 
 
“I have got ..got a profound interest in genetics of 
all sorts of things now. So I am forever reading up 
the latest things they have found out” line 75 S7 
Dave 
Participating in research “I get a phone call from my counsellor every six 
months but that’s because I’m on the CaPP3 trial” 
line 183 S3 Emma 
Taking action to adjust to 
new threat  
“I have done my own research and I have spoken to 
the Lynch experts at the conference I have just been 
to are very much advocating HRT and it is 
potentially, it has a protective role particularly in 





screening or testing 
“Yes, my brother's had testing and he didn't have 
the gene, um.. my uncle had testing and he didn't 
have the gene so that wouldn't have passed on to 
my cousins” line 203 S5 Natalie 
Family talk about the 
condition or diagnosis 
“As soon as my mum found out, everyone, everyone in 
the family, both sides of the Atlantic were informed 





7.6 Theme 3 – Practical information 
7.6.1 Practical information to support their understanding of the diagnosis 
When participants reflected on what supporting information they had received at the 
time of their diagnosis most reported receiving some written information. However, 
this was often limited to a clinical letter from the genetics service that was not 
necessarily regarded as appropriate material to share with other family members. 
Some spoke of receiving standard leaflets but almost all described how they had 
looked for information themselves, mostly via the Internet: 
 “I have looked at a lot of different websites particularly once my sister was 
 diagnosed” (Kay, S12 line 260). 
John described how he was given plenty of information after his pre-symptomatic test 
result but he found the information factual but too clinical; he wanted more practical 
information guiding him about the repercussions of the diagnosis: 
“..too much about the medical aspects I guess rather than what you really want 
to know is what is the real likelihood that you have this gene, what are the things 
that you need to do in terms of you know protecting yourself, really what is the 
impact on your life, do you need to worry about it, is it something you can manage 
with lifestyle changes” (John, S14 line 214). 
Robin commented how he would have found it helpful to have been given simpler 
written information. This would have enabled him talk about LS and its implications 
with his cousins, and people outside the family, in order to raise awareness of the 
condition.  Robin also described how it would be a practical benefit to him to be given 
a record of his colonoscopies to help him keep track of when the next one was due. 
Following her initial contact with clinical services, Gina described how she would have 





“Some information sheets, as soon as the doctor said we need this doing it would 
have been nice to read something about it and why, because all he kept saying 
was” you are really high risk” so it would have been nice to read something then 
when we first found out” (Gina, S13 line 200).  
 
Although different participants at times described which particular issues were of 
concern to them, it became apparent that the issues they wanted more information 
about changed as their understanding of the diagnosis deepened. They had questions 
for themselves and they also wanted information resources to support their 
conversations with their relatives.  
7.6.2 Website content requirements 
In the interviews participants were encouraged to suggest issues where they felt more 
information would be helpful. The coding then identified numerous different topics 
and the majority of participants did describe areas where they thought more 
information would be beneficial. The desired topics identified were:  
 risk reduction through diet and lifestyle  
 gene specific information  
 cancer risks and relevant screening  
 advice on talking to children  
 symptoms of cancer  
 inheritance and starting a family  
 research  
 where to go for support  
 insurance implications. 
 
These topics were mentioned numerous times across the interviews, which gave an 
indication of the broad spectrum of issues where the participants felt they needed 





through diet and lifestyle, which was specified by many of the participants. Gene 
specific information, cancer risks, screening and starting a family were all cited by 
several different people. Robin listed several which encapsulated the key issues:  
“talking to other people about Lynch syndrome um where to go for support, um like 
you said, healthy eating, keeping up to date with your scans, symptoms of bowel 
cancer” (Robin S4, line 194),  
Whereas Diane focused on information about the specific gene variant found in her 
family:  
“some information that is for your specific gene marker would be quite helpful I 
think, because we all approach this quite differently” (Diane S11, line 462). 
George was interested in: 
“encouraging people to adopt a better lifestyle” (George, S1 line 425).  
More information about a healthy lifestyle was the most frequently cited topic of 
interest, being mentioned by the majority (Anne, Bob, Fiona, George, John, Kay, 
Natalie and Robin). Advice that might help them in a practical way: 
 “That might potentially ward off or slow down the effects” (Robin, S4 line 201). 
In more general terms, most participants described how the format of supporting 
information could be improved. John, Robin, Natalie, Sandra and Fiona all spoke 
about how information provided should be simpler or tailored to the age of the 
recipient. While Diane, George, Emma, Dave and Anne all expressed the view that it 
would be helpful to have information that was “more positive” or more sensitive to 
people’s feelings.  Emma described this aspect, saying:  
“a little bit more.. sort of sensitive and encouraging about it, rather than just listing 





Information that was less clinical and focussed more on the benefits of knowing about 
the condition in the family, was considered desirable. 
What was apparent across the interviews was that participants wanted information 
that was practical for their needs. They needed to apply the information they received 
to taking action in their lives. The issue of being able to make some difference to their 
risk of cancer came up many times, as did the importance of being able to access 
bowel surveillance at the recommended intervals. 
 
7.7 Theme 4 - Appropriate communication 
7.7.1 Existing methods of communication 
When asked how they usually communicated with their family members it was 
apparent that participants used a range of different methods of communication with 
their relatives. They appeared to choose a way of contacting their relative that was 
appropriate or familiar for the family member concerned. Thus, Facebook messenger 
was used communicating with a niece (George) but a printed letter was better for an 
elderly parent (Fiona). Accessing information via websites was a common experience, 
so storing and sharing information via a secure website was envisaged as useful, if it 
was appropriate for the recipient. 
For most participants communication about the familial diagnosis was initially either 
in person or over the telephone and this was seen as the ideal. For example, Dave’s 
mother telephoned multiple family members:  
“As soon as my mum found out, everyone, everyone in the family, both sides of 





Many participants reported using texting or social media to keep in touch with their 
family (Gina, John, George, Emma, Natalie, Sandra & Anne) and texting was described 
by Anne as less upsetting than communicating verbally. Therefore it was apparent 
that consideration was taken by participants to use a method of communication that 
was appropriate for the relative and the content of the message being conveyed. 
7.7.2 Attitudes to the proposed website 
Although most participants did not consider it appropriate to use email to make an 
initial disclosure about the familial diagnosis they did regard a secure website as a 
useful tool in disseminating information. It was clear that the majority did welcome 
the idea and they could perceive using such a facility to share information with their 
relatives. Many were enthusiastic, describing which different topics they would like to 
see covered on the website. As noted earlier, several already reported having 
searched the Internet for reliable information relating to their diagnosis.  
Participants were almost unanimous in engaging with the idea of the website, 
including the function and the topics they would like covered in the resources.  Only 
Bill appeared disinterested, although he did think information about diet and lifestyle 
would be helpful. In contrast, several people engaged thoroughly with the idea, 
commenting on how equality of access and improved public awareness could be a 
significant benefit to them and other people with the condition.  Kay imagined how 
her brother might use the website as he was likely to take time to face the risk to 
himself, she said how providing information online might be really helpful to him:  
“once he gets to that point where he feels “I can face it now” he can go and have a 
look and he can find the information but he needs to do it in his own time and in his 
own way, and I think having that ability would be the key thing to it.  But it has not 





your time and you can do it as privately as you want to, to deal with it, and then 
discuss things once you have sort of taken that on board” (Kay, S12 line 379).  
The novel function of the website, as a way of facilitating sharing information about 
the diagnosis, was possibly less tangible when raised as a theoretical option but still 
some of the participants considered how this might work for them. Natalie imagined 
the website:  
“I don't suppose that I would mind having information personally on the website if 
it was password protected”(Natalie S5 line 355). 
However, she insisted that she should remain in control of who could see what 
information due to the confidential nature of some documents, saying:  
“I do feel that if we didn't have that control over what we could put, what could be 
seen on the website, I do feel I would be reluctant to want to take part” (Natalie S5 
line 416). 
John was more positive, he thought about the potential efficiency of using it: 
“I think the more you can share information together the better certainly I was 
doing the same thing with my family it would be a lot easier if you can go on line to 
access and upload so that aspect sounds really good.  Yes I think it sounds very 
sensible” (John S14, line 365). 
Diane considered the justice of making it easier to access relevant information, not 
only for herself but for others: 
“I think it’s just everybody having equal access to the information or having ease of 
access where to go for it” (Diane S11, line 592).  
An alternative perspective was expressed by Robin; he imagined how the website 
might help him manage his condition, saying: 
“(if) you had a little portal yourself, and you had an area where new guidelines, 
new screenings, when your screening might be coming up,  I think it would be 





Overall, the concept of a website which allowed confidential information to be shared 
securely was viewed positively, but as a way of reinforcing a disclosure that had 
already been made verbally. 
7.7.3 Perceived limitations of providing information via a website 
 
Some participants recognised the limitations of providing and sharing information via 
a website. Fiona described how electronic documents would not suit her father: 
“I would use whatever was appropriate for the person I was talking to. So, you 
know, if I was trying to explain to my father then I would use a patient information 
leaflet.  If I was trying to explain to my nieces, then I would say "Look at this 
website"” (Fiona S8 line 597) 
Almost all participants explained how they would prefer to first inform their family 
members face to face but would telephone relatives who lived further away. Providing 
written information was described as helpful but needed to be sufficiently simple to 
be interpreted. The clinic summary letter was considered too detailed, personal and 
clinical to be ideal for sharing, as John said it was: 
“probably too technical, too much about the medical aspects I guess rather than 
what you really want to know is what is the real likelihood that you have this gene, 
what are the things that you need to do in terms of you know protecting yourself, 
really what is the impact on your life, do you need to worry about it”(John, S14 line 
212)  
However, for several people the clinic letter was the only written information they 
appeared to have received. This meant that ‘written information’ was coded both 
within the barriers to sharing information theme and as a facilitating factor in 
accessing information. 
Eight of the participants reported using the Internet to search for more information 





genetic counsellor not to search the Internet. She reported that her genetic counsellor 
had told her that the information she might find could be “scary”, “exaggerated” and 
might make her “feel even worse” (Emma, S3 line 100). 
Therefore, using a secure website to share information was perceived as an 
acceptable approach but was regarded as not without its limitations. 
7.8 Conclusions 
The participants interviewed in this part of the research study were generally engaged 
with the need to improve information and support to themselves and their families. 
They were able to imagine the potential uses of a website designed to provide 
information. Most of them were also able to envisage a function that would also 
enable them to share documents securely with their relatives. They had numerous 
suggestions regarding how information should be presented and what content it 
could contain, often qualifying these needs with how they wished to help themselves. 
However, some of the participants appeared to be struggling with their own 
psychological adaptation to their diagnosis and could only conceive of barriers to 
communicating with their relatives at this time.  
Therefore the data from the interviews was very informative regarding the function 
and content of the proposed website. In addition, it provided insights into why some 
patients might find a website of this kind of limited use. I interpreted that some might 
look at the open access information on the site. However, they might not use the 
document sharing function if they themselves were not at an appropriate stage of 






Figure 7.1 Phase 2  - major themes and their suggested interactions 
The four major themes identified of impact, adaptation, practical information and 
appropriate communication could be regarded as interacting with each other as 
illustrated above (Figure 7.1). The postulated interrelationships between these themes 
and how they are relevant to familial communication are discussed in more detail in 
Chapter Nine. 
In the next chapter (Chapter Eight) I describe the results of 12 Think-Aloud interviews, 
which were conducted with volunteer users from across England and Wales. These 
interviews enabled the website content and function to be viewed and tested by 
people who had been diagnosed with a high risk of bowel cancer within the last two 
years. The three cycles of interviews contributed to the development of the website 







Phase 3 Think-Aloud interviews and website development 
 
8.1 Introduction 
As described earlier, patients’ views were investigated regarding which 
supplementary methods of providing information were most likely to be welcomed 
through a cross-sectional survey (Phase 1, Chapter 6) and telephone interviews 
(Phase 2, Chapter 7). The concept that providing information in alternative formats 
could support patients when they were sharing information in their families had 
culminated in the creation of a website. Whether the website approach and what it 
provided were both acceptable and feasible were then explored through a series of 
Think-Aloud interviews. These interviews involved volunteer users visiting the website 
while being interviewed via an online video conferencing platform called 
GoToMeeting (LogMeIn, 2017). This meant that volunteers could be in a location of 
their choice and using a computer, laptop or tablet that they were familiar with during 
the interview. 
The process of website development was an iterative one with three different stages. 
In the first stage volunteer users were given the link to the website at the start of the 
interview so that their immediate reactions to the site could be recorded.  In the next 
stage, the group of four different users were each provided a link to the website via 
their email two days prior to the interview and encouraged to view the website and 





recorded. The final group were given a link to the website several days before the 
interview and encouraged to try the functions of signing up and sharing documents. 
Recording the Think-Aloud interviews using GoToMeeting allowed the interviews to 
be transcribed into a matrix (Appendix 27) where the participant’s remarks were linked 
to the specific area of the website which they were viewing at the time. As in the 
previous chapter, all names of participants have been changed to preserve their 
anonymity and only pseudonyms have been used in this text.  
8.2 How the survey and interview results informed website content 
The survey conducted as Phase 1 of this study provided evidence that the participants 
wanted to receive additional supporting information about the familial diagnosis in a 
range of formats (Chapter Six). The participants were all either living with a high risk 
of bowel cancer, or from a family where a genetic susceptibility to bowel cancer had 
been found. They had indicated their need for information on a range of topics 
relevant to their condition. The cross-sectional survey captured data regarding which 
issues were of particular interest. This then enabled information on these topics to be 
included on the website.   
The 14 telephone interviews that followed the survey also contributed data regarding 
what issues interested participants (Chapter Seven). These were: their cancer risks, 
symptoms and relevant screening; how changes in diet or lifestyle could influence 
cancer risk; information about specific genes; how to talk to children about the 
diagnosis; starting a family and inheritance; research opportunities; insurance 
implications, and where to go for support. In addition to the choice of topics covered 





whether they would use the proposed website and how they would use it. All but one 
of the interviewees responded very positively and provided examples of how they 
might use it. The main considerations that they described were the ability to control 
who saw what personal information and how to educate their GP or specialists about 
their condition. However, several participants thought it was important to have 
information that described their condition more favourably, stating the benefits to 
knowing the diagnosis. This positive perspective they described as generally lacking in 
what was currently available to them. Participants wanted to be able to present 
information about the familial diagnosis in such a way as to explain the potential 
benefits of knowing about it; this was perceived as an important incentive in 
informing their relatives. 
Questions around how they found additional information following their diagnosis 
indicated that searching the Internet, talking to their relatives and interacting with 
other people with the same condition via an online support group, were the most 
significant sources of information for survey respondents. Whilst most interview 
participants described how they thought it was important to communicate initially in 
person or over the telephone with their relatives about the diagnosis,  they also 
described how they used email or social media to communicate with their relatives at 
other times. Therefore using a secure website to share personal information relating 
to the familial diagnosis was endorsed as an acceptable approach. 
8.3 Initial website structure and design 
The purpose of the website had been described to the web developer including the 
importance of creating a website with a high degree of security in order to maintain 





was chosen following a process of informal tender, competing against four other web 
development companies. This professional web developer was chosen because he 
engaged with the concept of the website, he was experienced creating commercial 
websites, he had undertaken other academic projects before and his quote was within 
the allocated budget.  
Figure 8.1 Screenshot of Homepage banner 
The choice of images, as well as the functional aspects of the website, were all 
discussed as part of the development of the initial website (Figure 8.1). Since some of 
the funding for the website development was provided by the charity Bowel Cancer 
West, their logo was placed on the title banner alongside Plymouth University who 
were the academic sponsor. The ‘Family Web’ logo was designed by the 
webdeveloper, again following discussion with the researcher. 
 





It was considered important to explain to users why the website had been created 
(Figure 8.2) and that the study had received NHS Health Research Authority approval. 
A small photograph of the researcher was put at the bottom of the ‘About the Family 
Web Study’ page in order to highlight that this study was being conducted as part of a 
PhD but the researcher had clinical experience in the NHS (as a Registered Genetic 
Counsellor) that had informed her approach. 
In the preliminary stages, and before the website was live and available to users, the 
structure and images were assembled in a draft form to help the researcher envisage 
the website and identify where content was needed for the different pages of the site 
(Figure 8.3). Therefore the construction of the website was through a close 
collaboration between the researcher and the webdeveloper.  
 
Figure 8.3 Screenshot of a basic web page prior to addition of content 
It was decided that people accessing the site could be at different stages of their 
understanding about the familial diagnosis. Some might be aware of their family 
history of bowel cancer but without having received specialist advice, while others 
might have known of the diagnosis for some time and be concerned about the current 





importance of making relatives aware of the diagnosis and the potential health 
implications, it was acknowledged that users might have a range of different 
information needs. Therefore the organisation of the open access resources was 
considered important and if possible needed to be logical and intuitive. The life cycle 
approach that was used to organise the information available on the website into 
‘Your Journey’ (Figure 8.4). This resulted in a series of pages on the website which 
included information to suit different perspectives depending on whether someone 
was a concerned relative or someone living with a diagnosis. These were entitiled: 
 Before Diagnosis 
o Being seen by the Genetics Team 
o What is Bowel Cancer 
 Sharing the news 
o Why telling your family is important 
o What do your family need to know 
o Talking to children (Figure 8.5) 
 Living your life (Figure 8.11) 
o Healthy Lifestyle: Diet 
o Healthy Lifestyle: Alcohol 
o How to get the right screening for you? 






Figure 8.4 Screenshot of 'Your Journey' introduction and first topics 
The different topics covered in the open access resources were guided by the 
participant responses to both the cross-sectional survey and the telephone interviews 
(Section 8.2).  
In addition, a ‘Useful websites’ page (Figure 8.22) had a brief description and 
hyperlinks to a variety of websites that provided more detailed information about 
some topics.  
 





The views of participants captured in both the survey and interviews had indicated 
that giving a positive or optimistic perspective would be welcome, therefore the 
images and content were written to reflect this. 
8.4 Think-Aloud Interview volunteers 
Participants in the Phase 1 survey who had indicated that they would consider being 
interviewed were contacted by email or telephone. In addition, eligible patients were 
approached by letter (Appendix 17) or in a clinical setting by their health professionals 
at the six NHS recruitment sites and given an information sheet (Appendix 20). The 
process of the Think-Aloud interview was explained in more detail and the fact that 
they would need to have access to a computer, laptop or tablet plus a telephone for 
the duration of the interview in order to have their reactions to the website recorded. 
Volunteers who wished to be interviewed were asked to sign a consent form 
(Appendix 19) and return it. Before recording each interview their decision to take part 







Table 8.1 Characteristics of interview volunteers and duration of interview 
Number Alias Gender Age Interview 
date 
Duration  
First Phase No prior experience – first impressions 
#1 Oliver Male 34 13.04.2017 56 minutes 
#2 Luke Male 39 26.04.2017 31 minutes 
#3 Jane Female 42 27.04.2017 1 hour 6 minutes 
#4 Freya Female 25 27.04.2017 1 hour 7 minutes 
Second Phase 2 days prior access to website before interview 
#5 Theo Male 63 04.05.2017 1 hour 17 minutes 
#6 Mike Male 65 07.06.2017 1 hour 30 minutes 
#7 Annie Female 48 13.06.2017 55 minutes 
#8 Harry Male 69 14.06.2017 13 minutes 
recorded 
Third Phase ~ 1 week prior access to website before interview 
#9 Mark Male 48 17.07.2017 1 hour 34 minutes 
#10 Stella Female 60 19.07.2017 1 hour 16 minutes 
#11 Jenny Female 48 31.07.2017 1 hour 19 minutes 
#12 Keith Male 47 31.07.2017 53 minutes 
 
The average age of the men taking part in interviews was 52 years and for the women 
it was 45 years. The participants in the interviews were selected as a purposive sample 
with a range of ages.  The intention was to have equal numbers of men and women 





8.5 Generalised responses to the Think-Aloud interviews 
8.5.1 First Iterative phase responses 
The first iterative phase of testing the website with four volunteer users (Table 8.1) 
sought to capture immediate impressions of the site. The users all expressed interest 
and commented on how much they liked the look of the website: 
“This is exactly the.. type of resource that I would have liked to have access to 
when I first got the diagnosis to be honest and there wasn’t anything like this 
made available to me.” Oliver (#1) 
“I think the content looks really good and the way it is laid out is really good, it is 
really clear.” Luke (#2) 
“It is nice and clear, it looks like a good page, I would look at this. I can see what it 
is all about”. Jane (#3) 
“Looks nice, looks good.. will it get an NHS badge?” Freya (#4) 
However, they did not immediately grasp what the function of the website was 
intended to be, Luke (#2) said: 
“It’s not instantly clear what it is regarding..  .. is this just about people with 
bowel cancer awareness?” Luke 
Whilst Freya (#4) did not know how to categorise herself, whether as a ‘patient’, 
‘family member’ or ‘professional’ since she could identify with all three terms. She 
explained that because she had not been diagnosed with cancer herself, she was not 
sure she felt like a ‘patient’: 
..from this bit I can tell it is for a number of different people, I presume I click on 
the patient’s thing? Although I also guess I am a family member so I am not 100% 
sure where I would, where I would go upon first getting here. Because I wouldn’t, I 
think I wouldn’t think I was a patient for someone who is at risk as opposed to 
someone having cancer is.. I don’t know if I like that, I am not sure.. Freya (#4) 
All the users in this phase liked the resources, two users drew attention to the way the 





“I like the fact that it is simple, I want to read it quickly.  If I don’t want to hear 
about it just yet I can go back to it”. Jane (#3) 
“I think it has a got a lot more information than anything I have seen before, even 
just looking quickly, just what you need to know, this bit here why telling your 
family is important, talking to children”.. Luke (#2) 
They all particularly liked the information about diet in the ‘Living your Life’ section: 
“This is my favourite page of it all because these are the questions that I have had 
to go away and find answers to myself” Oliver (#1) 
and 
“I think the content looks really good and the way it is laid out is really good, it is 
really clear… I like the way you have listed about getting the right screening and 
the insurance”. Luke (#2) 
These and other comments by the users confirmed that the appearance of the 
website was acceptable and the way the resources were presented made sense to 
them. 
Freya (#4) made a very pertinent suggestion that in her view more prominence 
needed to be given to the potential beneficial effects of following dietary advice. 
When looking at the Living your Life page she said : 
“I think I would put that right at the top.” Freya (#4) 
 and then repeated: 
“I think I would put that right at the top. Something like..  .healthy diet, exercise, 
everything, that is good for everyone but you are at a higher risk and it makes 
even more of a difference for you. Some people might think, I am at a high risk of 
getting it due to this problem with my mismatch repair, I am going to get it 
anyway, it doesn’t matter whether I am healthy or not so why should I bother 
changing my life? But if your behaviour can have even more kind of .. if your 







8.5.2 Second Iterative phase responses 
The next group of volunteers (Table 8.1) were provided with the link to the website 
two days before their interview and encouraged to sign up to the website so they 
could comment on that process within the interview. One chose to have their 
interview at the University (Theo, #5) but technical difficulties were encountered with 
the recordings for two of the interviews (#5 and #8) which then limited the data 
captured during this phase of development.  
The two other users (Mike, #6 and Annie, #7) had problems signing up to the website 
and did not understand that they needed to activate the account before using the 
document storage and file sharing facilities. Although Mike acknowledged that he had 
not read the instructions: 
“I had not read instructions about how to activate the account”. Mike (#6) 
Another user (Harry,#8) found the process “easy” and did not have problems but then 
expressed his concern that because changing a password was easy to do he thought 
this might make the website less secure. 
Again, in interviews #5, #7 and #8 the users commented about how much they liked 
the look of the website. One person explained how they understood the purpose: 
“Quite straightforward.  Initially I would take it as a sharing site where I can add 
to it and other people can add.  The initial feel I get is that it is like a one stop 
shop” Theo (#5) 
While others liked the information resources: 
“I think you have pitched it pretty much spot on, it’s clear it is uncluttered, you are 





“Particularly liked resources.  Sat and watched videos.  Really good, I did like the 
resources.. I think this is good,  very useful information, very clear” Annie (#7) 
However, ‘Mike’ (#6) was critical of many aspects of the website saying that in general 
he found the text “too wordy” and questioning who it was intended for: 
“What audience are you looking at? Some of the things are way beyond layman 
level? People are not going to plough through lots of stuff that is going to frighten 
them.” Mike (#6) 
He didn’t like the text being in dark grey as he felt it was harder to read. He was 
particularly critical of the diagram of biological mechanisms (Figure 8.13) and thought 
people would not get to the most vital information: 
“probably not hitting the crux of the thing about passing on knowledge of risk of 
cancer.” Mike (#6) 
When the document sharing function was demonstrated during the interview Mike 
was more positive, as he liked that aspect but he did say that it was still too 
complicated. The others were more optimistic about using the site, thinking how they 
might share documents with their relatives: 
“This seemed fine, that seemed straightforward…  I know my brother would be 
very keen I wanted to send him a link” Annie (#7) 
One aspect that seemed to be confusing was how to share files that were uploaded 
and it became apparent that users were not interpreting the blue folder icon (Figure 
8.24). 
8.5.3 Third Iterative phase responses 
In the last phase of development the volunteers were sent the website link in advance 
of their interview (Table 8.1). This ranged between 4 days (#9) and 13 days (#12) in 
advance and they were encouraged to sign up and try out the site. In fact none of the 





interviewed. Two of the users (#10 and #11) expressed their enthusiasm for the 
concept and endorsed the fact that their relatives were likely to benefit from it and 
probably would engage with it. One said: 
“I liked the fact that you can add only people from your family that you want to 
add.  So they can get to your information and if they don’t want to sort of or they 
feel uncomfortable talking to me, they can access the information without having 
to approach me so that they have got their own privacy with it. I think that is 
good for the grandchildren more than anything.” Stella (#10) 
and another said: 
“I would send a link to the website to friends and family because it is very 
informative… My son would much prefer to receive an email with a link on it than 
a letter in the post.” Jenny (#11)  
Although a different user was concerned that the approach would not suit all relatives 
and some might still prefer a printed document: 
“It is the modern way isn’t it. It will probably help people like me and in my age 
group. Whether it helps people of an older age group would be different. They are 
more inclined to want a paper version aren’t they?” Keith (#12) 
The document sharing function was demonstrated during the interviews by the 
researcher, through pretending to be their health professional and connecting with 
each user to share a variety of documents. Two of the three for whom this worked 
successfully were apparently delighted, saying: 
“Oh, my documents!” Stella (#10) 
“I love the icons, this is really good!” Mark (#9) 
Although the final volunteer Keith was less enthusiastic, he did comment: 
“I thought it was all pretty straight forward really. There wasn’t anything that I 
thought “Oh that shouldn’t be there.”” Keith (#12) 





  “It is a good database isn’t it?” Keith (#12) 
Since the volunteers had not attempted to connect with their relatives before the 
interviews, it was necessary to explain the function and what their relatives would 
encounter, such as the email invitation (Figure 8.6). 
Figure 8.6 Screenshot of the email message received inviting a relative to view 
documents 
One volunteer user (#10) was particularly excited by the website and how it was 
specifically designed to meet her needs: 
“The actual look of the site is brilliant. I think it’s modern, I mean the colours are 
great. I know that sounds silly but it’s all visual isn’t it, things like that. I think the 
links are good, and you tend to read things and then all of a sudden you think oh.. 
you go into it and think oh… I don’t always to do that with a lot of websites if I am 
looking for stuff… so it did make me want to explore a little bit more” Stella (#10) 
Qualifying that she found it particularly helpful to be able to read information at her 
own pace, adding about the open access resources: 
“I think it is much easier to cope with than when you are actually talking to 
somebody. I tend to get much more emotional with people. And I prefer to have 
something that I can read and digest and think about, and it doesn’t get so 
muddy, and it’s sort of then you can start making informed choices for yourself 
and rationalising whether it is important for you and whether there are things you 
can improve for yourself..” Stella (#10) 
While another, Mark (#9) liked the resources section and endorsed the importance of 





“It is very factual it is very good. The pitch is right…”  





8.6 How the interview results translated into changes to the website 
For each volunteer user a matrix was constructed linking their comments to specific 
areas of the website as they interacted with it during the interview. These data were 
amalgamated and summarised (Table 8.2) to illustrate how suggestions for 







8.6.1 Matrix of the changes made to the website 
Table 8.2 Changes made to the website linked to suggestions given in the Think-Aloud interviews 





Need to say what people can do, what they can 
find on the site, at a glance list showing 
relevance to users. 
Bullet points added with short cuts to provide quick 
access to different parts of the site. 
(Figure 8.8 to Figure 8.9) 
#4, #7 
 
#2, #4  
About Family 
Web 
Banner picture too big, you have to scroll down 
to see text. 
More explanation needed about what website 
function is. 
Some pictures removed or reduced in size (Figure 
8.11). 




Banner picture unnecessary, just obscures 
information 







Problems with creating username 
 
Need more directions for sign-up 
Added statement that username must be in lower 
case letters (Figure 8.17) 
Text added to explain account activation needed 
before use.(Figure 8.16 and Figure 8.17)  






No partner as option in drop down list of relatives 
Blue folder icon meaningless 
‘Partner’ added as an option to drop-down list 
(Figure 8.20) 
Change blue folder icon to ‘Share Files’ 










Disliked biological mechanisms graphic. 
 
Screening very important so wanted more 
information about it. 
Information about aspirin & CAPP3 
Some pictures distract from the text. 
Biological mechanisms graphic moved to another 
page.(Figure 8.13 to Figure 8.14) 
Added more information about colonoscopy 
(Figure 8.12) 
Information about aspirin added (Figure 8.15) 




More links to different sites wanted More websites added, including link to CAPP3 study 













Blue folder icon changed to ‘Share 
Files’  
9.06.17 
Graphic added to ‘About Family Web’ + 
Biological mechanisms picture moved + 
activate account information 
12.06.17 






Text added to make file sharing easier + 
more account information                   + 
‘partner’ added to options 
20.07.17 
Homepage text changed + picture removed 






Eatwell plate updated + only lower case 
letters in username 




The picture of a cheerful family used in the banner to this page (Figure 8.1) was 
broadly welcomed by the volunteer users. One commented: 
“I liked the feel of it. It is really good, it is quite a positive feeling” Mark (#9). 
While another said she liked the picture and the test was sufficient: 
“Nice picture, not too much information at one go. Little bits and not too much. 
Very happy, very straightforward” Annie (#7). 
 
Figure 8.8 Screenshot of the original Homepage layout 
However, both Mike (#6) and Mark (#9) said that they thought the information 
(Figure 8.8) needed to be simplified, so bullet points were added to help people 
orientate towards the areas of the site that would be of most interest to them 
(Figure 8.9). 





8.6.3 About Family Web 
This page on the website explained why the website had been created and provided a 
brief description of who the researcher was and the NHS ethical approval. When 
volunteer users were asked to read and comment on this page many still asked 
questions about the purpose of the site. This led to changes being made and a 
diagram representing the file sharing function of the site was inserted to make the 
function clearer to users (Figure 8.10). 
 
Figure 8.10 Screenshot of the updated 'About Family Web' page 
 
This graphic was well received by the later phase users and did appear to contribute to 
understanding. One user commented that they didn’t like the pastel colours but no 





8.6.4 Living your Life resources 
Lifestyle resources welcomed 
The Healthy lifestyle sections (Figure 8.11) were almost unanimously praised by the 
volunteer users in their interviews, one spoke of the reassurance he felt reading the 
information: 
“The living your life bit, which I have just read, that is just brilliant!”… “I don’t 
know, instantly, I just felt a sense of confidence and reassurance about my own 
situation by looking at this website.” Oliver (#1) 
 
Figure 8.11 Screenshot of the original 'Living your Life' page 
Although one volunteer was less enthusiastic, saying that much of the advice was 
‘common sense’: 
“A lot of it to me is common sense. Life is like a pair of scales, what you eat and 
drink can balance your outcomes in life. Aspirin is an interesting one. I was asked 
to go on to aspirin once as a study but I wasn’t keen. It is everything in 
moderation really” Keith (#12). 
While another volunteer felt there should be even greater emphasis on the ways that 
people could reduce their risk of cancer through changes to their lifestyle: 





Information about screening 
There was some criticism of this section of the website that there could have been 
more detailed information about screening and colonoscopy. One user said what an 
important aspect of her condition this was: 
“How to get the right screening is quite important. Obviously diet, lifestyle, 
alcohol but the screening is what is most important. People want to know what 
they have to do.” Jenny (#11) 
She also suggested adding practical advice about how best to manage the preparation 
taken prior to the colonoscopy: 
“I learnt that the prep needs to be ice cold, drink it through a straw, drink extra 
fluid like ginger ale, some people eat jelly, clear broth. You can still drink black 
coffee and it is important to keep hydrated” Jenny (#11) 
While another volunteer user made the suggestion that it would be helpful to explain 
what a colonoscopy involves, with diagrams, in order to show people that it is: 
“nothing to be afraid of” Mike (#6) 
These comments led to the inclusion of a short animated video (Figure 8.12) of what a 












Dietary advice pages 
Several users commented on the diagram representing the biological mechanisms 
linking food consumed to bowel cancer risk (Figure 8.13). One person particularly liked 
it but qualified that by saying it was probably because he was a scientist. Most disliked 
it and thought it would be confusing or daunting to most people: 
“I think for a patient website I think this graphic is a bit much. I have a degree in 
biology and I think this is a bit much. I don’t know what glucosamine is..   I think 
the summary of the paper is nice and the link to the paper but the use of 
acronyms and words that patients won’t understand is a bit overwhelming.” 
Freya (#4) 
“Diagrams and explanation about how food is metabolised that right over my 
head.” Mike (#6) 
Therefore this diagram was moved to a separate page and a link to that page was put 
below the advice about eating red and processed meat (Figure 8.14).  
Figure 8.13 Screenshot of the diagram of biological mechanisms and ‘Eatwell plate’ 
Another image that was changed was the ‘Eatwell plate’ image, which illustrated the 
best proportions of foods that should be consumed. Freya (#4) was aware that this 





most recent ‘Eatwell Guide’ (Figure 8.14) published by Public Health England in 
February 2017.  
Figure 8.14 Screenshot of the updated dietary advice and 'Eatwell plate' 
 
Information about aspirin 
Initially the website did not include information about the risk reducing properties of 
taking regular aspirin.  However, several of the people who took part in the Think-
Aloud interviews were surprised by this as they were already taking part in a dose 
optimisation trial of aspirin, the CaPP3 trial.   
 





This led to the inclusion of an additional section with a hyperlink to the trial website 
(Figure 8.15). This page was positively received in the later Think-Aloud interviews, 
particularly by Mark (#9) and Stella (#10). 
One person emphasised how important it was for patents and their relatives to be 
aware of medical advances and what research they could contribute to: 
“We are part of the CAPP3 study, so these studies are going on. It would be nice 
to know what else is going on behind the scenes” Luke (#2). 
 
8.7 How the website function was improved 
Problems with the function of the website that were observed were difficulties in the 
process of signing up to become a ‘member’ (Figure 8.16) and therefore have access 
to the secure document storage and file sharing facility. The difficulties were in two 
main aspects, the choice of username and understanding that the account had been 
activated. The webdeveloper had specified that usernames could only include lower 
case letters but this wasn’t immediately clear so this was then stated below the 
username entry box (Figure 8.17). 
 






The other recurrent issue around the sign-up process was that it was not immediately 
clear to the volunteer users that they needed to activate their account by clicking on a 
link in their email. Therefore this aspect was explained in the instructions for sign-up 
(Figure 8.23) and a sentence was added at the bottom of the sign-up pages for both 
patients and health professionals (Figure 8.17).  
 
Figure 8.17 Screenshot showing additional information on the Patient Sign Up page 
Two users (#4 and #7) drew attention to the size of the banner pictures on each page 
of the website. They complained that due to the size of the picture this obscured 
some of the text and made it necessary to scroll down the page to understand what 






Figure 8.18 Screenshot of the account information page 
 
This aspect was modified on one page with the banner picture removed (Figure 8.18) 
but was retained on other pages as the website was designed using ‘responsive’ 
technology where the image displayed adapts appropriately to the physical size of 
screen.  
 
Figure 8.19 Screenshot of the Contact page banner 
The researcher also wished to maintain a variety of images within the website to keep 






It was only when volunteers were engaging with the site and utilising the file sharing 
function that one (#9) pointed out that there was no option of ‘partner’ on the drop 
down list of family members. The function had been envisaged as a way to help 
families share information about the familial diagnosis with those relatives potentially 
at risk of the condition. However, passing on files to a partner could also be useful, so 
this option was added (Figure 8.20). 
 
Figure 8.20 Screenshot of the Sharing Documents Member page 
 
In response to the interest that nearly all the volunteer users showed in the ‘Living 
your life’ section, more hyperlinks were added to the content (Figure 8.21). 
 





To accommodate the increase in text, the size of some images were reduced (Figure 
8.21 and Figure 8.11). 
Another aspect of the website which was welcomed by the users were the useful 
website links. These were increased in number during the course of development in 
response to some of the questions posed by users (Figure 8.22) but not due to any 
specific requests. 
 
Figure 8.22 Screenshot of the updated Useful Website Links page 
Although the webdeveloper had designed the sign up process to as intuitive as 
possible, several of the volunteer users (#1, #2, #7, #12) had problems getting signed 
up as a member to the site. In order to maintain the confidentiality of files being 
shared via the website it was necessary to create password protected  





identities for users of the file sharing facility. Therefore more comprehensive step by 
step guides were written for both the patient users and health professionals (Figure 
8.23). 
Two of the volunteers (#4 and #5) questioned what the blue folder icon (Figure 8.24) 
meant when they had received files during the demonstration of file sharing with the 
researcher. However, it was apparent from the behaviour of the earlier users that they 
also found this icon uninformative and this icon was changed to ‘Share Files’ (Figure 
8.25) which was a functional link and a necessary step when sending links to relatives 
to view specific files. 
Figure 8.24 Screenshot of the original Member documents page showing the blue folder icon 
 
 






8.8 Suggestions for changes that were not implemented immediately 
All the interview volunteers made comments and had creative ideas about how they 
envisaged using the website and what changes they felt would be helpful. Two of the 
volunteers (#4 and #6) made particularly numerous suggestions and followed up their 
interviews with emails to the researcher regarding their ideas. However, it was not 
possible to act on all the suggestions made due to limited resources and time 
constraints. 
The website had been designed to provide a very high level of data security, 
exceeding the criteria specified by NHS Information Governance (Appendix 34) and 
following recommendations from the National Data Guardian and the Care Quality 
Commission (Caldicott, 2013; National Data Guardian, 2016). Nonetheless, Harry (#8) 
worried about the security of the site and wanted some indication that the documents 
were encrypted. However, the web developer had advised against putting overt 
descriptions about the data security on the website. This was because such 
statements were more likely to provoke interest from hackers who target websites 
that they perceive to be challenging. Instead he provided a detailed description the 
security mechanisms that could be shared with interested users or clinicians if 
necessary (Appendix 35). 
Some of the ideas expressed would be developments that would align with the 
objectives of the website and therefore justify future consideration, such as adding a 
calendar option for patients to store a record of their colonoscopy or other screening 
dates (#7) and adding stories or video testimonies from users (#6). Additional content 





elderly parents or adult children (#9 and #11) and more advice on where to access 
support, such as links to counselling services or what to do if users were feeling very 
distressed (#4). 
A couple of the volunteer users spoke about aspects of the site which were particularly 
important to them and where they thought that the website should put more 
emphasis. Luke (#2) regarded the main benefit of the website to be in enabling him to 
connect online with his GP and specialists. He wanted to share reports with them, 
such as his most recent colonoscopy report where he had concerns about the size and 
number of the polyps found. Luke also really wanted information about current 
research: 
“Just really.. what is happening from the medical side… What stories you read in 
the papers what is true and what is not… Just ‘cos it gives you some kind of .. 
hope, more hope in the future about what is possible” Luke (#2). 
 
Another aspect that needed a greater priority was awareness around the actions that 
people could take for themselves that would reduce their risk of cancer. Freya (#4) 
eloquently explained how this information could be transformative for some.  She told 
me that she had not realised that healthy eating advice would influence her risk since 
she had inherited a susceptibility to cancer.  
8.9 Conclusions 
The website was an acceptable way of receiving, storing and sharing health 
information to this group of people. Several people recognised that using a secure 
website to share information was an approach that would not suit everyone; either 





someone who would find using the technology challenging. However, it was also 
acknowledged that providing information in a digital file would enable more people, 
particularly younger relatives, to access the information.  
Almost all the volunteers were engaged with the idea and they enthused about 
different aspects of the site, particularly the information resources, but also how it 
enabled increased scope for sharing information. Two users (#1, #4) immediately 
recognised the opportunity the website provided to store and retrieve their own 
health information online when they were away from home, whether that was on 
holiday abroad or when they were seeing their GP.  
The process of testing and refining the website as a tool for sharing information was 
possible with volunteers from across England and Wales through the use of an online 
platform for remote usability testing. Although this presented its own technical 
challenges at times, it meant that user’s reactions to specific aspects of the website 
could be captured. This process identified problems that would have been a barrier to 
its use and allowed for the refinement of the website to more closely meet the needs 










My intention throughout this research was to investigate through a pragmatic 
approach an additional method of providing information and support to patients 
following a diagnosis of an increased vulnerability to bowel cancer in their family. In 
this chapter I will draw together and discuss the findings of the different phases of my 
research. I have organised this chapter into sections reflecting the four major themes 
identified in Phase 2 of impact, practical information, appropriate communication 
and adaptation (Figure 7.1 p.193) and I discuss how my findings complement existing 
theories.  
I will consider in particular detail how the impact of learning about the familial 
diagnosis appeared to influence participants’ ability to share information with their 
relatives. I review how the narratives of some participants could be interpreted as an 
indication of their adaptation to the diagnosis and show that this would be congruent 
with the Theory of psychological adaptive modes (Lehti, 2016). I will discuss how the 
Family Web website could be used to the benefit of patients. I will relate some of its 
functions to constructs within the Theory of Planned Behaviour (Ajzen, 2002) where 
the provision of information that encourages a healthy lifestyle could give patients 





9.2 Impact of the genetic diagnosis  
9.2.1 Impact on the family 
I would like to elaborate on how profoundly the diagnosis affected some of the 
participants. This was not only something that affected the individual but an 
understanding that reverberated around the family and caused pain and anxiety to 
their relatives too. One participant described the effect it had on her and her son as 
“devastating” when they realised he had inherited the genetic vulnerability and “very 
traumatic” (Anne, S9 line 285). This illustrates the potential for patients to suffer 
compounded or disenfranchised grief (Doka, 1989).  
The long-term consequences of genetic testing to influence and change family 
relationships were explored by Cowley (Cowley, 2016). She found through interviews 
with 15 members of one LS family that those relatives who had declined a genetic test 
were characterised negatively, being described as ‘selfish’, ‘ostriches’ or ‘frightened’ of 
the testing. Since none of the family members who declined testing agreed to be 
interviewed, their perspectives were not captured. Cowley points out that if the view 
point of those promoting genetic testing is accepted as the moral imperative then the 
right not to know is undermined. This in turn is likely to contribute to the long-term 
impact on family dynamics if not all family members share the same perspective. One 
of the interview participants (Bob) describes his feelings of isolation because he alone  
was the one person in his family to have a pre-symptomatic test. It was evident from 
his narrative that the genetic diagnosis has had a profound, and largely negative, 





by Cowley, as the tested individual was in the minority, my findings appeared to show 
evidence of long lasting disruption to relationships in this family. 
9.2.2 Impact on the individual 
In Phase 1, survey participants were asked how they thought support could be 
improved (Appendix 18, question 3). My analysis of their free text responses is 
illustrated earlier (Chapter Six, Figure 6.7). That analysis showed that several different 
issues may have contributed to a negative impact on some participants’ mental state. 
Again, the impact of the diagnosis appeared central to the problems encountered and 
what aspects of care participants felt could be improved. 
I would suggest that improved access to relevant information via a secure website 
could potentially reduce that impact. This is because part of the impact of an illness, 
as experienced by an individual, could relate to their uncertainty around how the 
condition will affect them in the future. In line with this view, Skirton and Bylund 
(Skirton & Bylund, 2010) argue that uncertainty management theory can be applied in 
genetic conditions. Using the model described by Lau and Hartman (Lau & Hartman, 
1983) they suggest that ‘controllability’ is one of the five key domains that help people 
conceptualise the impact of the illness. The other domains are ’disease identity’, 
duration, consequences and causes. Taken together, the illness representation that an 
individual constructs then enables that person to develop strategies to combat the 
illness. If this is the case, then it is quite logical that focussing on the controllable or 
malleable aspect of the risk of cancer is likely to provide hope and a sense of 





A website provides the opportunity to provide more information to patients that is 
specific to them or generic about their condition. The flexibility of content that can be 
updated and expanded also gives the chance to provide more simple information, 
written to suit different reading ages or address specific questions. Where negative 
emotional reactions could be attributed to feelings of uncertainty, grief, or loss, but I 
think those feelings could be reduced or ameliorated by improved follow-up post 
diagnosis. I propose that a website like Family Web could be a useful tool in such 
follow-up.  
9.2.3 Factors influencing communication in families 
Other factors can also impact on whether communication is likely to occur and the 
clarity and accuracy of the communication (Keenan et al., 2005). The map of factors 
(Chapter Six, Figure 6.7) was constructed as part of the thematic analysis of the Phase 
2 interview data and illustrates the complexity of the influences on communication. 
Important factors previously identified include: the social norms of communication 
(Forrest et al., 2003) , understanding and knowledge (McAllister, 2003), anticipated 
reactions (Lafreniere et al., 2013) and feelings of responsibility towards relatives 
(Dheensa, Fenwick & Lucassen, 2016) .  
It is recognized that within a given family social norms will vary, but typically ‘vertical’ 
communication is more likely, that is between parent and child, or vice versa (Forrest 
et al., 2003). The identity of the family authority figure is also important as their views 
are likely to be particularly influential and the usual channels of communication in a 
family will influence communication about a genetic condition (Dilzell et al., 2014; 
Koehly et al., 2003). Families with less open communication around health are less 





illness (Bartuma, Nilbert & Carlsson, 2012; Petersen et al., 2014; Rowland & Metcalfe, 
2013). Often there is an assumption by family members that someone else will have 
informed their more distant relatives (Gaff et al., 2007).  For whatever reason, when 
communication about the diagnosis does not occur, this means that some relatives 
can be denied the opportunity to obtain information and take measures to reduce 
their risk of cancer. In order to address this I included in the Family Web website open 
access information in the ‘Before Diagnosis’ section that explains about bowel cancer, 
symptoms of bowel cancer and how to access clinical genetics services. I also wrote 
some basic guidance about communication in the ‘Sharing the News’ section. 
9.3 The need for practical information  
9.3.1 How patients are supported when sharing information about their familial 
diagnosis 
Through the survey and telephone interviews I gathered data about what information 
participants had received initially and whether they had wanted more information. 
These data revealed that participants had a range of experiences, with the majority 
reporting initial satisfaction with how they had learnt of their risk. Many also 
described how they needed more information about the condition and further 
ongoing support. 
The survey data reflected how difficult genetic information was to assimilate initially. 
Most participants indicated that a follow-up appointment would be ‘helpful’ and three 
out of four participants would have wanted more information at the time of their 
diagnosis. The survey data were consistent with the results of an earlier survey 
(Lapointe et al., 2013) with 246 men and women who had received genetic test results 





interested” in having access to an educational website to help support them 
communicate information about the genetic diagnosis to other family members. Their 
participants were also interested in receiving a personalised family letter (38%) or an 
educational booklet (50%) but only 35% of their participants were interested in a 
‘family information session’. 
In my study, the responses to both the survey and interviews confirmed my 
understanding about the current provision of information following a genetic 
diagnosis in the UK. This is that information is largely provided either through ‘family 
letters’ (Dheensa, Lucassen & Fenwick, 2017; Stol et al., 2010) or with general 
information about the condition. Evidence from the study by Dheensa, Lucassen and 
Fenwick suggested that providing family letters was not necessarily effective. They 
used focus groups to elicit the views of 80 health care professionals and interviews to 
gather the opinions of 35 patients. They found that providing letters specifically 
written for distribution to at risk relatives was not ideal, the letters were difficult for 
clinicians to word appropriately and patients experienced problems distributing them. 
These authors concluded that providing letters was not sufficient to support sharing 
information in many families. They (Dheensa, Lucassen & Fenwick, 2017) advocated 
that HPs should discuss with patients what additional support they might need and 
consider contacting relatives directly if patients wanted this. Aligning with my own 
perspective, these authors state their intention to develop an “online resource to 
facilitate communication” which they regard as justified and appropriate in the 






Several Phase 1 survey participants commented on the letters they received; they 
found them too technical, medical and detailed. They also described how the 
information they received lacked guidance on what the impact would be for them, 
how they could protect themselves, and what they needed to be concerned about. 
The free text responses in the survey revealed tension between the needs of the 
individual and their sense of responsibility to their relatives. This tension has 
previously been described (Chivers Seymour et al., 2010) and in addition, several 
authors (Mendes et al., 2017; Stol et al., 2010; Wiseman, Dancyger & Michie, 2010) 
have drawn attention to the potential disruption to family relationships when patients 
try to encourage their relatives to have a genetic test. Consequently content was 
included in the website that was intended to meet these needs. Different ‘layers’ of 
information were provided and guidance was given in the ‘Sharing the News’ section 
about how information might be received by relatives. 
9.3.2 Methods of communication 
Nearly half of survey participants reported searching for more information on the 
Internet and most of the participants in the survey and telephone interviews had 
reported using email, text messaging or social media to communicate with family 
members. Providing information in an electronic format could potentially help at least 
those individuals who already used information technology to communicate with their 
relatives. One interview participant, George, was frank that he used whichever 
method of contact that was preferred by the family member. He explained how he 
used Facebook to contact some younger relatives, although he admitted that he 





When investigating a method of digital communication that might be appropriate for 
development within the NHS I had decided that neither SMS texting nor social media 
(such as Facebook) were likely to meet the stringent data security requirements of the 
NHS (Caldicott, 2013; National Data Guardian, 2016; NHS Digital, 2017). Since that 
time the social media platform WhatsApp has introduced end-to-end encryption to 
ensure users privacy but this was not available at the inception of this project. In my 
experience, communication by email between health professionals and patients is 
controlled and often restricted or encrypted in many NHS trusts. Therefore, the 
preferences expressed by participants for digital technology endorsed the creation of 
a secure website as currently the best viable IT option available for information 
sharing.  
9.3.3 The importance of receiving accurate and trustworthy information 
A quarter of survey participants reported receiving no supporting information at the 
time they were informed of their risk. This could have presented these individuals with 
problems, both in accessing appropriate screening or referral for more detailed 
advice. The fact that these people were not given written information meant that they 
were more reliant on what they had been told verbally.  Potentially these people could 
have had an inaccurate understanding of what the familial diagnosis meant for them 
(Sustersic et al., 2017) which in turn might have inhibited sharing information or 
affected what they told others. 
The perceived reliability and trustworthiness of information provided through the 
NHS in the UK (Williams, Nicholas & Huntington, 2003) was specifically mentioned by 





“NHS badged” (Freya #4). While not in the UK context, an interview based study of CF 
carriers in Australia (Gorrie et al., 2017) noted that 18/21 of their participants were in 
favour of having an online source of information. Their participants acknowledged 
that most people do look for information on the Internet now but they can find it 
difficult to distinguish which sources of online information to trust (Gorrie et al., 2017). 
The Family Web website has an explanation of its purpose (which refers to the NHS 
Research Ethics approval and recruitment through six NHS Trusts) and this may have 
been interpreted as endorsement for the content by interview volunteers. Without 
specifically probing this issue it is difficult to know how far the NHS ethical approval 
might have influenced their responses. 
9. 4 Appropriate communication with relatives 
9.4.1 Positive framing of information 
Several authors have documented the wish to protect relatives (Chivers Seymour et 
al., 2010; Mendes et al., 2013; Metcalfe et al., 2011). Similarly, my data showed that 
participants felt motivated to help family members to access appropriate medical 
services. Volunteer users liked the positive stance of the information provided. I would 
speculate that following their own diagnosis and before they could attempt to inform 
their relatives, patients needed to understand the benefits of knowing about the 
diagnosis. This was so they could share that hope rather than be ‘harbingers of doom’. 
I would argue that in order to convey a message of hope patients need to have the 
necessary information to give. The open access resources pages were written with this 
in mind. For example, the webpages under ‘Living your life’ describe the benefits of 






One unexpected finding from the qualitative analysis illustrated how participants were 
taking a positive perspective, where some viewed their gene variant as being 
somehow better than the other gene variants. This finding, as far as I know, has not 
been reported before and it is interesting to speculate whether this could have been 
part of their coping mechanism? It appeared that participants compared the effects of 
different gene variants and distinguished an advantage in the one that affected their 
families. 
9.4.2 Open communication about health issues 
While most research focusses on the individual, some studies have examined how 
cancer survivors and their family members communicated about their genetic risk. 
Breast cancer patients and their unaffected relatives were interviewed in focus groups 
by Mellon and colleagues (Mellon et al., 2006), who found that communication styles 
varied both within and between families. They found that those families with more 
open communication styles about cancer, and particularly where relatives had 
concordant styles of open communication, reported greater satisfaction with their 
interactions. Another of their findings was that email was used as a common method 
of communication for some families where they shared information they had gleaned 
from the Internet (Mellon et al., 2006). This evidence endorsed the way that Family 
Web was set up to send invitations to relatives via email. In addition, some content on 
the ‘Sharing the News’ webpages encouraged readers to be open with their relatives 
and not to delay talking about the familial diagnosis. 
Providing supporting information for patients for their own understanding, but also to 
help them explain the health implications to their relatives, has been found to be an 





PHRs could provide the same type of information sharing function as the Family Web 
website. The advantage of using an existing PHR system is that it would have 
technical support associated with it and already be in use within a health care setting. 
Unfortunately not all health care providers have adopted this technology and 
evidence suggests that professionals need to view such systems positively if they are 
to utilise them (Nazi, 2013). Family Web could address this gap, although it can be 
used by families without the involvement of a health professional, it is potentially a 
more powerful tool when HPs upload documents that are specific to their patients. 
9.4.3 Information that gave hope or empowerment 
Almost half of survey respondents wanted more information about how to have a 
‘healthy lifestyle’. Several of the interview participants and Think-Aloud volunteers 
also spoke about their interest in adopting a healthier lifestyle and particularly eating 
food that might reduce their risk of developing bowel cancer. Considered from the 
perspective of the Health Belief Model (Rosenstock, Strecher & Becker, 1988) cancer 
risk reduction was a strong ‘perceived benefit’ in response to the ‘perceived threat’ to 
health posed by their inherited vulnerability. Dependant on the individual’s self-
efficacy in relation to dietary change (Visser et al., 2017) improved understanding 
might have provided a ‘cue to action’. Certainly risk reduction through changes to diet 
or lifestyle was one of the topics frequently mentioned across the telephone 
interviews (Section 7.6.2).  
Information on the website regarding risk reduction through a healthy lifestyle was a 
particular focus in two Think-Aloud interviews (Chapter Eight, Section 8.5.1). One 
volunteer spoke of his “sense of confidence and reassurance” (Oliver, #1) when 





his diet but at the time of his pre-symptomatic test he had struggled with the 
knowledge of his elevated risk. Another (Freya, #4) was particularly eloquent, 
explaining how she thought it was really essential to have information about the 
benefits of knowing genetic status. She told me that being given the opportunity to 
alter her risks of cancer through her own actions was a very important; it gave her 
hope and a greater sense of control. Both of these volunteers talked about how they 
had not understood whether general guidance on a healthy diet would apply to them. 
Therefore, the opportunity to educate or improve knowledge for those at risk was 
seen as vital. I was told that lifestyle advice needed more emphasis on the website. A 
reason given was that it would give those who might otherwise have a fatalist attitude 
about their risk of cancer greater confidence in their ability to alter their risk. 
The feelings of hope elicited by such knowledge could be attributed to a greater 
‘perceived behavioural control’ as defined by Ajzen (Ajzen, 2002; Ajzen, 2011) in the 
Theory of Planned Behaviour (TPB). This theory predicts that the controllability of 
certain behaviours are individual as the perception of the difficulty of performing the 
behaviour will be dependent on both internal factors (e.g. knowledge of what foods to 
avoid) and external factors (e.g. opportunity to exercise) which are specific to an 
individual and their circumstances.  
The TPB construct of perceived behavioural control could also be applied to other 
issues. My findings suggested that where people’s understanding of the potential 
benefits of being aware of what advice applied to them was a factor influencing their 
intentions. This could relate to how they themselves might access specialist services 
and cancer surveillance. Such understanding might also motivate patients when 





Another construct within TPB theory is ‘subjective norms’ (Ajzen, 2002) where an 
individual’s behaviour is influenced by their perception of the approval the behaviour 
would provoke with significant others. This is illustrated by one Phase 2 interview 
participant (Fiona, S8 ) who described how she needed to know what practical advice 
to give her brother. She didn’t feel it was sufficient to just tell him about the diagnosis 
of LS because he wanted to know what he needed to do next.  
It was evident when considering all data sources in this study that many of the 
participants were looking for some type of practical guidance and ways to deal with 
the uncertainty that was inherent in their genetic diagnosis. Consequently, ‘practical 
information’ was identified as one of the four major themes that emerged from the 
qualitative analysis. What participants apparently desired was information that could 
be applied in their lives; practical in format (simply written, accessible) and practical in 
content (covering issues of relevance and concern). Again, the way that information 
might be utilised could be seen as another example of providing improved ‘perceived 
behavioural control’ within TPB theory. 
9.4.4 Using a website to facilitate information sharing in families 
I recognised that viewing or using a website would be restricted to those patients who 
had access to the Internet. However, access to the Internet is now widespread as the 
majority of adults (88% of adults in the UK) are using the Internet at least weekly 
(ONS, 2018a). Plus 98% of young adults (aged 16 to 24 years) were using a portable 
device to access the Internet in 2017 (ONS, 2018b). It was estimated that over 60 
million people in the UK used the Internet in 2016 (92.6% of the population)(Internet 
Live Stats, 2016). Evidence which is more specific to family communication showed 





communicate with non-resident family about parenting issues (Rudi et al., 2015). 
Therefore I judged that a website could be useful to most people. However, having the 
capacity to print and make a hard copy of information accessed via a website would 
still be important to ensure that the opportunities to share web-based information 
was maximised. 
Another unanticipated finding was that volunteers envisaged using the website as a 
secure online repository for their own health information. This was not a primary 
function that I had considered when designing the website but it seemed logical when 
it was suggested. Two users (Freya, #4 and Mark, #9) explained to me how this could 
potentially help them to access their own records when away from home or if they 
had forgotten to bring printed copies to their appointments. They acknowledged that 
it would then be their choice if they shared any of their records with their health 
professionals outside genetics, family members, friends or employers. This function is 
one that most personal health record (PHR) systems would provide since password 
protected access enables patients to effectively take ownership of their health records 
when registered with a PHR (Chapter Two, section 2.11). 
9.4.5 Difficulties or barriers to communication in families  
Communicating about a health issue can be a difficult task within families where it is 
not the norm to discuss health or illness (Keenan et al., 2005; Metcalfe et al., 2011). 
Talking about the risk of cancer can provoke painful memories in some when they 
have lost multiple family members to cancer. Therefore, providing a means of 
communication which allows relatives to view that information at a time of their 





giving relatives’ access to their personal information online might particularly suit her 
adult grandchildren. She thought they might also appreciate the privacy this afforded 
and avoided the potential embarrassment of discussing issues related to bowel cancer 
with their grandmother (Chapter Eight, p.12 Stella, #10). Studies have shown that 
patients generally acknowledge their responsibility to pass on information about their 
diagnoses (Dheensa, Fenwick & Lucassen, 2016; Mendes et al., 2013) but some 
information is considered more private or sensitive. 
9.5 Adaptation to the genetic diagnosis  
9.5.1 Theories of psychological adaptation 
I analysed the Phase 2 interview data for signs of ‘adaptation’ and these were coded 
separately, in order to examine which individuals appeared to have adapted to their 
diagnosis and in what way. The issue of how well adjusted or adapted participants 
were to their diagnosis appeared to be fundamental to the process of sharing 
information. If adaptation is considered as a personal and dynamic process in 
response to change (Biesecker & Erby, 2008; Lehti, 2016), it is likely to be uniquely 
expressed by different participants. Rolland and Williams (Rolland & Williams, 2005) 
postulated that a long-term adaptation phase was part of the non-symptomatic stage 
in genomic disorders in their Family Systems Genetic Illness (FSGI) model. They 
described adaptation as following the test and post-testing phases in “at risk” 






Figure 9.1  Non-symptomatic time phases of genetic disorders from Family Systems Genetic 
Illness model (FSGI) Rolland & Williams 2005.  
Yellow circle highlights phases of adjustment and adaptation to the genetic diagnosis occurring 
over a time period. 
Lehti (Lehti, 2016) describes a theory of psychological adaptive modes which 
postulates that an adaptive struggle in response to a stressor is necessary before the 
individual can achieve a new level of equilibrium. The adaptive struggle interferes with 
normal functioning. However, through the utilisation of coping skills such as seeking 
information or asking for help a successful adaptation can occur which results in a 
raised sense of well-being. This theory appeared to be consistent with some of my 
findings and could explain why adaptation might be a precursor to disseminating 
information. Such a theory could also explain the findings by Forrest (Forrest et al., 
2008) that seeking social support through confiding in close relatives comes before 
sharing information with the wider family, as described below (Section 9.5.4). 
Although Figure 9.1 shows adaptation in relation to someone who is not symptomatic, 
I would suggest that adaptation is likely to be as important to those individuals who 
only receive their diagnosis of a genetic condition after their diagnosis of cancer. For 
symptomatic patients there may be the additional burden of coping with their cancer, 
both physically and psychologically, and then learning that their illness has health 






‘Crisis II’ Test/ Post testing Long-term adjustment 
she felt having seen a genetic counsellor in order to “do the right thing” for her family 
but not anticipating that this would be more than a logical conclusion to her cancer 
experience. This illustrates how patients may experience a form of compounded grief 
or threat when they are given a genetic diagnosis on top of a life threatening diagnosis 
like cancer.  
 
Figure 9.2  How adjustment or adaptation might influence information seeking and sharing 
[Phases of adjustment modified from Rolland & Williams (2005) FSGI model Figure 9.1] Yellow 
circle highlights the initial adjustment period when close family are informed in order to seek 
support. Red circle highlights longer term adaptation where communication happens with the 
wider family and information is shared to explain implications of the diagnosis for others. 
 
I postulate that the function of the Family Web website could assist patients in their 
longer term adjustment to their genetic diagnosis (Figure 9.2) as well as enabling 
them to share information with greater ease. I envisage that when a health 
professional provides information about the diagnosis to their patient via the website 
it will give that patient several choices. They can access the information at any time 





share them with any number of relatives or health professionals at times of their 
choosing.  
Initially sharing information may be associated with informing family members and 
seeking support for themselves. As they adapt and adjust to their diagnosis they can 
use the website to share information about the condition with more distant relatives. 
Since the website also allows text documents to be shared alongside other 
documents, it gives another level of non-urgent contact that could augment other 
methods of communication.  
 





The function of the website as a tool to facilitate communication in families does 
require further investigation. The only available evidence regarding a similar initiative, 
‘The Suntalk study’ (Bowen et al., 2017) did demonstrate a significant increase in 
family members discussing their risk of melanoma in the group that received 
personalised health information via the secure website. This supports my hypothesis 
that giving patients access to personalised health information via a secure website is 
likely to facilitate patients sharing that information with their relatives and may also 
promote adaptation. 
 
9.5.2 Long term adaptation 
The process of long term adaptation in women with Hereditary Breast and Ovarian 
Cancer (HBOC) (Hamilton et al., 2009) was studied in the USA. Their study showed 
that over a period of four years, the women interviewed (n=7) reported a transition 
from dealing with the immediate impact of their diagnosis to an adjustment to the 
consequences of knowing about their increased risk. The women appeared to learn to 
live with their choices. Initially they were unsure of the efficacy of their lifestyle 
choices on their risk. However, four years later they were making lifestyle changes to 
their diet and physical activity with greater confidence and determination. Another 
process the researchers observed was how the diagnosis had influenced family 
relationships. At the first interviews some women were still informing relatives about 
their potential risk. Four years later they had perceived how the diagnosis could 
negatively impact relationships in the family and were working to protect their 





This research, I think, illustrates the necessity of allowing time for patients to process 
and adjust to their new knowledge. It also shows how the long term outcomes of 
testing are not always clear at the outset. Sometimes the adjustment may be quite 
intangible but nevertheless is an important part of coming to terms with a new 
familial diagnosis. Skirton (Skirton, 2001) found in her longitudinal study of families 
who received genetic counselling for Huntington disease that commonly client’s 
spoke of gaining “peace of mind” p.324 (Skirton, 2001) although they had not 
reported any specific changes in their plans or relationships following genetic 
counselling.  
 
9.5.3 Engagement with the diagnosis 
Behaviours described by participants during the Phase 2 interviews were interpreted 
as demonstrating how engaged participants were with communicating with their 
family about their diagnosis. These associations indicated to me that participants 
needed to understand the diagnosis and its implications for themselves before they 
could extend that to explaining the implications to their family members. A theory of 
engagement in relation to a genetic risk in LS has been described by McAllister 
(McAllister, 2002; McAllister, 2003; McAllister et al., 2007). She defined it as “the 
degree of cognitive and emotional involvement with one’s increased risk of 
developing cancer as a result of one’s family history of cancer” (McAllister, 2003, 
p.180) and therefore related it to the individual only.  
The qualitative interview data that McAllister used to develop the theory of 





after, their pre-symptomatic genetic tests. McAllister described how those patients 
who were ‘intensely engaged’ (cognitively and emotionally) prior to their test 
appeared to cope better with learning they had inherited the pathogenic gene variant 
than those patients who were only ‘partially engaged’ (cognitively) prior to testing. 
She postulated that the intensely engaged patients had ‘rehearsed’ their mutation 
status and worked through some of the implications before their test. Using this 
theory of engagement I would interpret that at least one participant (Oliver, #1) had 
cognitive (partial) engagement prior to his test but this meant that he experienced 
more anxiety about his risk of cancer post test. Therefore I would agree, based on my 
own experience and interview data, that the concept of engagement is relevant to 
how patients adjust to their test result.  
What then is the consequence of engagement on the process of sharing information 
with relatives? Within her theory, McAllister puts forward the idea that the benefits of 
screening for cancer ameliorate people’s reactions to their predictive test result, at 
least in LS where screening and treatment is available(McAllister, 2002). This would 
tie in with my observation that participants wanted to focus on and communicate the 
potential benefits of knowing genetic status.  
The action of attempting to inform relatives can be met with denial, disagreement or 
anger (Chivers Seymour et al., 2010; Koehly et al., 2009) and this can challenge 
someone’s engagement and test their coping strategies. So how individuals act on 
their knowledge of their genetic risk will be influenced by the reactions they have 
from their family members; their actions are not happening in a vacuum. There is 
evidence that when a patient first attempts to inform their relative about the familial 





attempts to tell other relatives. If they are received positively and listened to this will 
encourage and reinforce the action but if they are rebuffed, or their communication is 
met with a negative response, this can inhibit further attempts to share information 
(Lafreniere et al., 2013). The relevance of this to the provision of information via a 
secure online portal is that the provider is distanced both in time and place from the 
recipient. This might provide some protection from negative reactions for the 
informant and also give the recipient the opportunity to view and return to the 
information at a later date. Providing information via a website could help individuals 
in both their ‘decision making’ and the ‘disclosure’ phases (Figure 9.4). 
 
Figure 9.4 Framework for understanding and guiding the process of communicating genetic 






My findings also showed that the initial disclosure to a relative about the familial 
diagnosis tended to occur in a step-wise fashion. The majority of the interview 
participants, when asked, did qualify that the initial ‘disclosure’ they made to their 
relatives were either face to face or over the telephone. Subsequent communication 
might have utilised email, letters or social media in order to share more in depth 
information or provide updates regarding screening or diagnoses. 
9.5.4 Importance of timing when attempting to share information with relatives 
As described earlier, when an individual is first diagnosed with a genetic condition 
they are likely to experience a variety of emotional sequelae. Some of which may 
relate to a sense of loss and be characterised by evidence of mourning (McAllister et 
al., 2007; Sobel & Cowan, 2003). How patients experience their adjustment to their 
diagnosis will probably influence the way they attempt to pass on information about 
it. This was reflected in the data from the surveys and interviews where some 
participants described feelings of shock and disbelief when they first learnt of their 
diagnosis. The impact of the diagnosis is discussed in more detail above (Section 9.2) 
but what also emerged from the qualitative data in Phases 1 and 2 were participants 
efforts to find out more information about the health implications of the diagnosis for 
them personally. It is only after these first reactions had subsided that participants 
appeared to attempt to communicate with relatives outside their immediate family 
about what the diagnosis might mean for them. These findings have led me to 
conclude that providing follow-up, repeated contact, or better ways that patients can 
communicate with health professionals, are all likely to be as important as support for 





considerate to patients regarding the timing of their encouragement to inform the 
wider family about the diagnosis which will depend very much on the individual. 
This approach is also supported by the findings of earlier research; “Health first, 
genetics second” by Forrest and colleagues (Forrest et al., 2008) and would be 
consistent with Lehti’s theory of psychological adaptive modes (Lehti, 2016). Forrest’s 
research investigated families’ experiences around communicating genetic 
information. The themes that emerged from their qualitative analysis of 12 interviews 
described a process of emotions, information seeking and communication. 
Interviewees talked about their initial shock immediately following the diagnosis 
which was followed soon after by contacting close family to seek emotional support. 
The interviewees’ main concern then centred on the health implications of the 
diagnosis and the needs of their child (or themselves). Subsequently couples looked 
for more information to help them understand the diagnosis but communication with 
family members continued, reaching the wider family sometime later, to inform them 
about the inheritance and what that implied. [This process is represented by a 
diagram (Appendix 29)] Their findings (across several different genetic conditions) 
together with my own, indicate that it would be valuable to have a resource which 
could be accessed whenever that person felt they wished to view it. Such a facility 
would also provide flexibility to suit different individuals who were adapting to their 
diagnoses at different rates. 
9.6 Prior research into interventions to facilitate family communication 
Interventions to improve family communication and disclosure about a genetic 





and the USA (Bodurtha et al., 2014; de Geus et al., 2014b; de Geus et al., 2016; Eisler et 
al., 2016; Hodgson et al., 2016; Hodgson et al., 2014; Kardashian et al., 2012; Katapodi 
et al., 2018; Mendes et al., 2010; Mendes et al., 2013; Montgomery et al., 2013; Smith, 
2007). What is common to these interventions is the perspective that patients may 
benefit from guidance in how to approach and explain to their relatives about the 
diagnosis (Appendix 37). Patients may also benefit from more tailored information 
which was specifically written for them (Kardashian et al., 2012)  
The effectiveness of such interventions can be difficult to quantify. Outcomes have 
included patients reporting which relatives they had informed (Montgomery et al., 
2013) and assessing what proportion of relatives have been referred to the relevant 
genetics services (Hodgson et al., 2016). What constitutes an effective intervention 
would depend on the objectives of the research.  No significant differences were 
found in rates of communication with relatives about HBOC (the stated objective) 
between cases and controls but sharing test results were associated with higher 
perceived control (in conveying information) and subjective norm variables across all 
subjects in one study (Montgomery et al., 2013). These authors interpreted their 
findings through the lens of the Theory of Planned Behaviour (Ajzen, 2002) which can 
be applied to the action of sharing health information.  
It is also important to understand why some relatives are receptive to this information 
while others are not. The constructs of the Health Belief Model (Rosenstock, Strecher 
& Becker, 1988) could be applied to predict the behaviour of individuals in relation to 
their own health by assessing the perceived threat, benefits, barriers and their self-
efficacy and whether these are in conflict.  I would argue that the key issue is whether 





their choice whether they seek more advice through a specialist, such as provided by a 
clinical genetics service, or access genetic testing. As stated earlier, people’s 
perception of the level of threat may be dependent on their understanding of it and 
their self-efficacy.  It has been difficult to obtain data about people who may be aware 
of their risk if they themselves do not wish to engage with health services (Cowley, 
2016) and this remains a challenging area in which to establish empirical evidence. 
However, capturing data on relatives who have not sought the advice of health 
services would be an area where a website like Family Web could provide a useful tool 
to research. This is because the website encourages patients to share documents with 
their relatives. When this has happened it would give an opportunity to create an 
anonymous log of activity, such as document views or downloads by relatives. This 
would then indicate not only how many relatives viewed documents per index case 
but it would also show which documents were most popular or most frequently 
downloaded. Overall views and basic website activity within the period of this study 
are presented in Appendix 38.  
It should be noted that the type of genetic condition does appear to have a bearing on 
the frequency of communication within families. Kardashian (Kardashian et al., 2012) 
observed in their small pilot study of providing tailored information and educational 
material to women with BRCA pathogenic variants (n-=19) that very little difference 
was seen between the intervention group and the control group regarding the number 
of relatives seeking genetic testing. Although the sample size was small, they 
interpreted this as indicating how motivated these women were already to inform 
their relatives, prior to receiving the intervention. Kardashian noted that the 





greater frequency of sharing information about the BRCA gene variant with their 
relatives. Given the small sample size, tests of statistical significance were not 
informative. However, Kardashian’s findings could be an indication that better 
knowledge of family history might translate into greater confidence and motivation in 
sharing information. Motivational and inhibiting factors were conceptualised in a 
mind map (Appendix 36) during the process of analysis of the Phase 2 interviews. 
Many different factors were identified that appeared to interrelate and could 
potentially influence someone’s ability to share information with their relatives. 
Building on the evidence accrued through these intervention studies which were 
intended to promote family communication (Appendix 37) it would be logical to 
design future research that investigated strategies to facilitate communication which 
could be applied across different genetic conditions. The Family Web website could be 
developed to research information sharing in many diverse conditions by extending 
the content to serve different patient groups. 
9.7 The influence of gender 
The issue of gender may be relevant. Typically women are reported to be better 
communicators with their relatives and it has been shown that women are most often 
the ones to share health information about a diagnosis in the family (Bartuma, Nilbert 
& Carlsson, 2012; Keenan et al., 2005). Conversely, men might be less likely to 
communicate with their relatives about a health issue. This was inferred from a study 
which demonstrated that the children of mutation positive women were three times 
more likely to seek testing than the children of mutation positive fathers (Aktan-





when there is a co-ordinator, usually a mother, sister, or female spouse who also 
provides emotional support within the family (Koehly et al., 2003). 
In the survey data few significant gender differences were found. One significant 
difference was that female respondents were more often interested in information 
about talking to children. Another gender difference was regarding the type of 
response, with a greater proportion of women responding online to the survey than 
men. However, the order of ranked preferences to different methods of receiving 
information (follow-up appointment, email, website, leaflet, phone call) were the 
same for both sexes.  
I had anticipated that providing information in digital format might be regarded as of 
particular benefit to younger people and to men who had to initiate communication. 
This was because other studies have found that men were more likely to use email to 
correspond with their doctor than women (Newhouse et al., 2015) and digital 
communication is often preferred by younger people (Duggan, 2015). Therefore a 
purposive sampling technique with maximum variance was used to ensure that equal 
numbers of men and women (across several age groups) were interviewed during the 
course of the study in order to gather data on a broad range of experiences and 
attitudes.  
The Think-Aloud interviews were focused on the acceptability and feasibility of the 
website but within them most volunteers took the opportunity to talk about their 
experiences relating to the diagnosis. I had anticipated that men might be more 
willing or interested in the website as a method for sharing information. What I heard 





enthusiastic about a new and additional way of receiving and sharing information. 
They nearly all appeared very keen to access more information about their condition. 
Based on my results I do not have evidence to support gender as a major contributing 
factor in why information about familial bowel cancer is not always shared and it was 
beyond the scope of this study to specifically address this in more detail.  
9.8 Prior knowledge of the genetic condition 
Differences in participant knowledge of disease at outset was considered to be a 
factor that explained the disparity in response to the intervention trialled in Australia 
(Hodgson et al., 2016). The intervention involved providing non-directive telephone 
follow-up calls to 95 newly diagnosed patients.  The proportion of relatives contacting 
the genetics service in the state of Victoria, Australia was the measured outcome in 
this randomized controlled trial. Amongst the different case vs control groups, the 
largest difference in response was in the rarer conditions where 39% cases versus 10% 
controls at risk relatives sought advice. The investigators (Hodgson et al., 2016) 
speculated that if patients were diagnosed with a rarer condition, providing a 
supportive telephone call could be particularly helpful to patients and give them 
greater confidence to share information about their diagnosis. This implies that 
previous knowledge of a genetic condition does influence patients’ capacity to discuss 
it with their family members. This concurs with my findings where an important factor 
reported by several interview participants (George, Robin, Sandra, Dave and Fiona) 
was the lack of knowledge or health literacy relating to familial bowel cancer amongst 
members of the public. This made some of them less confident in explaining the 





they felt, particularly by their GPs, who they perceived as knowing very little about 
their condition. 
A recent UK collaboration (Eisler et al., 2016) investigating ways of providing support 
in multi-family discussion groups (MFDGs) were clear that there was an advantage to 
bringing together families affected by different genetic conditions. They found that 
this removed the focus from the condition itself and allowed participants to consider 
instead the impact of the diagnosis on family functioning and how to cope better with 
the diagnosis. What all the families had in common was the challenges of dealing with 
the immediate risks of the condition in affected individuals, plus what the implications 
of the diagnosis were for the whole family. A very common concern amongst parents 
was the decision of when and how to tell their children about the diagnosis. This 
concurred with my study findings as talking to children was also a frequently cited 
topic of interest. This resulted in a section on the website about ‘Talking to children’ 
with tips and links to other websites, including a recommendation to a leaflet that 
explained how keeping secrets within the family in order to protect children from fear 
and anxiety has been shown to be disruptive to family life (Metcalfe et al., 2008). 
9.9 Ethical considerations 
Without making attempts to contact patients it is difficult to know what their 
experiences are in the months and years following their diagnosis. The conclusions I 
have drawn were that a subset of my study participants felt unsupported and anxious 
about how their ongoing care was being managed. One theme that emerged was 





needing to “push” for screening. This appeared to be the consequence of feeling 
unsupported and isolated following their diagnosis.  
Previous research has sought to identify risk factors for which patients are most likely 
to suffer serious psychological sequelae following a genetic test (Aktan-Collan et al., 
2013; Burton-Chase, Gritz & Peterson, 2013). Within current clinical practice there 
appears to be insufficient emphasis given to post-test follow-up or long term support 
and consequently patients are being offered testing but they are not necessarily 
receiving any further contact with their genetic counsellor or geneticist after receiving 
their test result. The high proportion of families referred to family therapy that have a 
genetic diagnosis (Alison Metcalfe personal communication August 2017) is indicative 
of the profound and sometimes destabilising effect that a genetic diagnosis can have.  
Earlier work by Skirton and colleagues (Skirton et al., 2013) following a consensus 
meeting of health professionals from across Europe, developed guidelines for pre-
symptomatic genetic testing. In these guidelines it was proposed that HPs counselling 
patients prior to pre-symptomatic testing need to explore the relevance of the result 
for other relatives. They should assist their patients to make plans regarding 
disclosure to other family members; family communication being a core component 
of a patient’s personal management decisions relating to such testing. Subsequently, 
a systematic review of empirical research concluded that while patients have a 
responsibility to inform their relatives about the implications of a genetic diagnosis in 
the family, it is also the health professional’s duty to assist their patients in the process 
of sharing information (Dheensa et al., 2015). I would argue that concomitant in that 






9.10 Strengths and limitations of this research 
In order to properly consider the impact of the findings from this study it is first 
necessary look at what might have either strengthened or limited the research, in 
terms of both intrinsic and extrinsic aspects. 
9.10.1 Recruitment through Clinical Services 
In undertaking a proof of principle study for an innovation suitable for use in the NHS I 
thought it was important to recruit through NHS clinical services in order to 
demonstrate that the innovation was suitable in that context. Typically patient 
satisfaction surveys show high levels of satisfaction with clinical genetics services 
(Nordin et al., 2002). This may be related to a ceiling effect in such surveys where 
nuanced responses are lost in the overall positive feedback (Andrew et al., 2011). 
Participants in this study said that they would have liked more support and specifically 
more information. Thus providing some guidance about how services could be 
improved in the future. 
At my lead recruitment site in Plymouth I was supported by the surgical (colorectal) 
and endoscopy services. At all other sites, recruitment was through the clinical 
genetics services (Peninsula Service in Exeter, All Wales Service in Cardiff, West 
Midlands Service in Birmingham, North West Thames Service and South East Thames 
Service in London). In order to make minimal demands on health professionals’ 
clinical time the process of identifying, approaching and recruiting eligible patients 
was designed to be as simple as possible. I had discussed the process with colleagues 
in these services at preliminary meetings in Plymouth (Appendix 30) and Exeter in 





that health professionals (whether genetic counsellors, clinical geneticists, 
endoscopists or surgeons) would approach their patients in clinic to give them 
information leaflets about the study.   
What happened at each phase of the study was that designated research staff 
identified eligible patients, checked with the clinical staff and then sent letters with 
information sheets to those patients. This did protect clinicians from any burden of 
this work but meant that health professionals did not engage with the website in the 
way that was important to test the function with volunteer users. Consequently, there 
was greater consistency during the website development phase as all the Think-Aloud 
interviewees had the website function demonstrated in the same way and received 
the same generic documents during the GoToMeeting video call. Nevertheless, health 
professionals’ participation as providers of documents for upload was not 
demonstrated so that is something I would wish to address in future research. 
In the final phase of the study I had originally only intended to recruit through the five 
sites with clinical genetics services because I wanted clinicians to upload appropriate 
documents for any participating patients. Unfortunately the rate at which eligible 
patients were being recruited and taking part in the survey through these clinical sites 
was slower than I had anticipated. Consequently, I applied for and was granted a 
substantial amendment to my NHS ethical approval which enabled me to extend 
recruitment beyond the original end date of June 2017 to 30th September 2017. In an 
earlier non-substantial amendment I had already modified my recruitment strategy to 
allow recruitment through online advertising. This enabled me to recruit survey 
respondents who had volunteered to be interviewed and to include patients who had 





9.10.2 Recruitment across England and Wales 
The survey was designed to capture data on the issue of family communication in a 
broad group of patients who had all been recommended to have regular colonoscopy 
on the grounds of family history or genetic vulnerability. Having eligibility criteria that 
encompassed a large number of patients was intended to make recruitment easier but 
it was outside the scope of this doctoral study to sample a statistically representative 
number of patients from this large population of patients.  
Postcodes were collected in the survey so that information on the number of patients 
who participated could be fed back to each of the recruitment sites. Once the 
recruitment sites were active it was difficult to distinguish if participants submitting 
online responses to the survey had initially been informed about the study through 
their genetics service or via an online link. Consequently, only online responses 
received before the NHS recruitment sites were active could be logged as non-NHS 
responses. In addition, I was only aware of the number of paper questionnaires that I 
had sent to each recruitment site and not the actual number of patients who had been 
approached by NHS staff at the recruitment sites, this meant data on response rates 
were not calculated.  
9.10.3 Investigation through families at risk of bowel cancer 
In order to create and test the website as a tool for sharing documents I decided to 
focus on families at increased risk of bowel cancer. I selected an increased risk of 
bowel cancer as it was a condition where there were potential benefits to relatives 
who learnt of their risk, since they could then access bowel surveillance and make 
changes in their lifestyle to reduce their risk. I perceived there would be more 





acknowledge that by restricting the eligible patients to those with a vulnerability to 
bowel cancer the findings from the study may be limited. This may lessen the impact 
of the research even though the function of the website could be applied to any 
condition where the diagnosis in one individual has health implications for their 
relatives.  
For this reason I intend to look at alternative approaches in my future research. I want 
to investigate the efficacy of the website as a way of informing relatives about the 
genetic condition in their family. I could extend the research by seeking to trial the 
document sharing function with families with a range of different conditions, similar 
to the approach by Hodgson and colleagues in their family communication 
intervention (Hodgson et al., 2016).  
Another approach would be to incorporate the website function in applied research 
investigating the pathway for consenting and support to newly diagnosed patients 
with bowel cancer who are offered tumour analysis to screen for LS. This applied 
research would be focussing on a more defined population of interest, restricting the 
research to LS families, but using the website in the broader context of informing 
individuals who are undergoing genetic testing or seeking more information about the 
cancer diagnoses in their family. Hampel (Hampel, 2016) described the potential 
utility of using such a tool in her discussion of methods of cascade testing in LS, 
referring specifically to the California based website: Kintalk.org. Given the 
differences in health care provision between the USA and the UK I think it would still 






9.10.4 Gender bias 
Another reason for focussing on a vulnerability to bowel cancer was that this cancer 
affects both men and women. Previous research in family communication regarding 
genetic diagnoses has shown that men encounter more difficulties communicating 
about such health issues than women (Forrest Keenan et al., 2009; Metcalfe et al., 
2008). In the survey more responses were received from women than men (77% vs 
23%). This was something I had anticipated as gender bias in response rates is a 
common issue in survey participation (Sax et al., 2008). In order to mitigate this I used 
a purposive sampling technique with maximum variance, interviewing an equal 
number of men and women across the two later phases of the study. 
It was interesting to me that four of the eligible female volunteers decided not to take 
part in a Think-Aloud interview once I had discussed with them what the interview 
would involve. Only one man declined to be interviewed after a similar conversation. 
With such a small number of participants it is impossible to draw any conclusions from 
this and I recognise that the volunteers were a self-selecting sample. 
9.10.5 A ‘Hawthorne Effect’ 
In common with other research I acknowledge that the way questions were framed 
(Appendix 21 interview guide) could have precipitated a more positive response 
regarding the concept of a secure website and therefore my data may not be a true 
reflection of participants’ views. Whether this potential distortion of response should 
be described as a ‘Hawthorne effect’ is debateable, as the term is usually applied in 
quantitative research (McCarney et al., 2007). The Hawthorne Effect has been used to 
describe the modification in behaviour by research participants in response to their 





term was originally applied to increased worker productivity under trial conditions in 
1928 (Adair, 1984; McCarney et al., 2007). 
A strength of qualitative research is that it investigates the personal and subjective 
views of participants. I acknowledge that their responses were likely to be influenced 
by our interaction at that time and that influence would have been difficult to 
eliminate. As part of that interaction I do recognise that participants may have been 
more likely to endorse my idea about using a secure website to share information (and 
less likely to challenge me) because I had suggested it  
9.10.6 Strengths and limitations of the survey design 
How individuals defined their family was not explored in the questionnaire but 
evidence suggests that commonly patients consider ‘family’ to be their nuclear family 
of first degree relatives (Chivers-Seymour et al., 2009) but can extend to include 
friends (Koehly et al., 2003). Although ‘family’ was a key concept in this research, it 
was potentially ambiguous, as the term ‘family’ was not defined but left to each 
individual’s subjective interpretation. This meant there would be variation in what 
participants considered to be their family which could introduce inconsistency into the 
data. However, this issue would mainly be confined to a few questions, such as in 
questions 4, 12 and 15. For example, in question 12 participants were asked if “all” or 
“most” of their relatives had been informed. This was intentionally vague as I was 
interested in whether participants considered that the process of informing relatives 
had been completed or not. Since the implications of a genetic vulnerability can 
extend into the wider family the potential reach of information about a genetic 





The survey was initially tested with volunteer patient advisers to check the wording of 
questions and validate the consistency between the online and paper copy survey. 
The order of question choices was fixed within the survey and this could have 
influenced the responses for some questions since there is evidence that participants 
more frequently tick the first available option where multiple options are given (Stern, 
Dillman & Smyth, 2007).  
As none of the survey questions were obligatory some questions were left blank by 
participants and some indicated that they had received more than one type of 
information at the time of their diagnosis. These factors may be confounding the 
calculations, but it is still evident that the majority of people, who received their 
diagnosis and information from a genetics professional, did at least receive general 
information about the condition and only a minority received no information at all. 
 
9.11 Summary 
In summary, in this chapter I have looked again at what was revealed regarding 
participants experiences of receiving and sharing information about the inherited 
vulnerability to cancer in their family. I have discussed how a website could facilitate 
communication in families and whether this is likely to be helpful given some of the 
barriers to communication that exist. I have suggested that information should not 
only be available in a digital format but it should be clear, accurate and trustworthy. 
Information that conveys a positive benefit to knowing genetic status is likely to help 
patients when they attempt to share information with their relatives. This is 





the timing of support may be important since patients need to adjust to their 
diagnosis before feeling able to share information about the implications of it with 
their relatives. 
I would consider that I have met my aims and objectives in this study. I did establish 
that a secure website, such as Family Web could ‘support families with an increased risk 
of bowel cancer to share information with their relatives’ as stated in my aim. Without 
demonstrating that the website was directly instrumental in promoting 
communication in families, the study did establish the proof of principle that such 
information exchange was possible using this type of tool. It would be appropriate to 
conduct further research to determine if this would facilitate family communication 
for families with an increased risk of bowel cancer. 
I considered it fundamental to the application of the website for future users that I 
first needed to gather data on patient experiences. So, in order to meet my objectives 
to investigate: 1).The perspectives of patients, their experiences of how they received 
information about the familial diagnosis themselves. 2).Invite patient’s suggestions for 
improvement in the way they were told about the familial diagnosis, and 3).Investigate 
patient’s preferences for information topics and also how they would like to receive 
information, including whether these varied by age or gender, I conducted a survey and 
telephone interviews. 
In addition, I explored patients’ views on the idea of a secure website through the 
Phase 2 interviews and also in the Think-Aloud interviews in Phase 3, thereby meeting 
my fifth objective. Finally, I tested ‘website function and acceptability’ and ‘investigated 





sixth and seventh objectives. In my last chapter I will draw conclusions from what I 
have learnt through this research. I will consider the implications of this research for 







Chapter Ten  
Implications of this research and conclusion 
 
10.1 Introduction 
In this final chapter I will consider the impact of this research for clinicians, researchers 
and policy makers and on my ongoing collaboration with other researchers to 
investigate how to facilitate communication in families affected by genetic disease. I 
will describe the opportunities for future research particularly focussing on the 
integration of the secure website into further studies. 
10.2 Reflection and assessment of the strengths and limitations of my approach 
10.2.1 Positioning as an NHS health professional and genetic counsellor  
I was aware that as a researcher I could not disassociate myself from my identity as a 
genetic counsellor, a woman and someone who usually seeks information in new 
situations. My personality and experiences have inevitably influenced my views and 
have acted as a filter and lens through which I have interpreted the data.  The themes 
that I identified in the interviews and survey were what I considered important to the 
issue of communicating genetic diagnoses in families from a pragmatic stance and 
from my perspective as a health professional with experience working in this field.  
Throughout the study I have been open about my background as a genetic counsellor. 
I realise that by positioning myself in this way it was likely to have influenced 
participants’ responses (Mays & Pope, 1995; Morrow, 2005). Participants might have 





what they expressed about their experience of genetics services. However, I think that 
by positioning myself in this way I was being genuine and congruent, describing my 
motivation to conduct the research as derived from the insights I had gained through 
my clinical practice. I also recognise that by identifying myself as an NHS health 
professional this may have conferred a degree of trust towards me by participants. 
Conversely, the opposite could be argued that those patients who had negative 
experiences of their encounters with health professionals could be deterred from 
taking part in the study or some might take part in order to voice their frustrations.   
10.2.2 Qualitative interviews 
In this research I was conducting telephone interviews and Think Aloud interviews for 
the first time. In the PIS and on the questionnaire I had identified myself as a PhD 
student and Registered Genetic Counsellor as I wanted to indicate to participants that 
I had professional credibility to research their views. With my clinical experience I was 
confident that I could develop a rapport with the participants and draw them out to 
talk about their subjective experiences and views. I considered it important to 
establish such a rapport in order that participants would feel comfortable discussing 
issues that might have been distressing to them.   
As a novice researcher I think my interviewing style developed over the course of the 
interviews and I became more confident keeping the participant on the topic. My 
confidence was helped by checking my interview topic guides and lists of planned 
questions (Appendices 21 and 25) but mainly it developed with experience and 
reflection. In retrospect I think that my style of questioning may have been too 





participants felt free to express themselves candidly. I also suspect that participants 
might not have wished to offend me during the interviews and therefore they may 
have expressed more enthusiasm for the idea of the website than would otherwise 
have been the case. 
Talking to participants during interview gave me pleasure as I enjoyed the time of 
engaging with them and learning about them and their families. It also felt to me that 
the interviews gave an opportunity for most participants to tell their story and maybe 
get some therapeutic benefit from the process of explaining what they experienced to 
an interested third party. I realised that participants were self-selecting; I perceived 
that some had a message they wished to convey, for example ‘Fiona’ who had learnt 
about the diagnosis by letter initially and found this a profoundly shocking experience. 
I had not anticipated my own feelings of sadness when I said “goodbye” at the end of 
each interview. It felt awkward to me saying goodbye as I had no reason to talk with 
them again, unlike in my role as a genetic counsellor when I had an ongoing 
responsibility to my patients. The contrast between my role as a genetic counsellor 
and my role as a researcher was evident to me during a few of the interviews. This was 
most obvious when participants made comments, which showed an inaccurate 
understanding of something about their condition, and I had to stop myself from 
correcting them.  
10.2.3 Recruitment process and collaboration 
I found that when talking to people prior to consenting them for the Think Aloud 
interviews that some of the volunteers did not meet the eligibility criteria. This meant 





take part. It reminded me that I was very dependent on the research staff and 
clinicians interpreting my criteria correctly and I would need to make such criteria very 
clear in the future. On other occasions I have realised during an interview that because 
the participant had known about the diagnosis in their family for so long they were 
unable to remember much about what information they had first received. This 
initially has made me feel frustrated that my eligibility criteria were not more specific 
and limited to people who had only recently learnt about the condition in their family. 
I then realised that their inability to remember what information they had been given 
further demonstrated the need for more enduring sources of information than printed 
leaflets.   
Although I already considered the research to be worthwhile, it was very affirming 
when participants endorsed what I was doing. They told me how important they 
regarded the issue of improving support to families affected by an increased risk of 
bowel cancer. What was harder to hear were the criticisms of how some genetic 
services had appeared to abandon or restrict support to some people. I realised that 
these comments had been provoked by me asking what participants thought could be 
improved. Nonetheless some accounts that I heard were very sobering; what I heard 
made me feel angry and upset that patients were suffering. I also felt naive that I had 
not been more perceptive in my clinical role and contacted my patients more 
proactively as follow-up to their appointments. Some survey participants did praise 
the service they had received (in their free text responses) but the majority provided 
comments about what could be improved and were quite critical. 
At times, reading the comments and reflecting on the interview transcripts, I have felt 





attempts to improve clinical services supporting patients in this position. However I 
have acknowledged that by conducting this research I am contributing to a body of 
knowledge that will over time potentially lead to changes.  
I have been encouraged by meeting other researchers and clinicians who have similar 
interests in the subject of family communication or the needs of individuals living with 
a genetic vulnerability to bowel cancer. I realise that my perspective has matured over 
the course of this research; having commenced in the somewhat isolated role of a PhD 
student, the process of conducting a multi-site study has reinforced to me how vital it 
is to develop good working relationships with collaborators.  Looking forward, I 
remain hopeful that this PhD study will feed into larger studies and together provide 
evidence to inform how clinical services can be changed for the better. 
10.3 Implications for clinical care  
10.3.1 Web-based information 
The potential health benefits concomitant with improved provision of information and 
support using these methods should be of interest to health service managers and 
policy makers as well as clinicians. As stated before, if patients feel able to pass on 
information about their diagnosis to their relatives this has the potential to save lives. 
There are many reasons why information may not be shared within a family in a 
timely manner. In my view it is fundamental to this process that patients can access 
clear, simple, accurate information about their diagnosis, so that they themselves can 
be confident that they understand their own diagnosis. This then gives them the tools 





Providing open access information via a website can augment traditional methods of 
providing information verbally and in paper format. The advantage of web-based 
information is that it can be easily augmented and updated by health professionals. 
Having documents available via a secure website doesn’t restrict them to being 
viewed online as such documents can be printed out to share with family members 
who may not use this technology. Most significantly, providing web-based health 
information means that it is more readily available to young adults who might not 
otherwise retain paper copies of leaflets or letters. I remain concerned that younger 
relatives at risk of cancer may not have access to evidence of the diagnosis in their 
family. This then may result in greater difficulty for them being referred for the 
recommended surveillance. There is also the risk that they might not receive 
adequate support from their primary care team if their degree of risk is not 
appreciated by their GP (Weathers, 2014). 
10.3.2 Topics where patients wanted more information 
I was aware from my own clinical practice and from recent evidence (Dheensa, 
Lucassen & Fenwick, 2017) that the information provided to patients at diagnosis was 
often limited to generalised information about the condition and a letter to pass on to 
their relatives informing them of the new diagnosis in the family. Therefore, I included 
questions in the survey questionnaire, and within the telephone interviews, to enquire 
about what information participants received at the time of their diagnosis and what 
further information they thought would have been helpful.  
The results from the survey are detailed in Chapter Six, section 6.9. Different topics 
which related to the practical implications of a diagnosis of a high lifetime risk of 





lifestyle’ which was mentioned by many participants in each phase of the study. These 
data therefore have major implications for clinical practice; health professionals may 
not realise that their patients are unclear about whether they can reduce their risk 
through lifestyle changes. Recommendations to maintain a healthy weight, limit 
alcohol intake, eat plenty of fruit and vegetables but eat less processed meat and stop 
smoking, are all messages that are widely available to the public. The relevance of 
these messages to families with a genetic diagnosis needs to be emphasised in clinical 
encounters in my view. 
10.3.3 Testimonies or stories to encourage other patients 
Videos are used in many fields to engage users and promote understanding. The 
support group Lynch Syndrome UK use a series of videos to help explain the diagnosis 
to younger family members . These were incorporated into the Family Web website in 
response to the survey data that showed there was substantial interest in the issue of 
talking to children. One suggestion that was made in the telephone interviews (but 
not yet acted on) was that the website could incorporate video testimonies from 
patients. This was perceived as both reassuring and informative for newly diagnosed 
patients (Kirk et al., 2013). Another advantage to providing open access video 
resources via a website is that a visual explanation with British Sign language signing 
could make it more accessible to hearing impaired patients (Middleton et al., 2010) 
and the audible facility could help visually impaired patients. 
10.3.4 Changing the balance of clinical time  
Drawing on my findings with regard to the importance of adaptation to a diagnosis, I 
suggest that it is likely to benefit patients in the future if health professionals could 





Critically, this support should be provided before encouraging patients to discuss the 
health implications of the diagnosis with their relatives.  
Currently clinical encounters within clinical genetics are generally organised and 
funded in relation to date of referral. This means that the systems in place to book 
clinic appointments are focussed on the needs of the new patient. The flexibility to 
arrange follow-up contact appears to have been eroded due to increasing pressure to 
see more new patients. Pre-symptomatic testing protocols were developed in relation 
to the needs of individuals at risk of Huntington disease (Harper, Lim & Craufurd, 
2000) but have been extended to a range of conditions (Skirton et al., 2013). These put 
emphasis on how patients prepare for having a pre-symptomatic test and whether it is 
the appropriate time for them to have such a test. While these considerations are still 
important to individuals at risk of cancer in my experience many patients come for 
genetic counselling already clear that they want to be tested. However, they may not 
be able to perceive what the full impact of that testing will be until they have had their 
result. Consequently I would advocate a shift in how health professionals’ time is 
allocated in order to make provision for follow-up contact with patients and provide 
better support to families in the medium to long term. 
10.3.5 Optimal timing of encouragement to disclose 
If adaptation to their diagnosis is likely to influence how and when people share 
information with their relatives then health professionals need to be mindful of this. I 
suggest that this has implications for the health professionals and at what point they 
suggest to their patients that the diagnosis should be shared with family members. It 
may remain the most practical solution that information about the condition and 





that later contact by telephone or letter would be a more appropriate time to discuss 
how their patients plan to pass on information to their relatives. Each individual will 
have unique circumstances and support needs to be relevant to them if health services 
wish to optimise the benefit and minimise the harm of a genetic diagnosis. 
 
10.4 Opportunities for future research 
10.4.1 Planned future projects 
Providing adequate, appropriately worded and specific information to patients 
following their diagnosis with a life threatening condition is a reasonable intention at 
any time. Given the growing and widespread use of digital technology, the Family 
Web website has demonstrated that this is a feasible way of providing such 
information in digital format for flexible access at any time. The Think Aloud 
interviews tested the website’s acceptability with volunteer patients but how much 
this innovation could impact on information sharing in families has yet to be 
investigated. Therefore I am developing grant proposals intending to extend this 
research to look at the efficacy of this approach as a way of disseminating information 
about a diagnosis in families. This is being developed in collaboration with academics 
in the UK and in Europe as part of randomized controlled trials.  
10.4.2 Utilising opportunities provided by Personal Health Record systems 
The opportunity to provide accurate and trustworthy information in a digital format to 
patients would be supported by a secure website like Family Web but this could also 
be done using pre-existing Personal Health Record (PHR) systems such as ‘My Health 
Record’ (Dheensa, Lucassen & Fenwick, 2017) or ‘Patients Know Best’. I understand 





providing information to patients enrolled in a gene-sequencing project via their 
existing PHR system. Within the South West I am only aware of one NHS trust which 
currently uses a PHR system but previous discussions with clinicians and managers at 
that trust were very positive regarding the use of the system for genetics patients. I 
perceive that there would be further opportunities to explore whether the findings 
from this study could apply to a wider group of patients.  
It would be feasible as part of service development to create an extension to routine 
clinical care within existing clinical genetics services to upload clinical letters, test 
results and pedigrees for patients on to a PHR system. This could be followed with 
patient satisfaction surveys or more in depth investigations through interviews with 
patients to determine how beneficial patients found it to use the system and whether 
health professionals experienced any problems using it. Evidence regarding PHR use 
has shown that such systems are particularly helpful to patients with complex or 
chronic care needs, such as patients with cystic fibrosis, but they require the 
engagement and support of health professionals (Archer et al., 2011; Nazi, 2013). 
10.4.3 Proposed project to use the website in support of bowel cancer patients 
As a further application of the website, I have been developing ideas and considering 
another grant proposal with other researchers in the UK to set up a study to improve 
support, information and informed consent for patients with colorectal cancer whose 
tumours are being tested for microsatellite instability (MSI). This is following the NICE 
guidance (NICE, 2017) which recommended that all bowel tumours are tested for 
microsatellite instability (MSI). As a member of this project group I want to investigate 
novel ways of supporting patients newly diagnosed with Lynch syndrome which would 





by Bowel Cancer UK in 2018 revealed that only a minority of bowel cancer patients are 
having their tumours tested for MSI in the UK (Bowel Cancer UK, 2018). One aspect of 
this problem appears to be a shortage of appropriately trained staff who are 
knowledgeable about Lynch syndrome and can therefore provide information, take 
informed consent prior to tumour testing, counsel and consent prior to germline 
testing and give results to these patients.  
In this proposed research project we intend to integrate the provision of information 
to patients in digital formats via the Family Web website. The website could be 
incorporated into a care pathway and provide the function of helping patients 
understand their diagnosis and disseminate information about the diagnosis within 
their family. In the longer term such a resource could serve health professions outside 
genetics by improving awareness and could provide opportunities for education 
within surgical and oncology services in accordance with Department of Health goals 
to ‘mainstream’ genetics (Bennett et al., 2010; Davies, 2017; Kirk, Tonkin & Burke, 
2008).  
10.4.4 Capturing anonymous data on information views 
The function of the Family Web website could be used as a tool in future research. 
This is because the website will automatically collect anonymised data on usage via 
web analytics, logging which parts of the website are visited and how frequently. It is 
challenging to gather data regarding receipt of information when family 
communication is being investigated. I could envisage a project where there is an 
option to access information via the website and therefore how many times certain 
information resources were accessed, downloaded or shared could be captured by 





10.4.5 Opportunity to interview research participants using a video conferencing 
platform 
One of the novel methods used in this research was the use of the video conferencing 
platform GoToMeeting (GTM) in the remote online usability testing. Previous 
published evidence of online remote usability testing has been limited to audio 
recorded moderated sessions (Wozney et al., 2016). The use of GTM software meant 
that participants could be interviewed while interacting with the Family Web website 
wherever they were in the country. GTM is a relatively simple system to use and does 
not require every person who ‘joins’ the meeting to be registered with their system. 
Using GTM the interviewer (or moderator) was able to transfer the role of ‘presenter’ 
to the volunteer user. This meant that the user shared their computer screen with the 
interviewer while they explored the website and commented on what they saw.  
The Think-Aloud (Nielsen, 2012) interaction was recorded as video which in turn 
enabled the recording to be played back and analysed later, linking the users 
comments directly to their inter-actions with the website. Being able to see the 
interviewer may also have encouraged the users, although the prospect of using 
unfamiliar systems, even in the familiar situation of their own home, may have 
inhibited other potential volunteers from taking part. 
This method of collecting data using a video conferencing platform could be applied in 
many other research settings and would be particularly valuable when eligible 
participants are dispersed over a wide geographical area. This method could be used 
in other genetic research where there are only small numbers of eligible patients or 
any research setting where participants are widely geographically distributed.  I can 





usability testing of eHealth interventions. It could also be used to record the 
interactions of remote online focus groups or to assess student’s use of online learning 
tools.  
10.5 Implications for policy makers 
I would acknowledge that further research needs to be carried out using this website 
(or others like it) to refine it, expand its application and test to what degree this 
method of information provision assists families. If there is evidence available then I 
believe policy makers should be recommending such innovations. However, without 
technical support and availability to training, plus a clear incentive to clinical staff to 
incorporate this type of innovation into their practice, it is unlikely to be utilised fully. I 
acknowledge that the inertia inherent in any health care system is likely to mitigate 
against change even when patients and their relatives want information to be 
provided to them in digital format. 
10.6 Conclusions 
This research study has made a unique contribution to knowledge on several counts.  
 New theories have been developed that contribute to our understanding of 
what factors influence dissemination of information in families. A map of four 
major themes (impact, adaptation, practical information and appropriate 
communication) showed their suggested interactions. In addition, a model was 
postulated indicating the importance of a patient’s psychological adaptation to 
their genetic diagnosis and how this influenced the timing of disclosure to 
other relatives.  
 This research has made a contribution to clinical practice; indicating that 





information and support that is tailored to their needs; with emphasis on what 
they can do themselves to mitigate their increased risk of cancer. It has also 
shown that the timing of when clinical staff talk to their patients about sharing 
information is important and needs to come at a time when patients have 
adjusted to their own diagnosis. 
 This study has also contributed to research methods development in 
healthcare through the novel use of online video conferencing to interview and 
record usability testing with participants across a wide geographical area.  
Finally, I believe that many patients would use the type of web-based file sharing 
facility that I developed if it was available to them. In order to circulate information to 
the wider family patients need to be given time and support to adapt to their own 
diagnosis first. These original findings will be disseminated through peer-reviewed 
publications, scientific meetings and to a wider audience through the media, and I 
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Appendix 3 Research study protocol version 2 
 
Family Web Study 
Protocol 
Investigation into the use of emails and interactive websites for the provision of information 
by health professionals to families at increased risk of colorectal cancer to facilitate sharing 
information by relatives 
Introduction and summary 
Email is now a common form of communication; although it is still used less frequently in 
healthcare than in other arenas. However improving technology has enabled greater data 
security for the use of email in healthcare 1. In addition, alternatives to email such as 
password protected patient portals and websites 2 could now provide an opportunity for 
family members to share information that has been provided by their healthcare 
professional in a quick and secure manner.  
The issue of how information is communicated in families who have a shared vulnerability 
to disease is a focus of attention and debate 3, 4. Many different factors can impede 
communication 5 but in families with an increased risk of cancer, there are significant 
potential benefits to relatives if that information can help them access appropriate 
screening or be alert to early symptoms of disease 6, 7. 
This study will focus on families at an increased risk of bowel cancer. Those individuals who 
have been advised to have regular bowel screening by colonoscopy will have been told to 
warn their relatives of their risk. However, evidence indicates that only a minority of 
relatives access screening or genetic testing 8, 9. We will seek to develop improved methods 
of information provision through this research. 
Phase 1 A cross-sectional survey will be administered to around 300 people at increased risk 
of bowel cancer via websites, following genetics advice and at screening clinics. 
Phase 2 Semi-structured interviews will be conducted by telephone with a purposive sample 
of approximately 20 respondents to the survey.  
Phase 3 A pilot website will be developed by an iterative process of Think-Aloud interviews 
with about 30 participants and tested by users. 
Background 
In the United Kingdom (UK), colorectal cancer is now the third most common cancer for 
both men and women, with over 34,000 new cases diagnosed in 2012 [Office of National 
Statistics] and 1.4 million new cases diagnosed worldwide in 2012 10 . Of these cases of 





dominantly inherited vulnerability to cancer called Lynch syndrome (LS, previously 
hereditary non-polyposis colorectal cancer or HNPCC) 11, 1% will be due to another 
autosomal dominant condition, familial adenomatous polyposis (FAP) 12 and a further 20% - 
25% will have arisen because of an inherited vulnerability of usually unknown cause 13. In 
addition, recent data from Europe indicate that Lynch syndrome is much more common 
than previously believed, probably affecting 1 in 300 people 11 so the implications of such 
genetic diagnoses will affect many people. 
In Lynch syndrome the lifetime risk of colorectal cancer is up to 80% and there are 
significantly increased risks of multiple malignancies including endometrium, ovary, gastric 
and other cancers 14, while in FAP the risk of colorectal cancer approaches 100% by age 60 
12. However, in individuals known to have inherited an increased vulnerability to colorectal 
cancer, targeted bowel screening by colonoscopy can significantly reduce the morbidity and 
mortality of the disease 6, 15. 
Unfortunately, current methods used to diagnose the families with these conditions are 
only identifying a fraction of the families affected 9, 16. Recent research in the UK and 
Australia has looked into why individuals with colorectal cancer, or their relatives with a 
significant family history of cancer, are not being identified.  The evidence suggests that 
primary care physicians, as well as medical and surgical specialists are reluctant to refer to 
genetics services for a variety of reasons, with one main barrier being a lack of knowledge 
about Lynch syndrome 17, 18.  
Once a diagnosis has been made in an individual it is important that they are supported by 
healthcare professionals in understanding the implications of that disease for themselves 
and their families 19. However, even in families with Lynch syndrome where clear 
recommendations for management exist, evidence suggests that information is only shared 
with less than half of the relatives for whom it would be relevant 8. This may be because 
those with the information are not always confident or feel able to disseminate what they 
know to their relatives who are also at risk 20 despite the encouragement of their health 
care professional 21. Such inadequate or delayed communication can result in relatives 
developing cancers that could have been prevented 22. 
Therefore it is likely that many relatives remain uninformed and unable to access the 
appropriate advice and risk reducing surveillance available to them. We postulate that the 
current methods of patient support and information provision (with paper based leaflets) 
may be inadequate to meet the needs of families 17. We therefore hope to develop new 
ways to help families who are confronted with this burden of risk and the need to share 
health advice. In doing so it would seem logical to use methods of communication that 
reflect the changes that have occurred over the last decade in the ways family members 
communicate with each other 23. Although a website based in the United States  exists 
(www.kintalk.org) to promote education and communication in families at risk of cancer 24, 
there is as yet no published data on the acceptability and efficacy of such electronic 
communication, either by email or through interactive websites,  in healthcare.  A 





the impact of electronic communication by healthcare professionals on information sharing 
in families, found only one paper 25 out of 1720 that provided evidence on this issue.   
Objectives 
The aim of this study is to investigate how health professionals could support and facilitate 
information sharing in families at an increased risk of bowel cancer, in seeking to optimise 
the health benefit in those families. More specifically we aim to investigate what the impact 
would be of providing information about a genetic diagnosis, and the health implications of 
that diagnosis, in an electronic format such as email or via an interactive website.  
More specifically the objectives are to: 
1. Explore the perspectives of patients and their relatives about the acceptability and 
desirability of providing health information about a familial diagnosis by email or through an 
interactive website. 
2. Set up and test a password protected interactive website to facilitate information sharing 
in families with an increased risk of bowel cancer, to determine if this is feasible. 
3. Ascertain the impact of providing information electronically on information sharing with 
relatives. 
4. Make recommendations regarding methods of information sharing, timing and the type 
of information most useful to families with an increased risk of bowel cancer, based on the 
results of the study. 
Eligibility for participation 
Patients who are:  
Over 17, living in England or Wales, competent in reading and speaking English and: 
 Come from a family with a known genetic condition giving an increased risk of bowel 
cancer.  
OR 
 Have been advised to have regular bowel screening because of an increased risk of bowel 
cancer due to their family history of cancer. 
OR 
 Have had a cancer and they were told that it was due to a genetic vulnerability which 
included an increased risk of bowel cancer. 
 
Therefore, men and women will be eligible who are from a family with a known genetic 
vulnerability to bowel cancer such as Lynch syndrome or familial adenomatous polyposis 
(FAP), but also those with other inherited vulnerabilities to bowel cancer where regular 
bowel surveillance is indicated.  
Participants need to have had time to adjust to their diagnosis so they will be eligible if their 
diagnosis was made 3 or more months before.  All participants would need to be competent 
in reading and speaking English to take part in the study. 





 if they are unable to give informed consent,  
 do not comply with the criteria above or  
 if they are receiving active treatment (radiotherapy or chemotherapy) for cancer or 
were diagnosed with cancer within the last 3 months.   
However patients considered in remission who are taking maintenance medication would 
be eligible to take part as long as they were diagnosed at least 3 months before. This is to 
avoid giving greater burden to cancer patients while they are in the acute phase of their 
illness. 
Recruitment 
Recruitment to the anonymous online survey will be via a SurveyMonkey link to UK 
residents who fulfil the eligibility criteria.  Participants will be invited to take part in the 
survey through promotional material on charity websites such as Macmillan, Lynch 
Syndrome UK and Bowel Cancer West.  The same survey questionnaire will be available in 
paper copy format to participants who request a copy via the study email or leave a phone 
message.   
Recruitment to Phases One and Two of the study will also be to eligible patients attending 
colorectal surgical outpatient clinics and Endoscopy clinics in Plymouth and Truro. These 
patient will be given participant information sheets (PIS) and invited to contact the study for 
more information and a consent form if they are interested in taking part. 
Eligible patients who are known to Clinical Genetics Departments in any one of ten NHS 
Trusts in England and Wales (Exeter, Southampton, Cardiff, Bristol, Birmingham, Oxford, 
London, Harrow, Manchester and Newcastle) will be provided with the appropriate PIS for 
recruitment to each of the three Phases of the study.  
Through this strategy we hope to recruit participants from across each of our eligible patient 
groups. 
Experimental design and methods 
Research design: this will be a mixed-methods study 26. In order to capture the views and 
experiences of a range of individuals and achieve triangulation 27 we are combining both a 
quantitative approach and a qualitative approach in the different phases of the study. The 
purpose of this method is to attempt to gather a broad collection of people’s opinions and 
suggestions for improvement.  Through triangulation we will attempt to achieve consistency 
and convergence of the conclusions reached. We hope that by applying these methods it 
may also be possible to attain some complementarity 28 as the different approaches of the 
questionnaire and interviews are intended to investigate different aspects of the problem of 
sharing information in families and thereby lead to deeper interpretations and conclusions 
29.  
In Phase 1, we will use a cross-sectional survey 30 administered either online  (using 
SurveyMonkey) or in paper format 31, to elicit the views of a broad cohort of individuals. 





prevent or detect cancer in accordance with guidelines 32.  The questionnaire will be 
available online to reach respondents across a wide geographical distribution, to reduce 
costs and facilitate completion 33.  
The concurrent triangulation design of this study allows for data collection from the 
questionnaire responses to continue while some participants may already be proceeding to 
Phase 2 interviews.  This allows for a responsive dynamic and evolving interpretation of the 
qualitative data in conjunction with the process of gathering more quantitative data. This 
nested analysis 34 is intended to utilise the benefits of both methods simultaneously and we 
hope will allow for the investigation and interpretation of this complex issue.  
For those participants who use the paper format questionnaire a reply paid envelope will be 
provided. The quantitative data from this cross-sectional survey 35 will be analysed using 
descriptive statistics and SPSS software. Qualitative data from free text responses will be 
coded and analysed for recurrent themes using NVivo software . The survey concludes with 
an invitation to take part in further research. If participants, having read and understood the 
consent form, wish to be interviewed they are asked to contact the research team or 
provide their contact details.   
Phase 2  will be based on a qualitative grounded theory approach 36 in order to define 
concepts of interest or concern and develop information most suited to the needs of the 
potential recipients. This is designed to enhance and provide more in depth information 
about their experiences and their needs in relation to sharing health information in the 
family.   We will use semi-structured telephone interviews to collect data from a purposive 
sample of respondents from the survey 37. In this way we hope to understand the difficulties 
encountered and preferences for information provision of both men and women, and 
people of different ages and experiences. 
Phase 3 involves the creation and testing of an interactive password protected website with 
potential users who will be recruited through clinical genetics services. The proposed 
website will be developed in an iterative manner using a series of Think-Aloud interviews 38 
where the participant and the researcher sit together while the participant explores the 
website and voices their thoughts. These interviews will be recorded and then transcribed 
to allow coding and subsequent analysis by content and theme 39. 
The subjects of this phase will be people who have been given a diagnosis of an increased 
risk of bowel cancer and advised to have regular bowel screening by colonoscopy. The 
interviews should be conducted between three months and one year after they were given 
their diagnosis in the genetics clinic. The efficacy of the website will be tested by logging the 
number of occasions that relatives access the website. This will be done anonymously but 
people who access the website can also in turn complete an anonymous survey to provide 
feedback regarding the website. 
It is our intention to explore this method of information provision via the website and 
password protected portal. We propose further validation and work to test its efficacy as a 





Confidentiality and Data Protection 
The researcher conducting the interviews in Phase 2 (Selina Goodman) will have access to 
the participants name, their email address or telephone number in order to set up the 
interview at a convenient time for the participant.  Participants who complete the online or 
paper survey will have the opportunity to contact the researcher direct to express their 
interest in taking part in an interview before they make a decision of whether to do so.  
Therefore the survey will remain anonymous.  
If participants do tick that they are willing to be interviewed and provide their preferred 
method of contact (email or telephone) via the tear off slip, these personal details will be 
posted or sent separately from their survey responses in an additional reply paid envelope.   
Those participants that indicate they are happy to be contacted about being interviewed 
can choose to use an alias, pseudonym or username to conceal their identity. All 
participants data will remain confidential at all times.   
In each phase of the study where participants are introduced to the study by NHS clinical 
staff, the participants details will only be given to the researcher by clinical staff with the 
verbal consent of the participant. No information about the participants health or 
treatment is required by the study.   
However, in order to contact potential participants and explain the study in more depth, 
providing them with written information and consent forms, it will be necessary for clinical 
staff to pass on the telephone or email address of their eligible patients who are interested 
in taking part.  
The details of patients who decide not to take part will be removed and deleted as soon as 
they have expressed that decision. If patients receive information about the study but do 
not get in touch with the research team within a month, they will be sent a reminder about 
the study but not contacted again after that.   
The study will remain compliant throughout with the Data Protection Act 1998 and 
information governance standards as set out in the Caldicott Review of 2013.  
Analysis 
The three phases of this study are intended in an explanatory, sequential design using both 
quantitative and qualitative methods to investigate a complex problem 29. In order to 
understand the issues deeply we are hoping to recruit a mixed sample of participants across 
a range of ages and with different experiences. Although much of the data generated by the 
questionnaire will be numeric, due to the limitations of funding in this study we are only 
attempting to recruit a relatively small sample of 300 participants to the Phase 1 survey, 
approximately 20 in the Phase 2 interviews and 50 people to the Phase 3 interviews. 
Therefore our analysis will be confined to descriptive statistics, with bivariate analysis to 
examine covariance or measures of dependence between different variables and 
comparison of means but assisted by the application of SPSS software. The responses to the 





central tendencies and Chi-square as a measure of association 40.  In this descriptive survey 
we are seeking a sample with maximum variation of age, geography and educational 
qualification. However if half of the projected sample of 300 were to give clear preferences, 
say for information provided by email, this would give a 95% confidence interval of 44% to 
56% for that estimate. This is acceptable precision for this study. 
The free text parts of the questionnaire and the subsequent interviews will be capturing 
qualitative data, but we intend to attempt some data reduction and data correlation 
between the qualitative and quantitative data as part of this process of mixed-method 
analysis 41.  
The audio-taped recordings of the interviews will be transcribed and read several times 
prior to any coding. The analysis of the qualitative data both from the free text boxes in the 
questionnaire and from the interviews will follow a grounded theory approach 36. In order to 
develop recurrent themes, all statements will be coded and then the codes will be arranged 
into categories and themes. To make sure that there is no bias in coding, transcripts will be 
coded independently by the researcher and her supervisor and then they will meet to 
discuss their findings. Consensus will be achieved between the researchers following 
discussion about any discrepancies.  Eventually the resultant categories and codes will be 
compared across the participants to arrive at recurrent themes that reflect their experience 
of and opinions about the topic.   
The Think-Aloud interview transcripts will be analysed both by content and by thematic 
analysis 39 to achieve more comprehensive interpretation of the interaction of the 
participants with the website. 
Ethical considerations 
Anyone eligible for this research will have already been given a recommendation to have 
regular bowel screening on the basis of their increased risk of bowel cancer. Since this is the 
criteria for eligibility they should be aware of this risk and the concept should not be novel 
or alarming to them. However prior to potential participation in the study, patients will be 
provided with information sheets explaining whether they may be eligible and what the 
study involves. Every information sheet includes a telephone number and email address 
should they have questions of any sort about the study. We anticipate that potential 
participants may have questions about their eligibility or the study in general.  
Participants will be directed towards appropriate support services should they experience 
intrusive or burdensome thoughts at any time during the study. They will have read and 
signed a consent form before taking part in the study. They will retain a copy of the consent 
form and the original will be kept by the researchers in the university in a locked filing 
cabinet. An additional copy of the consent will be held in the site file if the participant is 
recruited through one of the NHS study sites. Participants will be reassured that their 
involvement and all their responses will remain confidential at all times. Participants will be 
provided with a letter to give to their GPs should they wish to make them aware of their 
involvement with the study. At each stage of the study, participants will be offered a list of 





There are a number of possible issues that may arise for participants through their 
involvement in any phase of this study.  Participants are likely to have heightened anxiety in 
relation to cancer and we are aware that participation in either the survey or interviews 
may trigger some emotional reactions in relation to the questions asked.  
Phase 1 
The most likely reactions we anticipate would be feelings of guilt and an increased concern 
regarding their risk of cancer. When participants answer the questionnaire or when they are 
interviewed, the questions may evoke latent cancer fears in participants as they will be 
reminded of their own increased. However evidence from genetic counselling suggests that 
such psychological distress is usually short lived following genetic counselling or genetic 
testing 42-46.  
Guilt could be in relation to their fears for the health of their children or grandchildren, who 
may have also inherited the increased risk of cancer from their parent. Feelings of guilt may 
also arise because participation in the study could remind them that they have not 
communicated with all their relatives about the shared risk of cancer 5. Evidence indicates 
that people with a genetic vulnerability to cancer do realise that they have a duty to warn 
their relatives, but they experience a conflict between the desire to protect their family 
from anxiety and distress and the knowledge that their relatives could reduce their risk of 
cancer through regular screening, taking medication and symptom awareness 47. 
If participants experience concern or distress we would encourage them to seek the advice 
of their GP (if they have any physical symptoms that give them concern), or alternatively, 
they should contact their genetic counsellor, or colorectal specialist nurse. If someone is 
experiencing profound and intrusive feelings of guilt, or other negative emotions, they could 
seek appropriate referral by their GP for supportive care. However, if the participant would 
prefer, the researcher can refer the participant to an appropriate health care professional. 
We considered the convenience of completing the survey online, and in someone’s chosen 
time and place, to be preferable to completing a paper copy. However paper copy surveys 
with reply paid envelopes will be offered to participants. We anticipate the paper survey will 
be the most likely method of completing the survey at the time of a colonoscopy, as there is 
unlikely to be easy access to the Internet in the Endoscopy unit.  
Phase 2  
The proposed questions to be used in the semi–structured interviews have been ethically 
approved (NHS REC ref: 15/SW/0250) but could be amended based on the survey 
responses. However, there will potentially be overlap between Phase 1 and 2. This is 
because Phase 2 interviews will be conducted in a purposive sample with maximum 
variation with people who have already completed the survey.  We will seek to avoid a 
sense of coercion, reminding respondents that they are free to be involved, or not, and can 
withdraw from the study at any time without compromising their care. Informed consent 
will be sought at each phase of the study. We are aware that participants may be sensitive 





telephone for their convenience and the fact that this will enable the researcher to 
interview participants from across England and Wales. The researcher is an experienced 
genetic counsellor and in that role she has undertaken many telephone calls regarding 
sensitive subjects.  
If a participant becomes upset or distressed during an interview the interview will be 
suspended. The interviewer will then give the participant the choice to decide whether to 
continue or to stop the interview then, or potentially withdraw from the study altogether. A 
similar approach, responsive to the vulnerabilities and sensitivities of the participants will be 
used for the Think-Aloud interviews in Phase 3 of the project. In each case, when an 
interview has been suspended for the above reason, the researcher will offer to refer the 
participant to an appropriate health care professional for support. 
We hope that participants may experience a sense of satisfaction being involved in a study 
which is seeking to elicit their views and take them into account in developing a better 
service and better support for families like their own. In a broader sense, health 
professionals have a duty of care to assist families in sharing information 21 but data 
suggests that it is only a minority of relatives in high risk families who are currently receiving 
bowel screening 9 so it could be argued that there is currently an urgent need to improve 
the support for families in this situation. 
All data (both collected electronically and that in paper format) will be kept securely in 
Plymouth University in a passcode protected secure office and locked filing cabinet. The 
only individuals with access to this data will be the Chief Investigator and her academic 
supervisors.  
Benefits of the study 
This original research is therefore being done to try and improve the way in which 
healthcare professionals inform, support and facilitate the dissemination of relevant 
information within families at increased risk of bowel cancer, in seeking to optimise the 
health benefits to those families. If setting up an interactive website is acceptable and 
feasible, then we would seek to test whether the use of the website does result in an 
increased uptake of bowel screening or genetic testing in families with an increased risk of 
bowel cancer. We hope that the proposed website could be set up, with proven efficacy and 
so established in a way that could be maintained by the NHS through Health Education 
England or another agency for the long term and future benefit of such families. The 
proposed website would not be intended for profitable purposes. In addition, it is possible 
that the principles of providing health information in an electronic format can be applied to 
help families with other genetic conditions. 
Chief Investigator 
Selina Goodman BA (Hons), MSc, Registered Genetic Counsellor (GCRB 192) 
This research is being undertaken as part of a full time PhD programme. There are no 
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Appendix 13  Advertisement for display in clinical waiting rooms to promote the study 
Family Web Study 
Are you interested in helping in our research? 
Some families have an inherited vulnerability to bowel cancer which runs in the family.  When someone is found to have an increased risk of 
cancer like this, their doctor may suggest that they tell their relatives.  This is because the health advice given to one person may apply to other 
people in the family.   
If you have an increased risk of bowel cancer in your family we are very interested in what you tell us.  Your views will guide us to provide 
better health care to families like your own.  You may have experience of sharing information in the family, or you may not; we are interested to 
learn from everyone’s experiences. 
We are conducting a survey (taking 20 -30 minutes) to gather the views of as many people as possible who have an increased risk of bowel 
cancer in their family. 
If you are interested, please ask a member of staff for an information leaflet.  Survey questionnaires are available on paper or can be completed 
online via https://www.surveymonkey.co.uk/r/familywebstudy  
If you have questions about this survey please email: familyweb@plymouth.ac.uk   text or leave a message on 07784785368 .  
 
 




Appendix 14 Phase 1 eligibility checklist for clinicians 
Family Web Study 
We are conducting a survey to find out the views of people with an increased risk of 
bowel cancer in their family.  We want to learn from people’s experiences so that we 
can improve support to families. 
To find out if your patient would be eligible to take part in this research, please 
answer the questions below?  Firstly, they need to be living in the UK and aged 17 or 
over.  Patients would not be eligible if they have been diagnosed with cancer within 
the last 3 months or they are receiving radiotherapy or chemotherapy for cancer.  
This is to avoid giving any greater burden to these patients. 
 
Then if you answer “Yes” to any of the following questions, your patient would be 
eligible:  
 Have they been advised to have regular bowel screening because of an increased 
















If you have answered Yes to at least one of the questions above, please give your 
patient a participant information sheet (PIS).  They would be eligible to take part in the 
survey and telephone interviews if they wish to.  We do not ask for any personal 
details or clinical information about your patient.   
If after reading the PIS your patient wishes to take part in the study they can access the 
survey online or they may ask you for a paper copy of the survey questionnaire.  
If you have any questions, please contact us on 07784785368 or email 
familyweb@plymouth.ac.uk. 






Appendix 15  Participant Information Sheet Phase 1 
Family Web Study 
Study of information given to families with an increased 
risk of bowel cancer and their information preferences  
We would like you to take part in this study 
 Please read the following information carefully. Take as much time as you need to 
think about it. Ask us for more information if you would like it or if anything is not 
clear. 
 Before you decide whether you wish to take part, it is important that you know 
why the research is being done and what it will involve.  
 If you choose not to take part this will not affect your healthcare in any way. You 
are free to decide what to do. 
---------------------------------- 
We are conducting a survey to find out the views of people with an increased risk of 
bowel cancer in their family.  We are aware that it is sometimes difficult to pass on 
information to relatives about the shared risk of cancer in the family.  We think that 
information could be given in different ways but we would like people’s views on this. 
We also want to learn from people’s experiences so that we can improve support to 
families like yours. 
Why am I being asked to take part?  
You will be invited to take part in this survey if: 
 You have been advised to have regular bowel screening because of an increased 
risk. 
OR 
 You have had a cancer and you were told that it was due to a genetic vulnerability. 
OR 
 You come from a family with a known genetic condition giving a risk of bowel 
cancer.  
What is involved? 
 You will be asked to fill in a questionnaire either online or on paper. 
 This will take about 20-30 minutes but you can stop at any time and go back to it 
later. 
 There is space in the survey if you want to give extra information. 
 This is an anonymous and confidential survey. 
 
What are the risks or benefits of taking part? 





 You may find it helpful to think about the situation in your own family 
 You may feel anxious or upset when you think about the cancer in your family. 
 You may worry about your family and what they understand about their risk. 
 You may have new questions for your health professional about your risk. 
 
What happens to my answers? 
 The information you provide in the survey will be kept securely on a password 
protected Plymouth University computer and only seen by the researcher and her 
supervisors.  
We hope that by providing your views you will be helping us work towards a better 
service for you, your family and other families like yours.   
This survey has been reviewed and approved by the NHS research ethics committee 
and Plymouth University. There will be no financial gain to anyone involved in this 
research. This research is being undertaken as part of a full time PhD programme. 
There are no conflicts of interest to declare. 
This survey is the first part in the Family Web Study.  It will be followed by telephone 
interviews (which will be audio recorded) where we are hoping to gather more 
detailed information about this issue.  We hope to recruit a total of 350 people to this 
study.  The Family Web Study will continue until Spring 2018 to provide enough time to 
gather people’s views, analyse and report the results. 
After that time, all participants will be able to see a summary of the results as they will 
be available online through website links at Bowel Cancer West, Macmillan, Lynch 
Syndrome UK or Plymouth University.  We can also send the results out by post or 
email on request. 
If you would be happy to complete our survey at a time that suits you, 
please ask a member of staff for a survey form and reply paid envelope 
or go to the survey online at 
https://www.surveymonkey.co.uk/r/familywebstudy. 
For any more information about the survey or the Family Web Study please contact us. 
How to contact us? 
Please email: familyweb@plymouth.ac.uk, text or leave a message on 07784785368 if 
you have any questions. 
Thank you for taking the time 
to read this 
 
Selina Goodman 
PhD student & Registered Genetic Counsellor   
School of Nursing & Midwifery 
Faculty of Health & Human 
Sciences 






Appendix 16  Letter to potential clinical collaborators 
Family Web Study  
<Name and address> 
 
<date to be inserted> 
Dear <name to be inserted> 
Family Web Study - A Study of information given to families with an 
increased risk of bowel cancer and their information preferences  
I am writing to you regarding the research that I am conducting.  I am a full time 
independent student researcher working towards my PhD at Plymouth 
University.  I am motivated to conduct this research based on my experiences 
working as a Registered Genetic Counsellor.  I have worked for many years in 
the field of cancer genetics with a particular interest in bowel cancer.  During 
that time I have come to the conclusion that better methods of information 
provision need to be developed, to assist and support families at risk of this 
disease.  
That conviction is shared by many of my clinical colleagues and we believe that 
this research is both timely and necessary.  You may have patients who would 
be eligible and interested in being involved, therefore I enclose a copy of the 
study protocol for your information.  Please let me know if you have any 
questions about the study and whether you would consider supporting this 
research?   




   
Selina Goodman 
 
PhD Student & Registered Genetic Counsellor 
  
8 Kirkby Place 
School of Nursing & Midwifery 
Faculty of Health & Human Sciences 
Plymouth University    Telephone: 01752 586584 
Plymouth 






Appendix 17  Letter of invitation to patients 
Family Web Study 
 
 




Re: Study of information given to families with an increased risk of bowel cancer 
and their information preferences  
We are asking people if they would like to take part in our research study.  You 
have been sent or given this letter because you may be eligible to take part.  
We would like to give you some information about what might be involved.  
Please read this Information Sheet which is given to all participants to read 
before deciding whether or not they would like to take part in this study. 
This letter has been sent by your own health professional.  The research team 
do not have your contact details or any information about you.  We therefore 
need you to contact us if you would like to help with the study.   
If you would like to be involved, and help us in our research to help families, 







PhD Student & Registered Genetic Counsellor 
  
8 Kirkby Place 
School of Nursing & Midwifery 
Faculty of Health & Human Sciences 
Plymouth University    Telephone: 07784785368 
Plymouth 






Appendix 18 Phase 1 survey questionnaire – paper version 
 
Family Web Study 
Thank you for helping with this survey for people with an increased 
risk of bowel cancer in their family.  Your views will guide us to 
provide better health care to families like your own. 
We would like you to answer every question, but if you cannot 
answer a question, please pass over to the next one.   
Firstly, please can you think back to how you first found out about the 
increased risk of bowel cancer in your family.  
1. Who first told you that there was a risk of bowel cancer in your family?  
Please tick one: 
□ Your doctor (General Practitioner “GP”) 
□ Specialist doctor (e.g. surgeon, gastroenterologist, oncologist, etc.) 
□ Genetics specialist (e.g. medical doctor or genetic counsellor)  
□ Another healthcare professional  
□ Your relative, can you tell us who? (e.g. mother, brother, cousin?) 
 
 
□ Other person, please tell us who? (e.g. friend or charity advisor?)  
 
□ Can’t remember 
Please answer the next questions (2, 3 & 4) only if you were told about the 
increased risk by a healthcare professional 
 2. Did you feel well supported at that time?  Yes / No / Not sure 





4. Are you the first person in your family to be told that there is an increased 
risk of cancer in the family? 











Information you received 
5.   Please can you tell us what written information you received when you were 
told about your risk of cancer? Tick all that apply 
□ None received 
□ General information about the condition 
□ Specific information about your family 
□ A copy of your family tree indicating who had cancer 
□ A copy of your family tree showing who could have bowel screening 
□ A ‘Dear Relative’ or ‘To Whom it May Concern’ letter to give to your 
relatives 





6.  Did you get the information you wanted?  
□ None of what I wanted. 
□ Some of what I wanted. 
□ Most of what I wanted. 
□ All of what I wanted. 
6a.  If you didn’t get all the information you wanted at that time, what other 













7. If you have found additional information about the shared risk of cancer in 
your family, who provided that information? Tick all that apply 
□ Your doctor, surgeon or other health professional 
□ Other relatives 
□ Friends 
□ Support group or charity meeting 
□ Internet website 
□ Social media 
□ Library 




□ Did not find out more information. 
 
8. If you found out more information via the Internet, what websites or social 
media were particularly helpful? 





Information you might like 
9.  Would you like to receive information in other ways? Yes / No / Don’t know 
o If yes, would this be  
□ Via a website 
□ By Email 
□ Social media 
□ In a follow-up appointment 













We would like to know if other forms of information for patients could 
make it easier to share information in the family. Below, we ask you to 
think about other ways that your doctor or genetic counsellor could give 
you information. Then please can you rate how helpful these might be to 
you and your relatives? 
10. Please indicate how helpful you think this would be for the different ways 
getting information by making a cross on each of the scales below: 
a.  A paper leaflet which has general information about an increased risk of 
bowel cancer, the implications for relatives and the screening available? 
_______________________________________________________________ 
very unhelpful  unhelpful   helpful very helpful 
 
b.  A secure email which has more specific information about your increased 
risk, the implications for your relatives and the screening advised? 
_______________________________________________________________ 
very unhelpful  unhelpful   helpful very helpful 
 
c.  A password protected website which has more specific information about 
your increased risk, the implications for your relatives and the screening 
advised ? 
_______________________________________________________________ 
very unhelpful  unhelpful   helpful very helpful 
 
d.  A follow-up appointment in the hospital clinic where you are given specific 
information about your increased risk, the implications for your relatives and the 
screening advised? 
_______________________________________________________________ 
very unhelpful  unhelpful   helpful very helpful 
e.  A follow-up telephone call where you are given specific information about 
your increased risk, the implications for your relatives and the screening 
advised? 
_______________________________________________________________ 









11.  What issues would you like more information about? Please tick all that 
apply 
□ Talking to children 
□ Healthy lifestyle 
□ How can I help my relatives who live abroad 
□ How to find out more about genetic testing 
□ Other issues   

















Now it would be helpful to us to know a bit about what difficulties there 
may be in your family about sharing information about the increased risk 
of cancer. This is so we can better understand how to help and support 
families like yours in the future. 
12. How many of your relatives are aware of the increased risk of cancer in the 
family?  
So, as far as you know  
□ All 
□ Most    (please tick the one which applies) 
□ Some 
□ None 
□ I don’t know 
 
13.  If you have experienced any difficulties sharing information with your 
relatives about the increased risk can you tell us what those difficulties were? 









14. Can you suggest ways in which your health professional could help you or 
your family more? Please give suggestions below, or pass on to the next 
question if none: 
(For example: These may be ideas of ways to help you overcome difficulties 
with communication, they may be ideas about getting screening or advice, or 












And finally, it would be helpful to know a little about you and your 
circumstances so that we know that different people have given us their 
views 
15.  Have you, or to your knowledge has anyone else in the family, had a 
genetic test for bowel cancer genes? 
Yes / No / Don’t know 
 
16.  Have you ever been diagnosed with cancer yourself?  
Yes, bowel cancer / Yes, another type of cancer / No cancer 
 
17.  Are you: Male / Female / prefer not to say 
 
18. Can you tell me the highest educational or school qualification you have 
obtained? 
Please tick one only 
□ GCSE/O Level/ CSE / Standard/Ordinary (O) Grade / Lower (Scotland) 
□ AS Level / Higher Grade/Advanced Higher (Scotland)/ Certificate of sixth 
year studies 
□ A Level / Welsh Baccalaureate / International Baccalaureate 
□ Nursing or other allied health professional qualification (not degree level) 
□ Teaching qualification (excluding PGCE) 
□ Diploma in higher education 
□ First degree level qualification including foundation degrees, graduate 
membership of a professional Institute, PGCE 
□ University Higher Degree (e.g. MSc, PhD) 
□ Other vocational qualification not yet mentioned 
□ None of the above 
19.  What age are you? Please tick 
17-19  30-34  45-49  60-64  75-79  
20-24  35-39  50-54  65-69  80-84  
25-29  40-44  55-59  70-74  85+  
Or if you prefer not to say, please tick here   









We want to improve the service and support that is offered to families in your 
situation, so would like to hear all your views on this issue.  If you have anything 
further to add, we would be grateful if you could tell us in the blank box below.  
For example, you may like to give us more information about the things that you 

























Thank you very much for taking part in this survey! 
As the next part of this research, we would like to interview a number of people 
to find out more about their experiences of sharing information in the family 
about the risk of cancer.  We are trying to develop a better service and provide 
support that more closely meets the needs of families.  For this we need the 
help of people who have experience of this situation.  We would like to improve 
things guided by families and their ideas.  We think that more information could 
be given by email or from special websites but we would like people’s views on 
this.  
We are aiming to interview men and women (living in England or Wales) with 
different experiences about this type of communication.  If you are interested, 
we will send you more information and a consent form. Then if you are happy to 
take part, we can arrange a time for a telephone interview lasting around 30 -40 
minutes.  
It may be that not everyone is needed for interviews, but we will contact you 
within two months to explain whether or not you would be offered an interview.  
Of course anyone taking part is free to withdraw at any time if they change their 
mind. 
Please tick here if you are interested in further supporting this research  
We can send you more information and consent forms, if you would consider 
being interviewed in this way. Please tear off the slip below and return it to us 
with your preferred contact details so we can get in touch with you and give you 
more information. 
If you have any questions about this survey, or being interviewed by telephone, 
please contact Selina Goodman by email at: familyweb@plymouth.ac.uk , text 
or leave a message on 07784785368. 
All the information we receive will remain strictly confidential. 
 
Family Web Study 
I would consider being interviewed by telephone, please contact me with more 
information about what that might involve  
 
Name/ alias  












Appendix 20  Participant Information Sheet Phase 2 Interviews 
Family Web Study 
Study of information given to families with an increased risk 
of bowel cancer and their information preferences  
We would like you to take part in this study 
 Please read the following information carefully. Take as much time as you need to 
think about it. Ask us for more information if you would like it or if anything is not 
clear. 
 Before you decide whether you wish to take part, it is important that you know why 
the research is being done and what it will involve.  
 If you choose not to take part this will not affect your healthcare in any way. You are 
free to decide what to do. 
---------------------------------- 
We are interviewing people with an increased risk of bowel cancer in their family to find out 
their views.  If you have already taken part in our survey we would like to interview you on 
the telephone to hear more about your experiences.  
We want to interview people with a range of experiences so we are aiming to interview a 
mixed group of men and women with different experiences about this type of 
communication.  This is because we want to learn as much as we can so that we can 
improve support to families like yours.  
We are aware that it is sometimes difficult to pass on information to relatives about the 
shared risk of cancer in the family.  We think that information could be given in different 
ways but we would like people’s views on this.  We are interested in people’s opinions 
about what could be improved or what has been done well. 
Why am I being asked to take part?   
You will be eligible to take part if are an adult (17+) you live in England or Wales and: 
 You have been advised to have regular bowel screening because of an increased risk. 
OR 
 You have had a cancer and you were told that it was due to a genetic vulnerability. 
OR 
 You come from a family with a known genetic condition giving a risk of bowel cancer.  
What is involved? 
 You will be asked to provide a telephone number that you are happy to be contacted on. 
 You will be interviewed on the telephone for about 30-60 minutes, but the interview can 
be stopped at any time if you do not wish to continue. 




 These interviews are completely confidential and they will be made anonymous once 
they have been transcribed (recording put into writing). 
 
What are the risks or benefits of taking part? 
 You will be helping us to find out how to help families at increased risk of bowel cancer  
 You may find it helpful to think about the situation in your own family 
 You may feel anxious or upset when you think about the cancer in your family. 
 You may worry about your family and what they understand about their risk. 
 You may have new questions for your health professional about your risk. 
 
What happens to my answers? 
 The information you provide in the telephone interview will be kept securely on a 
password protected Plymouth University computer and only seen by the researcher and 
her supervisors.  
 
We hope that by providing your views you will be helping us work towards a better service 
for you, your family and other families like yours.   
This study has been reviewed and approved by the NHS research ethics committee and 
Plymouth University. There will be no financial gain to anyone involved in this research. This 
research is being undertaken as part of a full time PhD programme. There are no conflicts of 
interest to declare. 
The interviews are the second part of the Family Web Study.  If the results of the survey and 
interviews indicate that it would be helpful, we plan to create a special website for patients 
to provide and share information with their relatives.  We hope to recruit a total of 350 
people to this study.  The Family Web Study will continue until Spring 2018 to provide 
enough time to gather people’s views, analyse and report the results. 
After that time, all participants will be able to see a summary of the results as they will be 
available online through website links at Bowel Cancer West, Macmillan, Lynch Syndrome 
UK or Plymouth University.  We can also send the results out by post or email on request. 
If you would be happy to be interviewed on the telephone at a time that 
suits you, please ring or email us. 
How to contact us?  Please email: familyweb@plymouth.ac.uk, text or leave a message on 
07784785368 if you have any questions or wish to be interviewed.  We will then contact you 
to ask for your consent and, if you are still happy to, we will arrange a time for the 
interview.  
Thank you for taking the time to read this 
Selina Goodman 
PhD student & Registered Genetic Counsellor  
School of Nursing & Midwifery 







Appendix 21  Telephone Interview Guide Phase 2 
 
Family Web Study 
Study of information given to families with an increased 
risk of bowel cancer and their information preferences  
 
Telephone interview to commence with introduction by researcher. 
 Check identity (or pseudonym). 
 Check PIS read by participant 
 Ask if any questions relating to PIS.  
 If participant wishes to proceed, read through consent form. 
 Read each item and request response. Tick each item, signed & dated. 
 Double check that participant is happy for interview to be recorded. 
 
Likely interview questions re semi-structured interview: 
 Experience of sharing information 
o Can you describe how you first learnt about your increased risk of 
bowel cancer/ risk of cancer in the family? 
o How long ago was that? 
o What information about this were you given then? 
o How were you supported at the time? 
o Can you tell me more about your experience? 
 Information sources, type and method 
o What information have you felt able to share with your/other 
relatives? 
o Can you tell me more about that? 




o How useful were they? 
o What would you like changed or improved in the way information was 
provided to you about the diagnosis/ increased risk? 
 Changes to how healthcare professionals provide information 
o We had questions on the survey about other ways of providing 
information, if you imagine that it was possible to give you information 
about the diagnosis in the family in other ways (e.g follow-up phone 
call, email, etc) how much difference do you think that would make? 
o Why is that? 
o What do you think you would use if it was available?  
 Leaflet, email, website, follow-up appointment, etc? 
 What information is needed and topics 
o What sort of information do you think would be helpful?  
 e.g. healthy lifestyle,  
 symptoms to be alert to,  
 talking to children, etc 
 Genetic testing (if there is a genetic test in the family)  
o What is the situation regarding genetic testing? 
o Have you or your family had any problems being seen in genetics? If 
there were problems, what improvements would you like to see?  
o Do you think that your GP / surgeon/ gastroenterologist has had all the 
support or information they needed?  





 Communication within the family 
o How do you usually contact your family (e.g. by phone, talk, email, 
Skype)? Can you tell me a little more about how you and your family 
communicate normally? 
o What if any difficulties have you had sharing information with your 
relatives about the diagnosis?  
 
 Other suggestions 
o Can you suggest anything else that you think might help other families 
in the same situation in the future? 
o Is there anything else you would like to add? 
Thanks and close. Offer to send letter which they can send to their GP.  Provide contact 







Appendix 22 Research Ethics Committee favourable opinion letter 

















33must only be used to notify NHS/HSC R&D office(s) of amendments, which are NOT categorised as 
Substantial Amendments.  
If you need to notify a Substantial Amendment to your study then you MUST use the appropriate 
Substantial Amendment form in IRAS.  
 
1. Study Information 
 
Full title of study: 
 
Investigation in the use of emails and interactive websites 
for the provision of information by health professionals to 
families at increased risk of colorectal cancer to facilitate 
sharing information by relatives – Family Web Study. 
 
 
IRAS Project ID: 
 
181861 




Sponsor Amendment Notification 
date: 
15th June 2017 
Details of Chief Investigator: 
Name [first name and surname] Selina Goodman 
Address: 8 Kirkby Place, Plymouth University,  
Drakes Circus, Plymouth 
 
Postcode: PL4 8AA 
Contact telephone number: 01752 586584 
Email address: selina.goodman@plymouth.ac.uk 
 
Details of Lead Sponsor: 
Name: University of Plymouth, Drake Circus, 
Plymouth, Devon PL4 8AA 
 
Sponsor Representative 
Contact email address: 
 
pam.baxter@plymouth.ac.uk 
Tel: 01752 437326 / 07484 869104 
Details of Lead Nation: 
 
 
Name of lead nation 
delete as appropriate 
England  
If England led is the study going 
through CSP? 
delete as appropriate 
N/A 
Name of lead R&D office: 
 
Plymouth Hospitals NHS Trust 
 
Notification of Non-Substantial/Minor Amendments(s) for NHS Studies 





2. Summary of amendment(s)  
This template must only be used to notify NHS/HSC R&D office(s) of amendments, which are NOT categorised as Substantial Amendments.  





Brief description of amendment 
(please enter each separate amendment in a new row) 
Amendment applies to  
(delete/ list as appropriate) 
List relevant supporting document(s), 
including version numbers 
(please ensure all referenced supporting documents are 
submitted with this form) 
R&D category 
of amendment  
(category A, B, C) 
For office use only 
Nation Sites Document Version  
1 Amendment required to extend study end date: 
To continue recruitment to Phase 3 Think-Aloud 
interviews to complete iterative process of website 
development for www.familyweb.org.uk. 
Recruitment to this study to continue until 30th 
September 2017. 
England All sites  All documentation remains 
unchanged to those already 
agreed by REC approval, ref: 
15/SW/0250 
  
Wales All sites  
2      
3      
4      
5      







3. Declaration(s)  
 
 
Declaration by Chief Investigator 
 
 I confirm that the information in this form is accurate to the best of my knowledge and I take full responsibility 
for it. 
 
 I consider that it would be reasonable for the proposed amendment(s) to be implemented. 
 
 
Signature of Chief Investigator:       
 
 
Print name:       SELINA GOODMAN 
 
 





Optional Declaration by the Sponsor’s Representative (as per Sponsor Guidelines) 
The sponsor of an approved study is responsible for all amendments made during its conduct.  
The person authorising the declaration should be authorised to do so. There is no requirement for a particular 
level of seniority; the sponsor’s rules on delegated authority should be adhered to. 
 I confirm the sponsor’s support for the amendment(s) in this notification. 
 
 
Signature of sponsor’s representative:  
 
 
Print name: Ms Pam Baxter 
 
 
Post: Research Governance Specialist 
 
 
Organisation: University of Plymouth 
 
 










Appendix 24  Participant Information Sheet Phase 3 
Family Web Study 
Study of information given to families with an increased risk 
of bowel cancer and their information preferences  
We would like you to take part in this study 
 Please read the following information carefully. Take as much time as you need to 
think about it. Ask us for more information if you would like it or if anything is not 
clear. 
 Before you decide whether you wish to take part, it is important that you know why 
the research is being done and what it will involve.  
 If you choose not to take part this will not affect your healthcare in any way. You are 
free to decide what to do. 
---------------------------------- 
We are asking people with an increased risk of bowel cancer in their family to help us test 
and adapt a new website that is aimed to help them. We have already carried out a survey 
of other people in this situation across the UK. We have also interviewed some of those 
people to give us more detailed information about their experiences and their information 
preferences.  
We are aware that it is sometimes difficult to pass on information to relatives about the 
shared risk of cancer in the family.  We think that information could be given in different 
ways but we would like people’s views on this. We are interested in people’s opinions about 
what could be improved or what has been done well. If you have been advised that you 
have an increased risk of bowel cancer due to an inherited vulnerability within the last year 
then we would like your help.  
Why am I being asked to take part?  
You will be eligible to take part if are over 17, you live in England or Wales and: 
 You come from a family with a known genetic condition giving a risk of bowel cancer.  
OR 
 Or you have been advised to have regular bowel screening because of an increased risk. 
OR 
 Or you have had a cancer and you were told that it was due to a genetic vulnerability. 
 
What is involved? 
 You will be interviewed through an online link via your computer, laptop or tablet. This 
will take about 30-60 minutes, but the interview can be stopped at any time if you do not 







 This type of interview is called a ‘Think-Aloud’ interview.  It will be recorded so that what 
you say about the website can be studied and analysed later.  
 You will be asked to provide a telephone number and email address that you can be 
contacted on.  These interviews are completely confidential and they will be made 
anonymous once they have been transcribed (recording put into writing). 
If you wish to take part in the Think-Aloud interview from a location of your choice, you will 
need to have access to a computer, laptop or tablet and be able to go online.  Alternatively, 
we can arrange an interview to take place in Plymouth University if you don’t mind 
travelling there. 
 
What are the risks or benefits of taking part? 
 You will be helping us to find out how to help families at increased risk of bowel cancer  
 You may find it helpful to think about the situation in your own family 
 You may feel anxious or upset when you think about the cancer in your family. 
 You may worry about your family and what they understand about their risk. 
 You may have new questions for your health professional about your risk. 
 
What happens to my answers? 
 The information you provide in the telephone interview will be kept securely on a 
password protected Plymouth University computer and only seen by the researcher and 
her supervisors.  
 
We hope to recruit a total of 350 people to this study. The Family Web Study will continue 
until Spring 2018 to provide enough time to gather people’s views, analyse and report the 
results.  After that time, all participants will be able to see a summary of the results as they 
will be available online through website links at Bowel Cancer West, Macmillan, Lynch 
Syndrome UK or Plymouth University.  We can also send the results out by post or email on 
request. 
This study has been reviewed and approved by the NHS research ethics committee and 
Plymouth University. There will be no financial gain to anyone involved in this research. This 
research is being undertaken as part of a full time PhD programme. There are no conflicts of 
interest to declare. 
If you would be happy to take part in a Think-Aloud interview at a time that 
suits you, please ring or email us. 
How to contact us?  Please email: familyweb@plymouth.ac.uk, text or leave a message on  
07784785368 if you have any questions or wish to be interviewed.  We will then contact you 
to ask for your consent and, if you are still happy to, we will arrange a time for the 
interview.  
Thank you for taking the time to read this  
Selina Goodman 
PhD student & Registered Genetic Counsellor  
School of Nursing & Midwifery 
Faculty of Health & Human Sciences 
Plymouth University 






Appendix 25  Think-Aloud Interview plan – Phase 3 Family Web Study 
 
Send by email link to website www.familyweb.org/home prior to their meeting time. 
10 minutes prior in first round of interviews. 
Once GoToMeeting is launched, introduce yourself and ask if they have read the 
information sheet, consented and are happy to proceed? 
Starting with the home page 
 What are your first impressions? 
 What do you like about it? (images, text, how to locate or navigate onwards) 
 What don’t you like? 
 Why do you think that is?  
 What would you change? 
 Scrolling down? 
Moving on to About Family Web  
 What are your first impressions? 
 What do you like about it? (images, text, how to locate or navigate onwards) 
 What don’t you like? 
 Why do you think that is?  
 What would you change? 




See how you get on with sharing a document with a health professional 
At sign up, stop recording.  
After sign up Press RECORD again to record rest of interview. 
 









The above screenshot was provided as a preview of the ‘home’ page of the website to 
inform the Research Ethics committee regarding the application for a substantial 
amendment prior to conducting the Think-Aloud interviews in Phase 3. 




Appendix 27  Matrix of Think-Aloud interview with ‘Freya’ #4 showing analysis by website area 
Area of site Positive Negative My reaction Change 
Overview  Had to zoom out as felt right “in 
there” so picture appeared too 
large. 
Probably how the website 
is viewed alters this aspect. 
Adaptive viewing needs to 
be flexible for use on small 
screens like smartphones 
as well as larger monitors. 
Discuss banner with web 
developer 
 
Home page Yes, it looks nice, it looks good.  
 
Will it get an NHS badge? 
Not 100% sure where to go as not 
sure whether to click on patient or 
family member. Doesn’t like the 
term ‘patient’ for people at risk. 
And Bowel Cancer West, is that? 
What organisation is this? I just 
don’t know... 
Need more explanation 
about what website is 
about. 
 
Create graphic to illustrate 
function of the website. 
About Family 
Web 
OK The other thing I wondered was 
about the login, what is.. what 
happens when someone logs in? 





But it all looks pretty necessary, it 
is not as if there are big junks of 
text, it is just that I have become 
accustomed to having about three 
lines to read.. yes, I think it is all 
pretty clear 
Quite a lot of text. Used to other 
websites with big words and not 
many of them.  
Typo “online online” needs 
to be corrected 
Correct typo 
Patient sign up Apparently no problem    
Document 
sharing 
This would be really useful to keep 
documents that are relevant to me 
and access them where ever I am. 
 
Successfully tested function of 
sharing documents and creating 
text file. 
That’s really cool! 
Didn’t understand use of blue 
folder icon 
Another user who doesn’t 
understand the relevance 
of the blue folder icon. It’s 
an important feature so 
needs to be modified. 
Change blue folder icon to 
some words to indicate sharing 
files. 
Member     






“Big and cheesy pictures” 
Your journey 
 
    
Before 
diagnosis 
 Once I am a patient I already 
know about this stuff 
Add headings that direct 
family members to the 




 I think there may be too much 
text, but some people like 
knowing what there is.  
Who can leave comments here? 
Could add instructions near 
comments boxes 
 
Living your life  This is what I was particularly 
interested in, the prevention angle. 
 
Diagram about effects of food too 
complicated 
Put more emphasis on how 
healthy lifestyle can have a really 
important effect on you if you 
have an inherited vulnerability. 
This is really interesting    
Add new text to top of 
lifestyle page to emphasise 
the relevance of these 
factors to people with 
genetic diagnosis. 





Oh good, you have some links Are there any counselling links? 
Useful to have somewhere if you 
are feeling distressed talk to your 
genetic counsellor 
  
Contact  Doesn’t like image. The banner 
pictures are too big 
Could add content to invite 
feedback to the contacts 
page. 
 
Comments   Uncertain what sort of comments 
are expected. 
Worried about people leaving 
inappropriate comments. 
Check method of 





Very thoughtful throughout. Works 
for CRUK so very familiar with 
website design. 
Wonder if a feedback section 
would be useful? 
 Useful concept that website 
could act as safe storage of 
medical documents for 


















Appendix 29  Process of communication developed from Forrest et al 2008 used in presentation to clinical colleagues 
 
 
Representation of the process of communication with families developed from Forrest et al 2008 

















Focusing on their needs or 
their child’s needs 
Communication continues 















Appendix 31  Poster presented at European Society of Human Genetics Annual 





Appendix 32 Poster presented at the International Society for Nurses in 





Appendix 33 Poster presented at the Joint UK/Dutch Clinical Genetics 



















Appendix 35 Specification of Family Web website security 
Family Web Study Website Security 
 
(described by Damien, web developer from Modern Websites) 
 
Site Security 
All connections to the website are secure and use https   protocol.  
That is, all communication from browser to website and back is encrypted. 
The site is verified as secure by cPanel Inc with SSL (Secure Sockets Layer) certificates.  
Email security 
Emails from the website are sent using SSL from the website.  
There is no guarantee that recipients have SSL connection set up their end. Some users may 
have badly set up accounts. These options are available whenever you set up the connection 
details for a new email account. 
It is likely that all NHS health professionals have SSL security set up on their email accounts. 
 
Website passwords are encrypted using a 512 bit hash and cannot be viewed by anybody 
(even me). 
eg the password 'Hell0ee' is stored as 
5eb93e3a849b3c41ee0f96430296e44e5becb6f6314b63f59e96e945d755a1b2abbf4dfda721
edf93503e0c16e2f2f410b7161376f35fc44b422c0f8b8671794 
We do not store any personal information about any user (HP or Patient) other than name, 
email address and the encrypted password, although their uploaded files and any 
connection to health professionals and family members are potentially sensitive. Patients 
will only enter name, relationship type and email address for their family members. 
File Security 
The files themselves are protected from external access by obscured location and a 10 digit 
alphanumeric code, stored in the database, which is never exposed on the site.  
Even when files are viewed, the real location is still disguised; the contents are recreated as 
required on a single ‘viewer’ page and only if the current user has appropriate privileges. If 





Once the files are saved to disk by a family member or other user, they can then be shared 
beyond the website, this is therefore outside the control of the system. 
There are multiple tiers of access requirement within the code for each document and 
account. 
Login 
The login script uses ‘pre-prepared sql statements’ to avoid sql injection. (SQL means 
Structured Query Language). 
Internal password for critical functions 
Most of the critical functions within the membership system have an extra layer of security 
and can only be performed from the appropriate, specific page on the website.  
Therefore it is impossible to perform anything like upload files, add family members etc 
from anywhere other than the appropriate web page on the site and when logged in as an 
appropriate member. Each function has it’s own hidden password that is passed from page 
to page. This is for added protection against direct access by robot scripts, even if they did 









Appendix 36  Factors influencing communication in families 
 
Map of factors influencing communication and their relationships to other factors taken 
from qualitative analysis of Phase 2 interviews (n=14)(Chapter Seven) 
Lower cluster represents motivational factors (green), inhibiting factors (red), influences that 
can be either motivational of inhibiting depending on circumstance (blue) and how the method 





















   






From: Selina Goodman 
Sent: 21 October 2015 10:49 
To: -------------------------- 
Subject: website development  
Attachments: Family web planning.pptx 
Dear ‘-----------------’  
  
You were recommended to me by Dr Chloe Grimmett at Southampton University.  I am currently looking for a 
webdeveloper to build a website that will function as part of my PhD investigating the use of electronic 
communication methods for sharing information in families where there is an increased risk of bowel cancer. One 
of the main reasons this is not occurring already is due to concerns regarding data security and breach of 
confidentiality.  
  
Therefore I have made some investigations into existing platforms that provide facilities for sharing data securely 
re health. I have spoken to people at both Southampton and Torbay NHS trusts regarding their use of the PHR 
platforms HealthVault and Patients Know Best (PKB) respectively, as both these allow sharing with third parties 
and an ability to choose what level of access different individuals have, plus they are already in use in the NHS.  
  
Currently different NHS trusts have different rules about email and some don’t allow any email traffic between 
health care professionals and patients. I would like to design something that is easy to use but secure enough to 
meet the NHS criteria. On that basis it may be that a patient needs to register with a site first and then ‘invite’ 
their health care professional to upload files to their area within the website, which the patient can then choose 
to share with trusted others, ie relatives. However what I would prefer is where a health professional could pre-
prime a site with patient specific information and then invite the patient to access it. The advantage of the patient 
taking ownership of the information and who can access it, is that then the responsibility for that data 
confidentiality passes to the patient.  
  
My research question is:  
“Can the use of emails or interactive websites for the provision of diagnostic information by health professionals to 
families at increased risk of bowel cancer facilitate information sharing by relatives?”  
  
This project aims to improve the outcomes of individuals with an increased risk of bowel cancer by seeking to 
increase bowel cancer awareness, screening uptake and early cancer detection through facilitating information 
sharing in these families, via secure electronic communication methods.  
  
Summary: A significant proportion of people with bowel cancer will have inherited a genetic predisposition to 
their cancer. Other members of their families will also have an increased risk of bowel cancer if they have 
inherited the vulnerability too.  Those individuals who have been recommended to have regular bowel screening 
by colonoscopy will have been advised to warn their relatives of their risk.  However, evidence indicates that only 
a minority of relatives access screening or genetic testing.   
  





Many different factors can impede communication, but in families with an increased risk of cancer, there are 
significant potential benefits to relatives if that information can help them access appropriate screening or be 
alert to early symptoms of disease.  
Email is commonly used to communicate; although it is still used less frequently in healthcare than in other 
arenas.  Improving technology has enabled greater data security for the use of email in healthcare.  Therefore, 
password protected patient portals and websites could provide new opportunities for family members to share 
information that has been provided by their healthcare professional in a quick and secure manner.  
  
Through this research we are seeking to develop improved methods of information provision, focussing on making  
information available electronically in order to facilitate sharing.  
  
1 
Phase 1 : A cross-sectional survey will be administered via websites, following genetics advice and at screening 
clinics to around 300 adults to find out the experiences and opinions of people at increased risk of bowel cancer 
about methods of sharing information.  
  
Phase 2 : Semi-structured telephone interviews of a purposive sample of 20 respondents to the survey will seek to  
capture more detailed opinions about how to improve supportive information .   
  
Phase 3 : A website will be developed and tested by 30 users through ‘Think-Aloud’ interviews to check acceptability  
and uptake. More comprehensive assessment of the impact of the website is anticipated as part of post-doctoral  
work, but hit rates and conversion ratios will be reported within the scope of this project.  
  
We intend to disseminate a summary of the results online through Macmillan, Lynch Syndrome UK, Bowel Cancer  
West, Plymouth University and participating NHS Trusts in October 2017.  
  
Therefore in anticipation of the website development I have been investigating possible PHR platforms which are 
currently in use within the NHS. The specific requirements we need is that:   
• Clinicians (in genetics, surgery or gastroenterology) could upload information about the diagnosis in the 
individual.  
• Patients with a diagnosis can choose to share that information with specific relatives electronically.  
• Relatives could download, print or share (on a device such as a smart phone or tablet) the information to 
show their GP.  
• This is secure, maintaining the confidentiality of the patient.  
  
I now have NHS research ethical approval and I am about to commence the online survey phase of my study. In 
terms of budget, I have recently been awarded a small research grant, which allows £4.5K for website 
development. I attach a short PowerPoint which gives some back additional information regarding my ideas for 
the website. In conclusion, I am now looking for tenders from potential collaborators/ web developers with 
whom I can work to set up an appropriate website, would you be interested?  
  










From: Selina Goodman 
Sent: 04 November 2015 14:48 
To: info@modernwebsites.co.uk 
Cc: Ray Jones; Heather Skirton 
Subject: RE: Website 
Attachments: SGoodman _Family Web timeline.docx 
Dear Damien  
  
Thank you very much for your email; you just beat me to it, I was planning to email you today and I am sorry if I 
had gone quiet on you.   
  
Ray and I had a long discussion last week and we agreed what we need to do in the process of developing the 
website ( I had been jumping a few steps). Since we are trying to develop something very much in response to 
user (families at increased risk of bowel cancer) needs and preferences we will have to wait for the results of the 
online survey and initial interviews before setting up too much function in the website. However we will need to 
mock up (stage1) a website and present that to my current group of patient advisors, with a view to showing the 
resultant (stage2) mock up to the interviewees to gauge their opinion of it. I will have to do the mock up but I 
would welcome some input from you regarding attractive design. I will need to ask my patient advisors to look at 
the first mock up during December/January with a view to having something available for interviewees to 
comment on by February.   
  
Then following the results of the interviews we could set up the first interactive/functioning website (stage3) for 
our first phase of user testing. Ray has advised me that in these early stages we do not need to have the function 
of the clinician uploading or populating the website with documents but we need to set up the front end and 
establish how many and what functions are key to the users.   
  
We have planned six phases of user testing, with the feedback via ‘think-aloud’ interviews carried out remotely so 
that we can recruit participants from across England and Wales. All the participants in the user testing of the 
website will have been recruited from clinical genetics services so they will be people who are genuinely 
experiencing the issue of how to inform their relatives about the diagnosis in their family. We may also wish to 
involve some of the clinicians who would be contributing documents to the website, although that would require 
a change in my protocol and an application to the ethics committee. We would also like to create a short 
feedback survey from the website which could capture the views of users who could be either patients or their 
relatives.  
  
I am currently gathering responses from my patient advisors in the process of validating the survey questionnaire 
prior to it going live online. I attach a copy of my timeline for the study for your information. In a nutshell, there is 
not much to do just yet although I would welcome a chance to talk to you, even by telephone.   
  





Would you like to plan a time for me to call you?   
  






From: Damien Soskin [mailto:info@modernwebsites.co.uk]   
Sent: 04 November 2015 13:16  
To: Selina Goodman  
Subject: Website  
  
Hi Selina  
  
I thought I would just jot you a message to say that I am here if you need any further information or 
would like to discuss your website further.  
Please let me know.  
  
I am confident that I can make you a great website that meets your requirements.  
  
If you would like to move forward with the site, it would probably be beneficial to arrange a SKYPE chat 
to discuss the development in further detail.  
  
Kind regards  
Damien  
  
--   
  
  
www.modernwebsites.co.uk  info@modernwebsites.co.uk   
Skype: damiensoskin  
01273 509762  
07752 222144  
Twitter: modernwebsites  














Appendix 42 PowerPoint slides describing ‘Your Journey’ concept to webdeveloper 
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